fluorodeoxyglucose f18 has been researched along with Lymphoma in 741 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (0.27) | 18.7374 |
| 1990's | 31 (4.18) | 18.2507 |
| 2000's | 229 (30.90) | 29.6817 |
| 2010's | 354 (47.77) | 24.3611 |
| 2020's | 125 (16.87) | 2.80 |
| Authors | Studies |
|---|---|
| Fujimoto, S; Ishishita, Y; Kawai, K; Koide, R; Mashiko, T; Matsuzono, K; Ohtani, K; Ozawa, T; Tanaka, R; Yagisawa, T; Yamaguchi, T | 1 |
| Ghazali, MW; Khoo, CH; Mahaletchumy, T; Ng, CS; Tan, TH; Wong, TH | 1 |
| Andersen, FL; Berthelsen, AK; Borgwardt, L; Dejanovic, D; Hjalgrim, LL; Lundgaard, AY; Maraldo, MV; Rechner, LA; Specht, L | 1 |
| Itti, E | 1 |
| Ahn, SS; Batchelor, TT; Chai Jung, S; Gon Choi, C; Guenette, JP; Han, K; Hong Choi, S; Hoon Kim, J; Huang, RY; Hyun Suh, C; Joon Kim, S; Kim, HS; Lee, SK; Min Lee, S; Nayak, L; Park, JE; Seong, M; Tae Kim, S | 1 |
| Lu, T; Yang, G | 1 |
| Farhadi, F; Hasani, N; Morris, MA; Paravastu, SS; Rahmim, A; Roschewski, M; Saboury, B; Summers, RM; Yousefirizi, F | 1 |
| Dai, D; Hazle, JD; Jaffray, D; Jimenez, JE; Li, T; Lin, Y; Lu, Y; Macapinlac, HA; Pan, T; Wang, L; Wang, Z; Wu, J; Xu, G; Zhao, R | 1 |
| Chen, M; Dong, A; Hu, Y; Li, H; Ran, P | 1 |
| Georgopoulou, AN; Lakiotaki, E; Sipsas, NV; Skoura, E; Vassilakopoulos, TP | 1 |
| Beyar-Katz, O; Cohen, D; Even-Sapir, E; Perry, C | 1 |
| Dietrich, S; Do, TD; Gehling, K; Giesel, FL; Haberkorn, U; Kauczor, HU; Mokry, T; Weber, TF | 1 |
| Ahmed, DAT; Al Kandari, F; Pinto, K; S Elhaggracy, R; Usmani, S | 1 |
| Georgi, TW; Kluge, R; Körholz, D; Kornrumpf, K; Kurch, L; Mauz-Körholz, C; Posch, S; Sabri, O; Zieschank, A | 1 |
| Derlon, JM; Gourand, F; Guillouet, S; Kalaeva, D; Khokholova, E; Kobyakov, G; Maryashev, S; Pitskhelauri, D; Postnov, A; Potapov, A; Pronin, I; Pyzhik, E; Rizhova, M; Toutain, J; Usachev, D; Valable, S; Vikhrova, N | 1 |
| Al-Hammadi, N; Chandramouli, SH; Divakar, SR; Gurusamy, VM; Hammoud, RW; Usman, M | 1 |
| Kaushik, P; Tripathi, M | 1 |
| Hui, SY; Nambiar, M; Ramdave, S; Wong, A | 1 |
| Backhus, LM; Berry, MF; Bhandari, P; Byrd, CT; Konsker, HB; Liou, DZ; Lui, NS; Moradi, F; Shrager, JB; Trope, WL | 1 |
| Akashi, K; Baba, S; Iawasaki, H; Ishigami, K; Kamesaki, K; Kato, K; Kikushige, Y; Kunisaki, Y; Miyamoto, T; Miyawaki, K; Mori, Y; Numata, A; Shima, T; Sugio, T; Takashima, S; Takenaka, K; Urata, S; Yoshimoto, G | 1 |
| Almeida Filho, PJ; Brandão, SCS; Dompieri, LT; Dourado, MLC; Leitão, GM; Markman Filho, B; Melo, MDT; Mourato, FA; Santos, RGG | 1 |
| Chan, LWC; Chiu, KWH; Jiang, L; Qiu, J; Wei, X; Yuan, H; Zhang, F | 1 |
| Cui, BP; Wang, P | 1 |
| Jiang, Y; Li, H; Wang, L; Wu, H; Zhang, Y; Zhou, W | 1 |
| Cao, X; Li, F; Li, J; Luo, Y; Pan, Q | 2 |
| Kang, HJ; Lee, I; Lee, KC; Lim, I; Lim, SM | 1 |
| Ao, Y; Chen, G; Cheng, L; Ding, J; Gao, J; Jiang, J; Lin, M; Lin, Z; Shi, H; Wang, S; Yang, X | 1 |
| Hu, Y; Jiang, Y; Li, Y; Li, Z; Sun, H; Tang, S; Wang, J; Wu, X; Zeng, J; Zhang, X; Zhao, Y; Zhou, Y | 1 |
| Eich, HT; Kobe, C; Oertel, M; Pepper, NB; Rehn, S | 1 |
| Aleem, J; Aziz Qureshi, PAA; Bashir, H; Hassan, A; Niazi, IK | 1 |
| Ceccato, F; Cecchin, D; Crimì, F; Evangelista, L; Lacognata, C; Trentin, L; Visentin, A; Voltan, G | 1 |
| Bian, Y; Hu, Y; Tian, C; Wei, Q; Zhang, X | 1 |
| Attané, G; Bousson, V; Nguyen, PT; Polivka, M; Sibileau, E | 1 |
| Fendler, WP; Herrmann, K; Pomykala, KL; Seifert, R; Umutlu, L; Vermesh, O | 1 |
| Cagdas, B; Görtan, FA; Gülaldi, NCM | 1 |
| Bai, S; Guan, Y; Hao, Y; Liu, J; Shao, H; Xin, M; Zhang, C | 1 |
| Honda, T; Inoue, A; Kanno, K; Kinnami, S; Kitazawa, R; Kunieda, T; Kurata, M; Kusakabe, K; Matsumoto, S; Miyazaki, Y; Ohnishi, T; Shigekawa, S; Suehiro, S; Taniwaki, M; Watanabe, H; Yamashita, D | 1 |
| Hapgood, G; Law, WP; Miles, KA; Mistry, V; Mollee, P; Scott, JR; Wang, TY | 1 |
| Huang, WS; Lan, WZ; Li, Y; Liang, J; Xu, JH | 1 |
| Chen, L; Li, J; Li, K; Pu, Y; Sun, H; Wang, C; Wang, Y; Xiang, A; Xie, R; Yang, C; Zhao, S | 1 |
| Farhadi, F; Hasani, N; Nikpanah, M; Roschewski, M; Saboury, B; Summers, RM; Veziroglu, EM | 1 |
| Chinot, O; Graillon, T; Guedj, E; Horowitz, T; Salgues, B; Tabouret, E; Verger, A | 1 |
| Barrington, SF; Georgi, TW; Hasenclever, D; Kluge, R; Kurch, L; Pike, L; Radford, J; Sabri, O; Warbey, VS | 1 |
| Asou, C; Asou, N; Ishikawa, M; Kayano, H; Kohri, M; Maeda, T; Matsuda, A; Okamura, D; Satoh, T; Takahashi, N; Tsukasaki, K; Yamaguchi, O | 1 |
| Alfieri, G; Assanto, GM; Catalano, C; De Maio, A; De Vincentis, G; Di Rocco, A; Frantellizzi, V; Gentiloni Silveri, G; Maccioni, F; Martelli, M; Mattone, M; Pulsoni, A; Viola, F | 1 |
| Dierks, A; Enke, JS; Gäble, A; Hirschbühl, K; Kircher, M; Lapa, C; Reitsam, NG; Schaller, T; Trepel, M; Welzel, J | 1 |
| Asante-Korang, A; Brown, AK; Carapellucci, J; Gomez, A; Meoded, A; Oshrine, B | 1 |
| Attarbaschi, A; Beishuizen, A; Buerke, B; Cepelova, M; Ceppi, F; Damek, A; Dieckmann, K; Fernández-Teijeiro, A; Fosså, A; Franke, FC; Georgi, TW; Hasenclever, D; Hraskova, A; Karlen, J; Klekawka, T; Kluge, R; Körholz, D; Kurch, L; Landman-Parker, J; Leblanc, T; Mauz-Körholz, C; Moellers, M; Steglich, J; Stoevesandt, D; Uyttebroeck, A; Vordermark, D; Wallace, WH; Wohlgemuth, WA | 1 |
| Barrington, SF | 1 |
| Dai, W; Feng, H | 1 |
| He, Y; Li, P; Li, Y; Yang, J; Zhao, W | 1 |
| Cai, L; Chen, Y; He, X; Shu, Q | 1 |
| Zirakchian Zadeh, M | 1 |
| Adam, JA; de Boer, JW; Diepstra, A; Jak, M; Kersten, MJ; Kleinjan, A; Koens, L; Kuipers, MT; Mutsaers, PGNJ; Niezink, AGH; Pennings, ERA; Spanjaart, AM; van der Poel, MWM; van Doesum, JA; van Dorp, S; van Meerten, T; Vermaat, JSP | 1 |
| Cheng, Y; Lu, KY; Shao, D | 1 |
| Bhalla, D; Jana, M; Kandasamy, D | 1 |
| Mei, H; Qin, C; Tan, Z; Wang, J; Yang, M; Zhang, L; Zhang, X | 1 |
| Kasibhatla, MS; Koontz, BF | 1 |
| Maruyama, D; Munakata, W; Nagai, H; Terauchi, T | 1 |
| Cayci, Z; Dincer, E; Linden, MA; Omer, AK; Ozturk, K; Peterson, BA; Sachs, Z; Ustun, C | 1 |
| Avila, NA; Carrasquillo, JA; Chen, CC; Jaffe, ES; Pittaluga, S; Price, S; Rao, VK; Whatley, M | 1 |
| Ma, X; Ou, X; Pang, F; Wang, J; Wang, Y; Wei, X; Zhang, J | 1 |
| Bloom, DA; Hutchinson, RJ; Sedig, LK; Shulkin, BL; Wong, KK | 1 |
| Banks, KP; Christensen, CT; Peacock, JG | 1 |
| Adams, HJA; Kwee, TC | 9 |
| Froelich, JW; Salavati, A | 1 |
| Jin, Q; Li, H; Qiao, Y; Wang, X; Yi, X; Zhang, L | 1 |
| Büyükşimşek, M; Güney, İB; Kolsuz, İ; Mirili, C; Oğul, A; Paydaş, S; Tohumcuoğlu, M; Yetişir, AE | 1 |
| Bordenave, L; Bouabdallah, K; Hindié, E; Mesguich, C; Milpied, N | 1 |
| Appaduray, SP; Chan, J; Khoo, J; Somasundaram, N; Yan, SX | 1 |
| Adhikari, N; de Idiaquez Bakula, DA; Singhal, A; Sotoudeh, H | 1 |
| Miao, W; Xue, Q | 1 |
| Chen, Y; Liu, H; Liu, L | 1 |
| Dietrich, S; Flechsig, P; Mokry, T; Weber, TF | 1 |
| He, Y; Li, C; Tian, Y; Wen, B; Zhang, Y | 1 |
| Scott, JA; Wang, Y | 1 |
| Haug, A; Mayerhöfer, ME | 1 |
| Currie, GM; Sanchez, S | 1 |
| Beheshti, M; Heinzel, A; Lindemann-Docter, K; Mottaghy, FM; Mueller, M; Schwerz, S | 1 |
| Autore, F; Fresa, A; Innocenti, I; Laurenti, L; Paolini, A; Sica, S; Sora, F; Zini, G | 1 |
| Dormont, D; Galanaud, D; Kas, A; Pyatigorskaya, N; Soussain, C | 1 |
| Cervati, V; Diegoli, M; Fanti, S; Golfieri, R; Monteduro, F; Mosconi, C; Zanoni, L | 1 |
| Bilwani, R; Chaudhry, A; Gorlin, D; Gul, M; Imam, MH; Khan, S; Muhammad, A; Naim, S; Salem, A | 1 |
| de Vries, EGE; Diepstra, A; Glaudemans, AWJM; Jorritsma-Smit, A; Kahle, XU; Kwee, TC; Lub-de Hooge, MN; Montes de Jesus, FM; Nijland, M; Noordzij, W; Plattel, WJ; van den Berg, A; van Meerten, T | 1 |
| Li, L; Ma, W; Qian, Z; Qiu, L; Song, Z; Wang, X; Xu, W; Zhang, H; Zhao, P; Zhou, S; Zhu, L; Zhu, X | 1 |
| Argnani, L; Bacci, F; Broccoli, A; Cappelli, A; Fanti, S; Gasbarrini, A; Ghermandi, R; Golfieri, R; Nanni, C; Piovani, C; Sabattini, E; Tabacchi, E; Zinzani, PL | 1 |
| Iltis-Roux, A; Leroy-Freschini, B; Nicolae, A | 1 |
| Antke, C; Arlt, W; Beuschlein, F; Casasnovas, O; Chortis, V; Fassnacht, M; Gattermann, N; Germing, U; Gimm, O; Haas, R; Haase, M; Habra, MA; Ho, ATN; Kanji, A; Kondakci, M; Laurent, C; Limvorapitak, W; Majidi, F; Martino, S; Petit, JM; Ronchi, CL; Rudelius, M; Salvatori, R; Schott, M; Spyroglou, A; Villa, D; Wahlin, BE | 1 |
| Chen, Y; Fu, W; Xu, T; Zhang, X | 1 |
| Mayerhoefer, ME; Schöder, H; Umutlu, L | 1 |
| Li, W; Lin, Z; Meng, Z; Yin, L; Zhen, Y | 1 |
| Friedberg, J; Li, H; Schoder, H; Stephens, DM | 1 |
| Fotopoulos, A; Hatzimichael, E; Kiortsis, DN; Prieto Prieto, JC; Sioka, C; Vallejo Casas, JA | 1 |
| Boustani, AM; Kulon, ME; Pucar, D; Young, CR | 1 |
| Jeong, J; Kim, SW; Sung, DH | 1 |
| Fan, W; Hu, YY; Li, YH; Long, W; Zhang, X; Zhao, YM; Zhou, C | 1 |
| Huot Daneault, A; Le Blanc, R; Rousseau, E; Turcotte, É; Voyer, N | 1 |
| Kim, K; Kim, SJ | 1 |
| Green, C; Lyburn, ID; Nawwar, AA; Searle, J | 1 |
| Brendle, C; Grams, E; la Fougère, C; Pfannenberg, C; Soekler, M; Stefan, N | 1 |
| El Khoury, M; Lalonde, L; Maietta, A; Mesurolle, B; Tran, A; Trop, I | 1 |
| Chen, P; Jiang, M; Zheng, J | 1 |
| Conti, M; Costa, PF; Fendler, WP; Herrmann, K; Hofferber, R; Jentzen, W; Kersting, D; Rischpler, C; Sraieb, M; Umutlu, L; Weber, M | 1 |
| Bogoni, M; Cerci, JJ; Cornelis, FH; Kirov, AS; Nanni, C; SchÖder, H; Shyn, PB; Sofocleous, CT; Solomon, SB; Tabacchi, E | 1 |
| Cai, J; Lin, Z; Miao, W; Yao, S; Zhang, Y | 1 |
| Lu, Y; Xu, G | 1 |
| González Mínguez, C; Loras, C; Martín-Cardona, A; Vall-Llovera Calmet, F | 1 |
| Kung, HF; Li, N; Xu, X; Yang, Z; Zhu, H | 1 |
| Chen, Y; Gong, W; Yang, X | 1 |
| Liu, J; Liu, X; Shi, A; Wang, J | 1 |
| Alizadeh, H; Balogh, P; Dezső, D; Hegedűs, N; Horváth, I; Jia, X; Máthé, D; Ritter, Z; Schmidt, E; Szöllősi, D; Tuch, D; Vyas, K; Zámbó, K | 1 |
| Hatakeyama, J; Oda, M; Ono, T; Shimizu, H; Takahashi, M | 1 |
| Baraniskin, A; Frey, AV; Herrlinger, U; Korfel, A; Kowalski, T; Ladigan-Badura, S; Margold, M; Schlegel, U; Schmidt-Wolf, IGH; Schroers, R; Seidel, S | 1 |
| Abe, T; Enomoto, H; Harada, M; Matsuzaki, S; Mitsuhashi, R; Onishi, H; Otomi, Y; Otsuka, H; Sakamoto, Y; Sasahara, M; Shinya, T; Shono, N; Takaoka, Y | 1 |
| Georgi, TW; Hirsch, FW; Sorge, I | 1 |
| Chen, C; Chen, G; Chen, W; Du, X; Huo, C; Lin, M; Zhou, S | 1 |
| Li, L; Wang, Y; Xiao, L | 1 |
| A-Risheq, MZ; Alhouri, A; Juweid, ME; Mottaghy, FM; Mueller, M | 1 |
| Chen, Z; Dong, H; Huang, J; Liu, C; Liu, E; Liu, Z; Wang, S; Xie, Q; Xu, W | 1 |
| Du, B; Li, X; Li, Y; Wang, S | 1 |
| Chen, B; Gao, F; Li, C; Li, Z; Shi, L; Sun, W; Wang, P | 1 |
| Cottereau, AS; Meignan, M; Mikhaeel, NG; Specht, L | 1 |
| Bordonne, M; Boursier, C; Campidelli, A; Perrin, M; Verger, A | 1 |
| Albano, D; Camoni, L | 1 |
| Berthelsen, A; Milgrom, SA; Rechner, L | 1 |
| Ji, Z; Jiang, H; Ke, S; Li, A; Liao, S; Tian, M; Zhang, H | 1 |
| Asadian, S; Hemmati Komasi, MM; Hosseini, L; Rezaeian, N; Toloueitabar, Y | 1 |
| Abbou, S; Courbage, S; de Pontual, L; Escudier, A; Galerne, A; Gaudelus, J; Houlier, M; Meignin, V; Sauvion, S; Simonin, M | 1 |
| Kostakoglu, L | 2 |
| Coche, E; Guischer, N; Houssiau, FA; Lhommel, R; Roelants, V | 1 |
| Kaste, SC; Metzger, M; Shulkin, BL | 1 |
| Ben Bouallègue, F; Cartron, G; Kafrouni, M; Mariano-Goulart, D; Tabaa, YA; Vauchot, F | 1 |
| Chen, Z; Jiang, J; Leng, H; Pan, M; Tong, J; Zou, Y | 1 |
| Berriolo-Riedinger, A; Bozzetto, J; Djaïleb, L; Dubreuil, J; Giammarile, F; Leenhardt, J; Meignan, M; Salles, G; Skanjeti, A; Tordo, J | 1 |
| Bird, D; Cosgrove, V; Gilson, D; Patel, C; Prestwich, RJD; Scarsbrook, AF; Thomas, E | 1 |
| Arranz, R; Cabezas, B; Cannata, J; Carreras, JL; Colletti, PM; Del Campo Del Val, L; Delgado-Bolton, RC; García, M; Gómez León, N; González Ortega, S; López-Botet, B; Mateo, M; Pérez Sáez, MÁ; Rodríguez-Vigil, B; Rubello, D | 1 |
| Armitage, JO; Bhatt, VR | 1 |
| Agarwal, R; Klencke, B; Messmann, R; O'Neal, M; Scarimbolo, R; Sokol, L; Strafaci, JA; Tunc, F; Van Heertum, RL; Wolodzko, JG | 1 |
| Hou, S; Shen, J; Tan, J | 1 |
| Becher-Boveleth, N; Bockisch, A; Broecker-Preuss, M; Dührsen, U; Müller, S | 1 |
| Huh, J; Jo, JC; Kang, EH; Kim, JH; Kim, S; Lee, K; Lee, SW; Park, CS; Park, JS; Ryu, JS; Suh, C; Yoon, DH | 1 |
| Barta, SK; Doss, M; Reddy, S; Tokar, JL; Wang, TP; Yu, JQ | 1 |
| Arakawa, Y; Fushimi, Y; Miyamoto, S; Okada, T; Togashi, K; Yamamoto, A; Yamauchi, M | 1 |
| Cottereau, AS; Meignan, M | 1 |
| Hatakenaka, M; Himi, T; Kamekura, R; Takahashi, H; Takano, K; Yajima, R; Yama, N; Yamamoto, M | 1 |
| Hu, N; Wang, Y; Yang, X | 1 |
| Chasen, BA; Lu, Y; Macapinlac, HA | 1 |
| Guerra-Garcia, P; Hirsch, S; Levine, D; Taj, M | 1 |
| Gates, EL; O'Brien, MM; Qi, Z; Trout, AT | 1 |
| Giraudo, C; Jaeger, U; Karanikas, G; Mayerhoefer, ME; Raderer, M; Simonitsch-Klupp, I; Weber, M | 1 |
| Albano, D; Bertagna, F; Bertoli, M; Bosio, G; Giubbini, R | 1 |
| Hashimoto, N; Kamada, H; Nishio, A; Takahashi, Y; Yamamoto, D | 1 |
| Blaufox, MD; Freeman, LM | 1 |
| Gallamini, A; Zwarthoed, C | 1 |
| Li, F; Luo, Y; Ma, Y; Pan, Q; Wu, H | 1 |
| Berriolo-Riedinger, A; Casasnovas, O; Cottereau, AS; Courbon, F; Kanoun, S; Kraeber-Bodéré, F; Meignan, M | 1 |
| Aide, N; Damaj, G; Fruchart, C; Gac, AC; Lasnon, C; Nganoa, C; Salomon, T | 1 |
| Lin, M; Lin, P; Naik, N | 1 |
| Arimoto, MK; Higashi, T; Ishibashi, M; Ishimori, T; Nakamoto, Y; Togashi, K | 1 |
| Jiang, W; Wang, Q; Wang, Z; Xue, H; Zhang, X; Zhao, C | 1 |
| Colletti, PM; Delgado-Bolton, R; Esposito, G; Jadvar, H | 1 |
| Aide, N; Enilorac, B; Lasnon, C | 1 |
| Murakami, T; Nogami, M; Shirai, T; Zen, Y; Zeng, F | 1 |
| Barrington, S; Boellaard, R; Dührsen, U; Hoekstra, OS; Johnson, PWM; Kobe, C; Mikhaeel, NG; Müller, S; Zijlstra, JM | 1 |
| Bechter, O; De Keyzer, F; De Paepe, KN; Dierickx, D; Janssens, A; Oyen, R; Vandecaveye, V; Verhoef, G; Wolter, P | 1 |
| De Renzo, A; Del Vecchio, S; Ferrara, IL; Fonti, R; Mainolfi, CG; Marano, L; Pace, L; Pane, F; Pellegrino, S; Salvatore, B; Selleri, C | 1 |
| Donald, J; Sanders, V; Siegel, BA | 1 |
| Cen, XN; Chen, Q; Dong, YJ; Liang, ZY; Liu, W; Ou, JP; Qiu, ZX; Ren, HY; Sun, YH; Wang, LH; Wang, MJ; Wang, Q; Wang, WS; Yin, Y; Zhu, LT | 1 |
| Albano, D; Battistotti, M; Bertagna, F; Bertoli, M; Giubbini, R; Rodella, C; Statuto, M | 1 |
| Baech, J; Cheah, CY; El-Galaly, TC; Gormsen, LC; Lo, A; Villa, D | 1 |
| Aide, N; Lasnon, C; Salomon, T | 1 |
| Keramida, G; Pencharz, D; Peters, AM | 1 |
| Ilhan, G; Kavvasoglu, GH; Ucar, E; Yalcin, H | 1 |
| Ding, CY; Li, TN; Tang, B | 1 |
| Garip-Kuebler, A; Hintschich, C; Klingenstein, A; Mueller-Lisse, UG | 1 |
| Barré, L; Fillesoye, F; Gourand, F; Guillouet, S; Hovhannisyan, N; Ibazizene, M; Plancoulaine, B; Toutain, J; Valable, S | 1 |
| Basques, K; Behzadi, AH; Carrino, JA; Gholamrezanezhad, A; Jadvar, H; Kosmas, C; Matcuk, GR; Patel, J; Raza, SI | 1 |
| Bailly, C; Béné, MC; Blin, N; Bodet-Milin, C; Bonnet, A; Bouard, L; Bourgeois, AL; Chevallier, P; Dubruille, V; Garnier, A; Gastinne, T; Gouill, SL; Guillaume, T; Kraeber-Bodéré, F; Lok, A; Mahé, B; Moreau, P; Peterlin, P; Touzeau, C | 1 |
| Baranska, D; Gorska-Chrzastek, M; Grzelak, P; Krajewska, K; Matera, K; Podgorski, M; Trelinska, J | 1 |
| Bazarbachi, A; Blaise, D; Charafeddine, M; El-Cheikh, J; Jabbour, J; Manana, B; Saade, C; Zahreddine, A | 1 |
| Bernstine, H; Domachevsky, L; Soudry, E; Tzelnick, S | 1 |
| Belkhir, R; Besson, FL; Blanc, E; Henry, J; Keraen, J; Leguern, V; Mariette, X; Meyer, C; Nocturne, G; Seror, R | 1 |
| Bhatia, A; Grommes, C; Malani, R; Wolfe, J | 1 |
| Amaral Ferreira, L; Caseiro-Alves, F; Costa, JF; Donato, P | 1 |
| Cao, X; Li, F; Luo, Y; Pan, Q; Zhang, Y | 1 |
| Wang, Z; Wu, F; Yu, M; Zhao, J | 1 |
| Matsushima, S; Nishimura, M; Okuyama, C; Yamada, K | 1 |
| Berthelsen, AK; Dieckmann, K; Eich, HT; Hodgson, D; Mikhaeel, NG; Milgrom, SA; Qi, SN; Specht, L; Terezakis, S; Yahalom, J | 1 |
| Berzaczy, D; Berzaczy, G; Haug, AR; Kiesewetter, B; Mayerhoefer, ME; Raderer, M; Weber, M | 1 |
| Barrington, SF; Meignan, M | 1 |
| Meyer, HJ; Surov, A; Wienke, A | 1 |
| Chauvie, S; Kostakoglu, L | 1 |
| Alavi, A; Kothekar, E; Raynor, WY; Yellanki, DP; Zadeh, MZ | 1 |
| Broccoli, A; Fanti, S; Fonti, C; Lambertini, A; Lodi, F; Nanni, C; Pellegrini, C; Stefoni, V; Zanoni, L; Zinzani, PL | 1 |
| Chen, H; Chen, L; Duan, S; Ma, X; Ou, X; Shen, C; Wang, Y; Xu, H; Xu, W; Zhu, S | 1 |
| Hao, R; Liu, Z; Yang, J; Yang, X | 1 |
| Dauwalder, O; Dhomps, A; Foret, T; Skanjeti, A; Tordo, J | 1 |
| Ramsay, AD | 1 |
| Dang, CJ; Li, YJ; Wang, WH; Zhan, FH | 1 |
| Bal, C; Dhull, VS; Khangembam, BC; Kumar, R; Sharma, P; Singla, S | 1 |
| Kluge, R; Kurch, L; Mauz-Körholz, C; Montravers, F | 1 |
| Ha-Kawa, S; Ueno, Y | 1 |
| Adam, JA; Adams, HJ; de Keizer, B; de Klerk, JM; Fijnheer, R; Kersten, MJ; Kwee, TC; Nievelstein, RA; Stoker, J; Vermoolen, MA | 1 |
| Cabral, FC; Jagannathan, JP; Kim, KW; Krajewski, KM; Ramaiya, NH | 1 |
| Gardin, I; Gouel, P; Hapdey, S; Jardin, F; Modzelewski, R; Ruan, S; Tilly, H; Vera, P | 1 |
| Ferretti, A; Groheux, D; Hindié, E; Rubello, D; Teyton, P; Vercellino, L | 1 |
| Agrawal, A; Purandare, NC; Puranik, AD; Rangarajan, V; Shah, S | 1 |
| Ishii, A; Koizumi, M; Nakadate, M; Nakagawa, T; Ryu, Y; Shibuya, H; Suzuki, Y; Tochigi, N; Umehara, I; Yoshida, K | 1 |
| Garza, I; Pittock, SJ; Siddiqui, MA; Thompson, CA; Toledano, M | 1 |
| Ford, RJ; Kong, FL; Yang, DJ | 1 |
| Kawai, N; Miyake, K; Nishiyama, Y; Tamiya, T; Yamamoto, Y | 1 |
| Awan, UE; Bashir, H; Farooqui, ZS; Mahmmood, MT; Muzaffar, N; SaadUllah, M; Siddiqui, N | 1 |
| Bárdi, E; Csóka, M; Garai, I; Györke, T; Kajáry, K; Kiss, C; Kovács, G; Müller, J; Nemes, K; Szegedi, I | 1 |
| Chen, Y; Li, C; Li, F; Shen, Z; Tian, J; Wang, R; Xu, B; Yu, L; Zhu, H | 1 |
| Allen-Auerbach, M; Czernin, J; de Vos, S | 2 |
| Tateishi, U | 1 |
| Lartizien, C; Niaf, E; Ricard, F; Rogez, M | 1 |
| Barrington, SF; Mikhaeel, NG | 1 |
| Lee, NJ; Liu, B; Otero, HJ; Servaes, S; Zhuang, H | 1 |
| Gönen, M; Lilienstein, J; Maragulia, J; Moskowitz, CH; Ulaner, GA; Zelenetz, AD | 1 |
| Kaneko, H; Kano, T; Kubota, K; Mimori, A; Minamimoto, R; Morooka, M; Takahashi, Y; Yamashita, H | 1 |
| Fan, Q; Li, F; Li, L; Su, M; Tian, R | 1 |
| Abramson, SJ; Beylergil, V; Carrasquillo, JA; Kang, HJ; Price, AP | 1 |
| Ahuja, AT; Wong, SS; Yuen, HY | 1 |
| Bairey, O; Bernstine, H; Edel, Y; Groshar, D; Lahav, M; Shpilberg, O; Wolach, O | 1 |
| Chan, S; Liu, B; Servaes, S; Zhuang, H | 1 |
| Cheson, BD; Kostakoglu, L | 1 |
| Baqir, M; Lowe, V; Ryu, JH; Yi, ES | 1 |
| Arnold, C; Gibson, GM; Ravi Kumar, AS | 1 |
| Barber, I; Beek, FJ; Bierings, MB; de Keizer, B; Enríquez, G; Granata, C; Hobbelink, MG; Kwee, TC; Littooij, AS; Nievelstein, RA; Soh, SY; Stoker, J; Vermoolen, MA; Zsíros, J | 1 |
| Aaløkken, TM; Bogsrud, TV; Geier, OM; Hagtvedt, T; Holte, H; Lund, KV; Løndalen, AM; Seierstad, T; Smith, HJ | 1 |
| Beaussart, P; Chalaye, J; Enache, C; Evangelista, E; Haioun, C; Itti, E; Lhermite, C; Luciani, A; Meignan, M; Rahmouni, A; Safar, V; Sasanelli, M | 1 |
| Dai, D; Dang, N; Ma, W; Song, X; Wang, J; Xu, W; Zhu, L; Zhu, X | 1 |
| Berzaczy, D; Dolak, W; Gaiger, A; Hoffmann, M; Jaeger, U; Karanikas, G; Kiesewetter, B; Kletter, K; Lukas, J; Mayerhoefer, ME; Müllauer, L; Pinker-Domenig, K; Porpaczy, E; Prosch, H; Raderer, M; Sillaber, C; Simonitsch-Klupp, I; Skrabs, C; Ubl, P; Weber, M | 1 |
| Chiewvit, P; Chiewvit, S; Phongsawat, N; Pooliam, J; Thephamongkhol, K; Ubolnuch, K | 1 |
| Choi, YY; Kim, JY; Yang, SO | 1 |
| Okamoto, M | 1 |
| Terauchi, T | 1 |
| Aigner, RM; Feichtinger, M; Gstettner, C; Klein, A; Pau, M; Reinbacher, KE; Wallner, J; Zemann, W | 1 |
| Hirata, K; Houkin, K; Kobayashi, H; Kobayashi, K; Manabe, O; Motegi, H; Shiga, T; Terasaka, S; Yamaguchi, S | 1 |
| Song, Y; Zhu, J | 1 |
| Boreham, DR; Lemon, JA; Phan, N; Taylor, K | 1 |
| Brindle, R; Gandhi, A; Mullan, D; Yap, BK | 1 |
| Liu, Y | 2 |
| Alavi, A; Basu, S; Carlsen, PF; Hess, S; Salavati, A; Zaidi, H | 1 |
| Li, JJ; Sheng, JF; Sheng, ZK; Ye, J; Zhao, K | 1 |
| Bal, C; Karunanithi, S; Kumar, R; Roy, SG; Sharma, A; Sharma, P; Thulkar, S; Vettiyil, B | 1 |
| Beuthien-Baumann, B; Kitzler, HH; Kotzerke, J; Laniado, M; Maus, J; Ordemann, R; Platzek, I; Schramm, G; van den Hoff, J | 1 |
| Fujiwara, Y; Ikegaya, S; Kimura, H; Kishi, S; Okazawa, H; Tsuchida, T; Tsuji, K; Ueda, T; Urasaki, Y; Yamauchi, T | 1 |
| Ishitsuka, K; Kuwabara, Y; Nonokuma, M; Takano, K; Tamura, K; Yoshimitsu, K | 1 |
| Barrington, SF; Biggi, A; Cheson, BD; Fisher, RI; Hicks, RJ; Hoekstra, OS; Hustinx, R; Hutchings, M; Kostakoglu, L; Meignan, M; Mikhaeel, NG; Müeller, SP; O'Doherty, MJ; Schwartz, LH; Trotman, J; Zucca, E | 1 |
| Adler, S; Choyke, PL; Kurdziel, KA; Lindenberg, ML; Logan, J; Mena, E; Shih, J; Turkbey, BI; Wilson, W; Wong, K | 1 |
| Han, YJ; Huang, S; Wang, M; Wang, QS; Weng, CS; Wu, HB; Zhou, WL | 1 |
| Bachmann, KR; Foster, WC; Fox, MG; LeGallo, RD; Marti, JK | 1 |
| Bai, X; Chen, L; Gao, J; Hu, H; Nie, Y; Niu, X; Xu, H; Zhao, W | 1 |
| Bi, L; Feng, D; Fulham, M; Kim, J | 1 |
| Lin, M; Lin, P; Rosenfeld, D; Sidhu, P; Son, H | 1 |
| Beech, P; Cherk, MH; Kalff, V; Patil, S | 1 |
| Ding, CY; Fan, L; Li, JY; Li, TN; Liang, JH; Sun, DP; Tian, T; Wang, L; Wu, YJ; Xu, W | 1 |
| Iida, S; Inagaki, H; Ishida, T; Kusumoto, S; Masaki, A; Mori, F; Suzuki, T | 1 |
| Hirata, K; Houkin, K; Kaneko, S; Kobayashi, H; Kobayashi, K; Onimaru, R; Shiga, T; Shirato, H; Tamaki, N; Terasaka, S; Yamaguchi, S | 1 |
| Dunleavy, K; Wilson, WH | 1 |
| Fu, Z; Kang, L; Li, Q; Liu, M; Zhang, J | 1 |
| Feng, DD; Fulham, M | 1 |
| Daldrup-Link, HE; Donig, J; Link, M; Quon, A; Rosenberg, J; Uslu, L | 1 |
| Gallamini, A; Itti, E; Meignan, M; Younes, A | 1 |
| Djaldetti, R; Lotan, I; Luckman, J; Siegal, T; Steiner, I | 1 |
| Bal, C; Karunanithi, S; Kumar, R; Murugan, V; Roy, SG | 1 |
| Cheson, BD | 2 |
| Laffon, E; Marthan, R | 1 |
| Adams, HJ; Kwee, TC | 1 |
| Bennani-Baiti, B; Bennani-Baiti, N; Flynt, L; Yadav, S | 1 |
| Barrington, SF; Biggi, A; Cavalli, F; Cheson, BD; Fisher, RI; Hicks, RJ; Hoekstra, OS; Hustinx, R; Hutchings, M; Kostakoglu, L; Lister, TA; Meignan, M; Mikhaeel, NG; Müeller, S; O'Doherty, MJ; Schwartz, LH; Trotman, J; Zucca, E | 1 |
| Illés, Á; Simon, Z | 1 |
| Campbell, N; Chandarana, H; Friedman, KP; Heacock, L; Ponzo, F; Raad, R; Weissbrot, J | 1 |
| Adachi, S; Koizumi, M; Kojo, M; Kubota, K; Matsuno, S; Morioka, N; Nishimura, M; Nishioka, S; Seto, H; Yamamoto, H | 1 |
| Jacene, HA; LaCasce, AS; Tirumani, SH | 1 |
| Wang, X | 1 |
| Fan, W; Hu, YY; Li, YH; Liang, PY; Lin, XP; Long, W; Xiao, ZZ; Zhang, X; Zhang, YR; Zheng, RL | 1 |
| Hall, NC; Martin, EW; Murrey, DA; Povoski, SP; Wright, CL | 1 |
| Adams, HJ; de Klerk, JM; Dubois, SV; Fijnheer, R; Heggelman, BG; Kwee, TC; Nievelstein, RA | 1 |
| Chang-Hong, L; Dan, S; Qiang, G; Shu-Xia, W | 1 |
| Chang, CA; Kumar, B; Nandurkar, D | 1 |
| Meignan, M | 2 |
| Mena, E; Meoded, A; Solnes, L; Subramaniam, RM; Wray, R | 1 |
| Choi, CM; Kim, MY; Kim, SS; Koo, HJ; Lee, SW; Shin, S; Shin, SY | 1 |
| Hutchings, M; Meignan, M; Schwartz, LH | 1 |
| Abe, K; Baba, S; Honda, H; Kamitani, T; Kawanami, S; Matsuo, Y; Nagao, M; Nakamura, K; Okamoto, T; Sasaki, M; Sunami, S; Yabuuchi, H; Yamamoto, H; Yamasaki, Y; Yonezawa, M | 1 |
| Keramida, G; Peters, AM | 1 |
| Barrington, SF; Biggi, A; Cheson, BD; Fisher, RI; Hicks, RJ; Hoekstra, OS; Hustinx, R; Hutchings, M; Kostakoglu, L; Meignan, M; Mikhaeel, NG; Müeller, S; O'Doherty, MJ; Schwartz, LH; Trotman, J; Zucca, E | 1 |
| Han, YJ; Li, HS; Wang, LJ; Wang, M; Wang, QS; Wu, HB; Zhou, WL | 1 |
| Azoulay, É; Lemiale, V; Pineton De Chambrun, M | 1 |
| Machida, Y; Maeda, S; Matoba, M; Motono, N; Sagawa, M; Tanaka, M; Tonami, H; Ueda, Y; Ueno, M; Usuda, K; Watanabe, N | 1 |
| Li, F; Ma, YR; Niu, N; Xing, HQ; Zhu, ZH | 1 |
| Baillet, C; Dewalle-Vignion, AS; Fechter, T; Gardin, I; Gibon, D; Massoptier, L; Modzelewski, R; Nemer, U; Nestle, U; Parcq, C; Schaefer, A; Vera, P; Vermandel, M | 1 |
| Ballestri, S; Lonardo, A; Loria, P; Losi, L; Romagnoli, D | 1 |
| Belhabri, A; de Charry, F; de Parisot, A; Faurie, P; Ghesquières, H; Nicolas-Virelizier, E; Ninet, J; Rey, P; Sadoune, K; Sebban, C | 1 |
| Duan, L; Li, J; Qiu, H; Tian, T; Wang, D; Wang, J; Zhang, Q; Zhang, X | 1 |
| Ham, H; Maes, A; Mees, G; Smeets, P; Van De Wiele, C; Verstraete, K | 1 |
| Fanti, S; Zinzani, P | 1 |
| Buck, A; de Galiza Barbosa, F; Herrmann, K; Huellner, MW; Queiroz, M; Schaefer, N; Stolzman, P; Veit-Haibach, P | 1 |
| Arisaka, Y; Nakajima, T; Tokue, A; Yudistiro, R | 1 |
| Balbo-Mussetto, A; Bruna, R; Cirillo, S; De Crescenzo, A; Fornari, A; Gottardi, D; Gueli, A; Lario, CV; Petracchini, M; Saviolo, C; Tarella, C | 1 |
| Ijichil, S; Kitawaki, J; Nishigaki, H; Okuda, T; Yamashita, S; Yoshioka, T | 1 |
| Agnello, F; Albano, D; Cannizzaro, G; Ficola, U; Galia, M; Grassedonio, E; La Grutta, L; Lagalla, R; Midiri, M; Mulè, A; Patti, C | 1 |
| Daisaki, H; Hamada, K; Katayama, Y; Narita, A; Shiomi, S; Watanabe, Y; Yamanaga, T | 1 |
| Dodge, C; Krishnamurthy, R; Paldino, MJ; Rohren, EM; Seghers, V; Sher, AC | 1 |
| Cai, Y; Chen, E; Li, Q; Wang, Q; Zhang, X | 1 |
| Khanna, G; Laforest, R; McConathy, J; Ponisio, MR | 1 |
| Baba, S; Hiwatashi, A; Honda, H; Iihara, K; Isoda, T; Iwaki, T; Kikuchi, K; Kitamura, Y; Kuga, D; Mizoguchi, M; Suzuki, SO; Togao, O; Yamashita, K; Yoshimoto, K | 1 |
| Abildgaard, N; Alavi, A; Christlieb, SB; Gerke, O; Høilund-Carlsen, PF; Kristensen, BW; Larsen, TS; Mylam, KJ; Møller, MB; Nielsen, AL; Olsen, BB; Olsen, KE; Rohde, M; Strandholdt, CN | 1 |
| Balzarotti, M; Bergesio, F; Biggi, A; Brambilla, M; Cabras, MG; Chauvie, S; Federico, M; Fioroni, F; Gallamini, A; Guerra, L; Luminari, S; Martelli, M; Musto, P; Rigacci, L; Storto, G; Versari, A; Vitolo, U | 1 |
| Alongi, P; Bomanji, J; Fallanca, F; Gianolli, L; Incerti, E; Kayani, I; Picchio, M | 1 |
| Yabuuchi, H | 1 |
| Priola, AM; Priola, SM | 1 |
| Baquero, M; Bassa, P; García-Garzon, JR; Riera, E; Soler, M; Villasboas-Rosciolesi, D | 1 |
| Jantunen, E; Partanen, A; Pukkila, S | 1 |
| Chen, Z; Rao, L; Shi, X; Wang, X; Yang, Z; Yi, C; Zhang, X; Zong, Z | 1 |
| Chung, EM; Pavio, M | 1 |
| Han, EJ; Kim, SH; Park, HL | 1 |
| Alam, MS; Guan, W; Wang, QS; Wu, HB; Zhou, WL | 1 |
| Hitomi, T; Kinoshita, H; Kitamura, A; Kitano, T; Miyamoto, M; Nakamoto, Y; Okada, T; Sawamoto, N; Takahashi, R; Takaori-Kondo, A; Yamakado, H; Yamashita, H | 1 |
| Alavi, A; Ayers, EC; Fardin, S; Gholami, S; Mato, AR | 1 |
| Ge, J; Guan, Y; Zhao, G; Zuo, C | 1 |
| Cheson, BD; Ujjani, CS | 1 |
| Bashir, H; Naz, F; Niazi, IK; Riaz, S | 1 |
| Koizumi, M; Koyama, M; Takeuchi, K; Tanaka, H; Terauchi, T | 1 |
| Albano, D; Galia, M; Lagalla, R; Midiri, M; Patti, C | 1 |
| Afaq, A; Akin, O; Ardeshna, K; Chen, SH; Fraioli, F; Groves, A; Kayani, I; Lambert, J; Linch, D; Miles, K; Punwani, S; Sidhu, H; Wan, S | 1 |
| Yoon, SN | 1 |
| Ayala, E; Chavez, J; Gage, K; Jeong, DK; Kharfan-Dabaja, MA; Khimani, F; Locke, F; Miladinovic, B; Mishra, A; Nishihori, T; Shah, B | 1 |
| He, F; Liu, Y; Wang, G | 1 |
| Asenbaum, U; Furtner, J; Karanikas, G; Mayerhoefer, ME; Nolz, R; Raderer, M; Senn, D; Simonitsch-Klupp, I; Staudenherz, A; Weber, M; Woitek, R | 1 |
| Alongi, P; Bomanji, JB; Fallanca, F; Gianolli, L; Incerti, E; Kayani, I; Picchio, M | 1 |
| Colletti, PM; Dubreuil, J; Giammarile, F; Glehen, O; Rousset, P; Rubello, D; Skanjeti, A | 1 |
| Anees K, M; Jayaprakash, PG; Joy, A; Madhavan, J; Nair, S; Nanabala, R; Pillai, MR; Sasikumar, A | 1 |
| Knopp, MV; Maly, JJ; Wright, CL; Zhang, J | 1 |
| Abadi, P; Gerke, O; Godballe, C; Høilund-Carlsen, PF; Johansen, A; Thomassen, A | 1 |
| Bi, L; Feng, D; Fulham, M; Kim, J; Kumar, A; Wen, L | 1 |
| Alam, MS; Fu, L; Han, YJ; Li, HS; Ren, YY; Wang, QS; Wang, Z; Wu, HB; Zhou, WL | 1 |
| Baxa, J; Ferda, J; Ferdová, E | 1 |
| Charalampopoulos, A; Farrugia, FA; Martikos, G; Misiakos, E; Surgeon, C; Tzanetis, P; Zavras, N | 1 |
| Brown, RK; Coleman, M; Elstrom, RL; Leonard, JP | 1 |
| Moskowitz, C; Schöder, H | 1 |
| Gambhir, SS; Goris, ML; Iagaru, A | 1 |
| Bae, YA; Lee, KS | 1 |
| Ajisaka, H; Hoso, M; Ii, T; Matsuki, N; Miwa, K; Oba, M; Sasaki, M | 1 |
| Almusa, O; Daly, B; Shreve, P | 1 |
| Chong, EA; Downs, LH; Mato, AR; Schuster, SJ; Torigian, DA | 1 |
| Chiofalo, MG; Corazzelli, G; De Chiara, A; Franco, R; Pezzullo, L | 1 |
| Hata, H; Kitagawa, Y; Sakakibara, N; Shindoh, M; Tmamaki, N; Yamazaki, Y | 1 |
| Hatazawa, J; Higuchi, I; Inoue, A; Ishikawa, J; Isohashi, K; Kanakura, Y; Nakajo, K; Nakamura, H; Shimosegawa, E; Tatsumi, M | 1 |
| Alavi, A; Basu, S; Bural, G; Li, G | 1 |
| Filice, R; Jacene, HA; Kasecamp, W; Wahl, RL | 1 |
| Arslan, N; Ataergin, S; Ozet, A; Ozguven, MA | 1 |
| Abrey, LE; Deangelis, LM; Mohile, NA | 2 |
| Baarslag, HJ; de Haas, MJ; de Jong, PA; de Klerk, JM; Quekel, LG; van Ufford, HM; Wittebol, SH | 1 |
| Cheson, B | 1 |
| Alinari, L; Ambrosini, V; Baccarani, M; Bacci, F; Broccoli, A; Castellucci, P; Derenzini, E; Fanti, S; Fina, M; Marchi, E; Montini, G; Musuraca, G; Pellegrini, C; Pileri, S; Stefoni, V; Tani, M; Zinzani, PL | 1 |
| Meyers, BF; Puri, V | 1 |
| Badler, RL; Katz, DS; Mahboob, S; Santoro, MS; Scalcione, LR; Yung, EY | 1 |
| Inoue, T; Tateishi, U; Terauchi, T; Tobinai, K | 1 |
| Barrington, SF; Hutchings, M | 1 |
| Chua, SC; O'Connor, SR; Rozalli, FI | 1 |
| Avigdor, A; Davidson, T; Goitein, O; Goshen, E; Zwas, ST | 1 |
| Brindle, KM; Day, SE; Fulton, SM; Gallagher, FA; Hu, DE; Kettunen, MI; Neves, AA; Witney, TH | 1 |
| Hara, M; Mizuno, A; Nakagawa, M; Nishio, M; Ozawa, Y; Sakurai, K; Shibamoto, Y; Tamaki, T | 1 |
| Hatakeyama, T; Kameyama, R; Kawai, N; Kimura, N; Nishiyama, Y; Yamamoto, Y | 1 |
| Brepoels, L; De Groot, T; De Wolf-Peeters, C; Mortelmans, L; Stroobants, S; Verhoef, G | 1 |
| Dufault, DL; Dunphy, CH; Ivanovic, M; Khandani, AH; Meteesatien, P; Shea, TC | 1 |
| Coha, B; Daković, M; Gardasanić, J; Latić, A; Mitrecić, D; Radmilović, K; Stefanić, M | 1 |
| Fan, CZ; Fan, QP; Li, FL; Li, L; Su, MG; Tian, R; Tian, Y; Yang, XC | 1 |
| Endo, K; Higuchi, T; Kuji, I; Matsuda, H; Murakami, K; Nakajima, K; Oriuchi, N; Tsukamoto, N | 1 |
| Cho, DJ; Lee, DH; Lee, JH; Min, K; Min, KS; Shim, EJ; Yoo, KY | 1 |
| Furukawa, T; Imataki, O; Kawakami, K; Tamai, Y; Yokoe, K | 1 |
| Poulou, LS; Thanos, L; Ziakas, PD | 1 |
| Bai, HT; Cai, Q; Gao, YR; Jiang, JL; Wan, LP; Wang, C; Wei, J; Yan, SK; Yang, J; Zhao, JH; Zhao, M; Zhou, LL | 1 |
| Hofman, MS; Nunan, T; O'Doherty, MJ; Rankin, SC; Smeeton, NC | 1 |
| De Vriendt, C; Goethals, I; Ham, H; Hoste, P; Smeets, P; Verlooy, J | 1 |
| Bourre, JC; Vuillez, JP | 1 |
| Basu, S | 1 |
| Bourdon, A; Ilonca, D; Mariano-Goulart, D | 1 |
| Nakamoto, Y | 2 |
| Avisar, E; Goodwin, WJ; Moffat, FL; Molina, MA; Serafini, AN; Sfakianakis, GN | 1 |
| Callahan, J; Drummond, E; Drummond, KJ; Grigg, A; Hicks, RJ; Hogg, A; Lau, EW; Ryan, G; Ware, RE | 1 |
| Avivi, I; Bar-Shalom, R; Ben-Arie, Y; Ben-Barak, A; Bushelev, O; Dann, EJ; Epelbaum, R; Haim, N; Israel, O; Weiler-Sagie, M | 1 |
| Okamoto, R | 1 |
| Gnanasegaran, G; Nunan, T; Szyszko, T; Trautner, M | 1 |
| Lupo, R; Merino, B; Monet, A | 1 |
| Bal, CS; Halanaik, D; Kumar, R; Malhotra, A; Reddy, R; Santra, A | 1 |
| Graham, MM; Syrbu, S; Thomas, DL | 1 |
| Hayasaka, K; Koyama, M; Yamashita, T | 1 |
| Chamroonrat, W; Cheng, G; Zhuang, H | 1 |
| Bainbridge, A; Bandula, S; Bomanji, JB; Daw, S; De Vita, E; Hain, SF; Humphries, PD; Olsen, OE; Prakash, V; Punwani, S; Shankar, A; Stevens, N; Taylor, SA | 1 |
| Martin, P | 1 |
| Kawai, N; Maeda, Y; Miyake, K; Nishiyama, Y; Okubo, S; Tamiya, T; Yamamoto, Y | 1 |
| Kawai, N; Miyake, K; Nishiyama, Y; Tamiya, T; Yamamaoto, Y; Zhen, HN | 1 |
| Elstrom, RL; Leonard, JP | 1 |
| Glass, JO; Mateja, SJ; Reddick, WE; Shan, ZY; Shulkin, BL | 1 |
| Chamroonrat, W; Cheng, G; Servaes, S; Zhuang, H | 1 |
| Hodgson, R; Huang, YT; Ravi Kumar, AS; Steinke, K | 1 |
| Ahmadzadehfar, H; Knoll, P; Mirzaei, S; Rodrigues, M; Zakavi, R | 1 |
| Bu, ZB; Chen, LH; Ding, Y; Feng, J; Guan, J; Wang, QS; Wu, HB; Yang, RM; Ye, XH; Zhou, WL | 1 |
| Ginat, DT; Puri, S | 1 |
| Dahabreh, IJ; Nihashi, T; Terasawa, T | 1 |
| Goudarzi, B; Jacene, HA; Wahl, RL | 1 |
| Cuganesan, R; Lin, M; Lin, P; Shon, IH; Som, S; Wong, C | 1 |
| Ambrosini, V; D'Errico-Grigioni, A; Fanti, S; Fini, M; Franchi, R; Giavaresi, G; Malvi, D; Nanni, C; Quarta, C; Torricelli, P; Zinzani, PL | 1 |
| Czernin, J; Hacke, K; Hildebrandt, IJ; Kelly, O; Kesner, AL; Lawson, GW; Phelps, ME; Schiestl, RH; Walter, MA; Weber, WA | 1 |
| Al-Ibraheem, A; Buck, AK; Dechow, T; Engels, HP; Herrmann, K; Langer, R; Ringshausen, I; Schwaiger, M; Sciuk, J; Wieder, HA | 1 |
| Cai, Y; Guan, Z; Ling, J; Sun, X; Wang, J; Xia, Y; Zhen, Z | 1 |
| He, W; Jiang, JJ; Jiang, MS; Zhang, MJ | 1 |
| Brown, RK; Dunnick, NR; Frey, KA; Kochhar, R; Manoharan, P; Wong, CO | 1 |
| Cen, XN; Dong, YJ; Li, Y; Liang, ZY; Ou, JP; Qiu, ZX; Ren, HY; Wang, MJ; Wang, WS; Xu, WL; Yao, H; Yin, Y | 1 |
| Aruga, T; Itami, J; Ito, K; Kubota, K; Matsuda, H; Morooka, M; Shida, Y | 1 |
| Howman-Giles, R; London, K | 1 |
| Gnanasegaran, G; Navalkissoor, S; Nunan, T; Szyszko, T | 1 |
| Aruga, T; Itami, J; Ito, K; Kubota, K; Matsuda, H; Mochizuki, N; Morooka, M | 1 |
| Cross, S; Dalla-Pozza, L; Howman-Giles, R; London, K; Onikul, E | 1 |
| Klaeser, B; Krause, T | 1 |
| Blumenkrantz, M; Hickeson, M; Makis, W | 1 |
| Cazaentre, T; Costa, K; Laurent, G; Pascal-Ortiz, D; Sanhes, L; Vallantin, X | 1 |
| Fujiwara, S; Matsuyama, T; Mori, M; Muroi, K; Nagai, T; Oh, I; Ohmine, K; Ozaki, K; Ozawa, K; Sato, K; Suzuki, T | 1 |
| Kameyama, R; Kawai, N; Kawase, Y; Kudomi, N; Nishiyama, Y; Yamamoto, Y | 1 |
| Hutchings, M | 1 |
| Chen, FY; Gu, HY; Jiang, XX; Wu, LM; Xu, JR; Yin, Y | 1 |
| Coya, J; Del Campo-Del Val, L; Gómez-León, N; Hernandez-Maraver, D; Jover-Díaz, R; Pinilla, I; Rodríguez-Vigil, B | 1 |
| He, W; Jiang, JJ; Jiang, MS; Xiao, L; Zhang, MJ; Zhu, YH | 1 |
| Hickeson, M; Makis, W; Novales-Diaz, JA | 1 |
| Bronstein, Y; Rohren, E; Tummala, S | 1 |
| Can, N; Celasun, B; Ulubay, H; Unlü, M; Yakupoğlu, H | 1 |
| Cen, XN; Dong, YJ; Li, Y; Liang, ZY; Ou, JP; Qiu, ZX; Ren, HY; Wang, LH; Wang, MJ; Wang, WS; Xu, WL; Yao, H; Yin, Y | 1 |
| Dhawan, M; Li, G; Lilien, DL; Takalkar, AM | 1 |
| Juweid, ME | 1 |
| Alavi, A; Basu, S; Rosenbaum, J; Urhan, M | 1 |
| Beek, FJ; de Klerk, JM; Fijnheer, R; Kwee, TC; Nievelstein, RA; Takahara, T; van Leeuwen, MS; van Ufford, HM | 1 |
| Sathekge, MM; Warwick, JM | 1 |
| Hiraga, J; Mizuno, S; Okuda, T; Sakemura, R | 1 |
| Lee, G; Lee, JH; Park, SG | 1 |
| Hirai, R; Hiroe, M; Ito, K; Kubota, K; Masuda-Miyata, Y; Minamimoto, R; Mitsumoto, T; Morooka, M; Okazaki, O | 1 |
| Akter, M; Hirai, T; Iwashita, K; Kitajima, M; Kuratsu, J; Makino, K; Murakami, R; Nakamura, H; Nakashima, R; Shigematsu, Y; Shiraishi, S; Uetani, H; Yamashita, Y | 1 |
| Ramsdale, E; Smith, SM; van Besien, K | 1 |
| Brower, V | 1 |
| Fijnheer, R; Kersten, MJ; Kwee, TC; Nievelstein, RA; van Leeuwen, MS; Vermoolen, MA | 1 |
| Abdulqadhr, G; Ahlström, H; Aström, G; Hagberg, H; Johansson, L; Molin, D; Suurküla, M | 1 |
| Alessio, A; Parisi, MT; Sammer, MB; Shulkin, BL | 1 |
| Bhogal, P; Booth, TC; Malhotra, A; Tang, YZ; Wilhelm, T | 1 |
| Li, F; Yu, L; Zhu, HY | 1 |
| Bartlett, NL; Wagner-Johnston, ND | 1 |
| Dierckx, RA; Eshuis, SA; Glaudemans, AW; Slart, RH; van Snick, PJ | 1 |
| Hagiwara, S; Hirai, R; Ito, K; Kitahara, H; Kubota, K; Masuda-Miyata, Y; Minamimoto, R; Miwa, A; Morooka, M; Tanimura, A | 1 |
| de Geus-Oei, LF; de Rooy, JW; Flucke, UE; Hambrock, T; Schreuder, BW; van de Luijtgaarden, AC; van der Geest, IC; Vriens, D | 1 |
| Jegouic, C; Retif, P; Slosman, DO | 1 |
| Calcagni, ML; Dambra, DP; De Gaetano, AM; Giordano, A; Leccisotti, L; Meduri, GM; Rufini, V; Spitilli, MG; Treglia, G | 1 |
| Alexandre, L; Castelli, JB; Futuro, G; Scanavacca, M; Soares Júnior, J | 1 |
| Solav, SV | 1 |
| Flemming, DJ; Fotos, JS; Tulchinsky, M | 1 |
| English, J; Evans, WC; Gilmore, D | 1 |
| Kao, YH; Phipps, C; Tan, D; Yiu, CR | 1 |
| Cai, S; He, Y; Peng, J; Sheng, J; Xu, J; Zhang, Z | 1 |
| Chan, T; Gu, J; Khong, PL; Kwong, YL; Leung, AY; Zhang, J | 1 |
| Arabi, M; Dvorak, R; Gross, MD; Kujawski, L; Smith, LB | 1 |
| Grant, FD; Treves, ST | 1 |
| Ciarallo, A; Lisbona, R; Makis, W; Novales-Diaz, JA | 1 |
| Huang, YY; Lee, MY; Lee, PI; Liu, MC; Tan, TD; You, DL | 1 |
| Barna, S; Borbély, K; Garai, I; Hascsi, Z; Illés, A; Szûcs, B; Tóth, Z | 1 |
| Germanos, MS; Manfredi, MG; Robertson, R; Silva, MD; Smith, PG | 1 |
| Kim, SH; Mulligan, ME; Smith, SE | 1 |
| Aboagye, EO; Glaser, M; Goggi, J; Luthra, SK; Morrison, M; Robins, E; Smith, G | 1 |
| Abe, K; Baba, S; Honda, H; Isoda, T; Maruoka, Y; Sasaki, M | 1 |
| Hart, J; Mills, T; Sanghera, B; Sonoda, LI; Vivian, G; Wong, WL | 1 |
| Ashkenazi, Y; Izbicki, G; Maayan, H; Nagler, A | 1 |
| Balasubramanian Harisankar, CN; Bhattacharya, A; Kashyap, R; Malhotra, P; Manohar, K; Rai Mittal, B; Singh, B; Varma, S | 1 |
| Hatazawa, J; Isohashi, K; Kato, H; Shimosegawa, E; Tatsumi, M; Watabe, H; Watabe, T; Yanagawa, M | 1 |
| Chatziioannou, AF; Chen, S; Ding, H; Dooraghi, A; Keng, PY; Kim, CJ; Phelps, ME; Sadeghi, S; Satyamurthy, N; Shah, GJ; van Dam, RM | 1 |
| Cho, KS; Kang, DW; Kim, HJ; Lee, JK; Roh, HJ | 1 |
| Hoefnagel, K; Olmos, RV; Stokkel, MP; van der Hiel, B | 1 |
| Maeda, M; Matsushima, N; Suzawa, N; Takeda, K; Umino, M; Yamada, T | 1 |
| Marcus, DM; Shim, H; Shu, HK; Zhu, A | 1 |
| Edenbrandt, L; Garpered, S; Höglund, P; Jönsson, E; Ly, J; Valind, S; Wollmer, P | 1 |
| Afshar-Oromieh, A; Giesel, FL; Haberkorn, U; Kratochwil, C | 1 |
| Sanghera, B; Sonoda, LI; Wong, WL | 1 |
| Kaneko, H; Kano, T; Mimori, A; Takahashi, Y; Yamashita, H | 1 |
| Borbély, K; Fülöp, M; Kásler, M; Lengyel, Z; Remenár, E | 1 |
| Chidiac, C; Ferry, T; Sénéchal, A; Valour, F | 1 |
| Chen, CY; Cheng, CY; Cheng, YL; Gao, HW; Lin, LF; Shen, DH | 1 |
| Reyhan, M; Yapar, AF | 1 |
| Alafate, A; Asakura, S; Fujii, S; Kanazawa, S; Sato, S; Shinya, T; Taniguchi, T; Yoshino, T; Yoshio, K | 1 |
| Iino, M; Iizuka, C | 1 |
| Ying, ZT; Zhu, J | 1 |
| Almodovar, S; Israel, D; Jacene, H; Lewis, A; O'Regan, K; Sakellis, C; Zukotynski, K | 1 |
| Abe, K; Hiwatashi, A; Honda, H; Iwaki, T; Kikuchi, K; Maruoka, Y; Mizoguchi, M; Suzuki, SO; Togao, O; Yamashita, K; Yoshimoto, K; Yoshiura, T | 1 |
| Beijert, M; Bongaerts, AH; Brouwers, AH; Nijland, M | 1 |
| Beuthien-Baumann, B; Kotzerke, J; Langner, J; Laniado, M; Ordemann, R; Platzek, I; Popp, M; Schramm, G; van den Hoff, J | 1 |
| Avril, N; Barwick, T; El-Najjar, I; Montoto, S | 1 |
| Kaneko, K; Masunari, S; Omagari, J; Yoshida, T | 1 |
| Arens, AI; de Geus-Oei, LF; Hutchings, M; Oyen, WJ; Vriens, D | 1 |
| Dote, Y; Fujimoto, S; Okayama, S; Saito, Y; Takeda, Y; Uemura, S | 1 |
| Torizuka, T | 1 |
| Ardito, RB; Baudino, B; Bisi, G; Caroppo, P; Castellano, G; Castelli, L; Cauda, F; Cauda, S; D'agata, F; Geda, E; Geminiani, G; Manfredi, M; Mortara, P; Orsi, L; Pinessi, L; Sacco, K; Torta, R | 1 |
| Brown, RK; Corbett, JR; Dvorak, RA; Kazerooni, EA; Lobert, P; Wong, KK | 1 |
| Aburano, T; Ishitoya, S; Nakayama, M; Okizaki, A; Sakaguchi, M; Sato, J | 1 |
| Alavi, A; Kwee, TC; Torigian, DA | 1 |
| Huang, G; Ku, G; Li, C; Lu, W; Song, S; Xiong, C | 1 |
| Bailly, C; Bodet-Milin, C; Dupas, B; Eugène, T; Gastinne, T; Kraeber-Bodéré, F; Le Gouill, S | 1 |
| Song, YQ; Zhu, J | 1 |
| Augeul-Meunier, K; Bodet-Milin, C; Dupas, B; Frampas, E; Gastinne, T; Le Gouill, S | 1 |
| Chen, Z; Shi, X; Wang, X; Yi, C; Zhang, B; Zhang, X | 1 |
| Kawai, N; Miyake, K; Nishiyama, Y; Okada, M; Tamiya, T; Yamamoto, Y | 1 |
| Akiyama, H; Kumagai, T; Nakamura, Y; Umezawa, Y | 1 |
| Abella-Columna, E; Valk, PE | 1 |
| Mikosch, P | 1 |
| Albertini, P; Alinari, L; Baccarani, M; Chierichetti, F; Ferlin, G; Garraffa, G; Stefoni, V; Tani, M; Tura, S; Zinzani, PL; Zompatori, M | 1 |
| Grahek, D; Kerrou, K; Landman-Parker, J; Leverger, G; McNamara, D; Montravers, F; Talbot, JN; Wioland, M; Younsi, N | 1 |
| Borrego Dorado, I; Vázquez Albertino, R | 1 |
| Chen, T; Hayashi, K; Kaneko, K; Koga, H; Kuwabara, Y; Masuda, K; Nakagawa, M; Nakamura, K; Sasaki, M | 1 |
| Agoston, P; Esik, O; Fekésházy, A; Galuska, L; Kálvin, B; Lengyel, E; Lengyel, Z; Szakáll, S; Székely, J; Trón, L | 1 |
| Dodig, D; Huić, D | 1 |
| Beuthien-Baumann, B; Bredow, J; Ehninger, G; Fischer, R; Kittner, T; Kropp, J; Naumann, R; Ockert, D | 1 |
| Franzius, C; Hermann, S; Sciuk, J | 1 |
| Goldsmith, SJ; Kostakoglu, L | 4 |
| Balzarini, J; Bormans, G; De Wolf-Peeters, C; Dupont, P; Maertens, J; Mortelmans, L; Spaepen, K; Stroobants, S; Thomas, J; Vandenberghe, P; Verhoef, G | 1 |
| Even-Sapir, E; Israel, O | 1 |
| Aerts, J; Cataldo, D; Duysinx, B; Fassotte, MF; Foidart, J; Hustinx, R; Jerusalem, G; Lemaire, C; Luxen, A; Moreau, P | 1 |
| Diehl, V; Dietlein, M; Schicha, H; Tesch, H; Weihrauch, MR | 1 |
| Hoskin, PJ; O'Doherty, MJ | 1 |
| Mortelmans, L; Spaepen, K; Stroobants, S; Verhoef, G | 1 |
| Becherer, A; Jaeger, U; Kletter, K; Szabo, M | 1 |
| Franzius, C; Schober, O | 1 |
| Reske, SN | 2 |
| Ell, PJ; Visvikis, D | 1 |
| Barrington, SF; O'Doherty, MJ | 1 |
| Eibl, M; Gallowitsch, HJ; Heinisch, M; Kresnik, E; Lind, P; Linkesch, W; Mikosch, P; Pipam, W; Unterweger, O; Zinke-Cerwenka, W | 1 |
| Araki, T; Namura, M | 1 |
| Leonidas, JC; Palestro, CJ; Rini, JN; Tomas, MB | 1 |
| Czernin, J; Emmanouilides, C; Filmont, JE; Phelps, ME; Quon, A; Silverman, DH; Yap, C | 1 |
| Chengazi, V; Friedberg, JW | 1 |
| Pruim, J; Schot, B; Sluiter, W; Vaalburg, W; van Imhoff, G; Vellenga, E | 1 |
| Bae, SW; Hahn, JS; Hong, SP; Lee, JD; Youn, MJ | 1 |
| Demetri, G; Fauci, MA; Janicek, MJ; Janicek, MR; Shaffer, K | 1 |
| Granov, AM; Kostenikov, NA; Ryzhkova, DV; Savello, VE; Stanzhevskiĭ, AA; Tiushin, LA; Tlostanova, MS | 1 |
| Chen, YK; Kao, CH; Shen, YY | 1 |
| Larson, SM; Schöder, H; Yeung, HW | 1 |
| Diehl, M; Döbert, N; Grünwald, F; Hamscho, N; Menzel, C; Zaplatnikov, K | 1 |
| Bar-Shalom, R; Gaitini, D; Israel, O; Keidar, Z | 1 |
| Kasamon, YL; Swinnen, LJ; Wahl, RL | 1 |
| Cen, XN; Fan, Y; Fu, ZL; Wang, RF; Zhang, CL; Zhang, XM | 1 |
| Alavi, A; Bhargava, P; Charron, M; Kumar, R; Zhuang, H | 1 |
| Bar-Shalom, R; Israel, O; Keidar, Z | 1 |
| Adler, L; Bagheri, B; Cone, L; Doss, M; Maurer, AH | 1 |
| Burton, C; Ell, P; Linch, D | 1 |
| Beuthien-Baumann, B; Naumann, R | 1 |
| Steinert, HC | 1 |
| Alavi, A; Dadparvar, S; Dhurairaj, T; Kumar, R; Mavi, A; Potenta, S; Xiu, Y; Yu, JQ; Zhuang, H | 1 |
| Cook, G; Flower, MA; Lee, YK; Rowbottom, C; Shahidi, M; Sharma, B; Webb, S | 1 |
| Cerfolio, RJ; Chen, VK; Desmond, R; Eloubeidi, MA; Ojha, B; Syed, S | 1 |
| Choi, SJ; Kim, HT; Park, YH; Ryoo, BY | 1 |
| Alinari, L; Baccarani, M; Battista, G; Boschi, S; Canini, R; Castellucci, P; Fanti, S; Farsad, M; Marengo, M; Monetti, N; Moretti, A; Nanni, C; Pettinato, C; Zinzani, P | 1 |
| Chu, J; Jalaludin, B; Kiat, H; Kneebone, A; Lin, P; Moylan, E; Pocock, N; Rosenfeld, D | 1 |
| Alavi, A; Alinari, L; Battista, G; Canini, R; Castellucci, P; Fanti, S; Farsad, M; Franchi, R; Monetti, N; Nanni, C; Pourdehnad, M; Rubello, D; Stefoni, V; Tani, M; Zinzani, P | 1 |
| Divgi, C | 1 |
| Celsing, F; Jacobsson, H; Siösteen, AK | 1 |
| Cheson, BD; Juweid, ME | 1 |
| Belhadj, K; Brice, P; Garderet, L; Gaulard, P; Haioun, C; Itti, E; Lepage, E; Meignan, M; Rahmouni, A; Rain, JD; Reyes, F | 1 |
| Imam, SK | 1 |
| Cheon, GJ; Choi, CW; Choi, SJ; Kim, S; Lee, SS; Lim, SM; Park, YH; Ryoo, BY; Yang, SH; Yoo, JY | 1 |
| Fotopoulos, AD; Ioannidis, JP; Pakos, EE | 1 |
| Carreras Delgado, JL | 1 |
| Alinari, L; Baccarani, M; Battista, G; Boschi, S; Canini, R; Castellucci, P; Fanti, S; Farsad, M; Franchi, R; Marengo, M; Monetti, N; Nanni, C; Pettinato, C; Rampin, L; Rubello, D; Stefoni, V; Valentini, D; Zinzani, P | 1 |
| Blaufox, MD; Isasi, CR; Lu, P | 1 |
| Ell, PJ | 1 |
| Schwaiger, M; Wieder, H | 1 |
| Beguin, Y; Fillet, G; Hustinx, R; Jerusalem, G | 2 |
| Kazama, T; Macapinlac, HA; Podoloff, DA; Swanston, N | 1 |
| Coleman, M; Goldsmith, SJ; Kostakoglu, L; Leonard, JP | 1 |
| Momose, T | 1 |
| Bender, H; Biersack, HJ; Bucerius, J; Joe, A; Linnebank, M; Matthies, A; Palmedo, H; Pels, H; Schlegel, U; Schmidt-Wolf, IG; Urbach, H | 1 |
| Eisen, RN; Fey, C; Hollister, D; Lee, MS; Portlock, CS | 1 |
| Cohade, C; Fishman, EK; Nakamoto, Y; Tatsumi, M; Wahl, RL | 1 |
| Gibbs, SD; Gill, SI; Hicks, RJ; Seymour, JF | 1 |
| Alavi, A; Andreadis, C; Chiang, S; Fuster, D; Guan, L; Schuster, S; Zhuang, H | 1 |
| Cheng, DW; Cooper, DL; Kuo, PH | 1 |
| Itti, E; Luciani, A; Rahmouni, A | 2 |
| Avram, AM; Brown, RK; Francis, IR | 1 |
| Ames, E; Bhargava, P; Brown, J; Eapen, E; Glass, E | 1 |
| Gong, HY; Yu, JM | 1 |
| Avila, N; Bacharach, SL; Carrasquillo, JA; Chen, CC; Dale, JK; Dugan, F; Fleisher, T; Jaffe, ES; Puck, JM; Rao, VK; Straus, SE; Tretler, J; Whatley, M; Wilson, W | 1 |
| Kawai, N; Miyake, K; Nagao, S; Nishiyama, Y; Tamiya, T | 1 |
| Fukuda, H; Hakamatsuka, T; Higano, S; Kaneta, T; Kinomura, S; Sato, A; Takahashi, S; Takase, K; Yamada, S; Yamada, T | 1 |
| Pruim, J; Schot, BW; Sluiter, WJ; Vaalburg, W; van Imhoff, GW; Vellenga, E | 1 |
| Beguin, Y; Jerusalem, G | 1 |
| Hoekstra, OS; Hooft, L; Huijgens, PC; Lindauer-van der Werf, G; Riphagen, II; Zijlstra, JM | 1 |
| Aurer, I; Dodig, D; Grosev, D; Huić, D; Labar, B; Mutvar, A; Nemet, D; Radman, I; Zuvić, M | 1 |
| Mikhaeel, NG | 1 |
| Al-Nahhas, A; Alavi, A; Ambrosini, V; Castellucci, P; Fanti, S; Farsad, M; Nanni, C; Rubello, D; Tehranipour, N; Zinzani, P | 1 |
| Ciernik, I; Hany, TF; Koma, AY; Pestalozzi, B; Schaefer, NG; Strobel, K | 1 |
| Alinari, L; Ambrosini, V; Castellucci, P; Fanti, S; Farsad, M; Franchi, R; Nanni, C; Rubello, D; Stefoni, V; Tani, M; Zinzani, PL | 1 |
| Kawai, N; Monden, T; Nishiyama, Y; Ohkawa, M; Sasakawa, Y; Satoh, K; Yamamoto, Y | 1 |
| Davidson, T; Goshen, E; Yeshurun, M; Zwas, ST | 1 |
| Endo, K; Hanaoka, H; Higuchi, T; Iida, Y; Ishikita, T; Koyama, K; Miyakubo, M; Oriuchi, N | 1 |
| Bourguet, P | 1 |
| Al-Nahhas, A; Castellucci, P; Fanti, S; Farsad, M; Franchi, R; Gross, MD; Nanni, C; Rampin, L; Rubello, D | 1 |
| Hany, TF; Schaefer, NG; Strobel, K; Taverna, C | 1 |
| Bosly, A; Graux, C; Krug, B; Nollevaux, MC; Sonet, A; Vander Borght, T | 1 |
| Coya, J; Gomez-Leon, N; Hernandez-Maraver, D; Hernandez-Navarro, F; Madero, R; Martin-Curto, LM; Pinilla, I; Rodriguez-Vigil, B | 1 |
| Bar-Sever, Z; Bar-Shalom, R; Ben Arush, MW; Ben-Barak, A; Guralnik, L; Israel, O; Keidar, Z; Postovsky, S | 1 |
| Hicks, RJ | 2 |
| Alinari, L; Ambrosini, V; Berkowitz, A; Castellucci, P; Elstrom, R; Fanti, S; Farsad, M; Franchi, R; Nanni, C; Stefoni, V; Tani, M; Zinzani, PL | 1 |
| Bommer, M; Buck, AK; Bunjes, D; Döhner, H; Glatting, G; Juweid, M; Krause, BJ; Mattfeldt, T; Möller, P; Mottaghy, FM; Neumaier, B; Reske, SN; Schirrmeister, H; Stilgenbauer, S; Tepsic, D | 1 |
| Lin, EC | 2 |
| Aide, N; Bardet, S; Cheze, S; Fruchart, C; Le Stang, N; Leporrier, M; Levaltier, X; Liegard, M; Macro, M; Musafiri, D; Peny, AM; Reman, O; Switsers, O | 1 |
| Jones, RJ; Kasamon, YL; Wahl, RL | 1 |
| Kaburaki, J; Kubo, A; Nakahara, T; Shiga, H; Takagi, Y; Uchida, H | 1 |
| Bautz, W; Hornegger, J; Hothorn, T; Kuwert, T; Nömayr, A; Römer, W; Wolz, G | 1 |
| Hany, TF; Husarik, D; Koma, AY; Renner, C; Schaefer, NG; Strobel, K; Veit-Haibach, P | 1 |
| Bai, RJ; Gao, S; Li, YJ; Zhang, Y | 1 |
| Alavi, A; Basu, S; Iruvuri, S; Mahne, A | 1 |
| Brepoels, L; Stroobants, S; Verhoef, G | 1 |
| Mayor, S | 1 |
| Kirby, AM; Mikhaeel, NG | 1 |
| George Mikhaeel, N; Kirby, AM | 1 |
| Hayasaka, K; Ishigaki, T; Ito, K; Ito, Y; Itou, T; Kato, R; Naganawa, S; Nihashi, T; Sobajima, T | 1 |
| Blinder, MA; Krem, MM; Pan, L | 1 |
| Bui, C; Frey, KA; Hutchinson, RJ; Mody, RJ; Shulkin, BL | 1 |
| Egerer, G; Eisenhut, M; Gronkowski, M; Haberkorn, U; Haufe, S; Ho, AD; Kasper, B; Lehnert, T; Mechtersheimer, G | 1 |
| Advani, RH; Allred, C; Benson, AB; Brown, E; Burstein, HJ; Carlson, RW; Coleman, RE; Czuczman, MS; Delbeke, D; Edge, SB; Ettinger, DS; Grannis, FW; Hillner, BE; Hoffman, JM; Kiel, K; Komaki, R; Larson, SM; Mankoff, DA; Podoloff, DA; Rosenzweig, KE; Skibber, JM; Yahalom, J; Yu, JM; Zelenetz, AD | 1 |
| Specht, L | 1 |
| Brice, P; Briere, J; Cuenca, X; De Kerviler, E; Deville, L; Ertault, M; Filmont, JE; Gisselbrecht, C; Larghero, J; Moretti, JL; Mounier, N | 1 |
| Galanski, M; Gratz, KF; Rosenthal, H; von Falck, C | 1 |
| Bar-Shalom, R | 1 |
| Macapinlac, HA; Podoloff, DA | 1 |
| Cheson, BD; Juweid, ME; Seam, P | 1 |
| Chung, SK; Hyun O, J; Kim, CH; Kim, SH; Sohn, HS; Yoo, IeR | 1 |
| Alavi, A; Bural, GG; Houseni, M; Shriaknthan, S | 1 |
| Bongers, V; Comans, EF; Gundy, CM; Hoekstra, OS; van Lingen, A; Willem Coebergh, J; Zijlstra, JM | 1 |
| Hicks, RJ; MacManus, MP; Seymour, JF | 1 |
| Hsu, CH; Lee, CM; Lee, FP; Lee, TJ; Lin, YH; Yang, CM | 1 |
| Kwee, RM; Kwee, TC; Nievelstein, RA | 1 |
| Collins, CD | 1 |
| Arakawa, T; Fujiwara, Y; Higuchi, K; Ochi, M; Oshitani, N; Sasaki, E; Shiba, M; Tanaka, F; Tominaga, K; Uchida, T; Watanabe, T; Yamada, T | 1 |
| He, ZY; Qiao, WL; Wang, C; Wang, TS; Xing, Y; Zhao, JH | 1 |
| Ben-Arie, Y; Gaitini, D; Israel, O; Levy, Z; Shalom, RB; Soudack, M | 1 |
| Arluk, GM; McDivitt, JD; Turton, DB | 1 |
| Chiba, S; Izutsu, K; Kako, S; Kanda, Y; Kurokawa, M; Momose, T; Motokura, T; Ohtomo, K; Oshima, K; Takahashi, M; Yoshimi, A | 1 |
| Price, P; Rembielak, A | 1 |
| Bartenstein, P; Becker, C; Bröckel, N; Hacker, M; Hundt, W; la Fougère, C; Morhard, D; Pfluger, T; Schneider, V; Tiling, R | 1 |
| Davis, D; Dockery, KF; Puri, S; Qazi, R | 1 |
| Ban, S; Hayabuchi, N; Ishibashi, M; Kaida, H; Kurata, S; Meno, S; Okamura, T; Oshima, K; Takata, F; Uchida, M; Uchida, S; Uozumi, J | 1 |
| Faria, SC; Ito, H; Kazama, T; Macapinlac, HA; Uchida, Y | 1 |
| Fiumara, F; Pinkerton, R; Shankar, A | 1 |
| Geus-Oei, LF; Oyen, WJ | 1 |
| Bar-Shalom, R; Dann, EJ; Epelbaum, R; Fischer, D; Gaitini, D; Haim, N; Israel, O; Radan, L | 1 |
| Alavi, A; Basu, S; Berkowitz, A; Sankaran, S; Schuster, S; Srinivas, S | 1 |
| Aras, O; Lustberg, MB; Meisenberg, BR | 1 |
| Castell, F; Cook, GJ | 1 |
| Bashir, H; Nunan, TO; Shabo, G | 1 |
| Imura, J; Okumura, T; Sato, M; Shioyama, Y | 1 |
| Arimizu, N; Imaseki, K; Itami, J; Okada, J; Oonishi, H; Uno, K; Yoshikawa, K | 1 |
| Castle, VP; Dole, MG; Hernandez, RJ; Hutchinson, RJ; Koeppe, RA; Mitchell, DS; Prakash, D; Shulkin, BL; Ungar, DR | 1 |
| Lewis, PJ; Salama, A | 1 |
| Alavi, A; Buchpiguel, CA; Loessner, A | 1 |
| Larson, SM | 1 |
| Bergman, J; Knuuti, MJ; Lindholm, P; Minn, H; Nuutila, P; Ruotsalainen, U; Teräs, M | 1 |
| Francis, IR; Kaminski, MS; Newman, JS; Wahl, RL | 1 |
| Bares, R; Büll, U; Dempke, W; Galonska, P; Handt, S; Osieka, R | 1 |
| Larcos, G; Maisey, MN | 1 |
| Becker, M; Benchaou, M; Donath, A; Lehmann, W; Lemoine, R; Rufenacht, D; Slosman, DO | 1 |
| Ide, M; Shohtsu, A; Takagi, S; Yasuda, S | 1 |
| Bangerter, M; Diederichs, CG; Guhlmann, A; Herrmann, F; Kolokythas, O; Kotzerke, J; Merkle, E; Moog, F; Reske, SN | 1 |
| Deloar, HM; Fujiwara, T; Hayashi, Y; Itoh, M; Kanamaru, R; Miyake, M; Nakamura, T; Takahashi, H; Watabe, H; Yoshioka, T | 1 |
| Cronin, V; Galantowicz, P; Nabi, HA | 1 |
| Karwal, MW; Murphy, SP; Nathan, MA | 1 |
| Büll, U; Cremerius, U; Fabry, U; Günther, R; Hellwig, D; Neuerburg, J; Osieka, R; Thill, R; Wagenknecht, G | 1 |
| Barrington, SF; Carr, R; Madan, B; O'Doherty, MJ; Saunders, CA; Timothy, AR; van der Walt, J | 1 |
| Beese, M; Beyer, W; Bücheler, E; Bumann, D; Clausen, M; de Wit, M; Lübeck, M | 1 |
| Buck, A; Glanzmann, C; Steinert, HC; Stumpe, KD; Urbinelli, M; von Schulthess, GK | 1 |
| Artus, JC; Herry, JY; Lumbroso, J; Maublant, J; Muratet, JP; Talbot, JN; Vuillez, JP | 1 |
| Büll, U; Cremerius, U; Fabry, U; Kröll, U; Neuerburg, J; Osieka, R; Zimny, M | 1 |
| Hatazawa, J; Kawamura, M; Orino, K; Sazawa, Y; Suzuki, I | 1 |
| Bleckmann, C; Bohuslavizki, KH; Buchert, R; Clausen, M; Lorenzen, J; Mester, J; Schulte, U | 1 |
| Delbeke, D | 1 |
| Büll, U; Cremerius, U; Kaiser, HJ; Reinartz, P; Sabri, O; Schreckenberger, M; Zimny, M | 1 |
| Kotzerke, J; Moog, F; Reske, SN | 1 |
| Bangerter, M; Bergmann, L; Elsner, K; Griesshammer, M; Kotzerke, J; Reske, SN | 1 |
| Brenner, W; Czech, N; Henze, E; Kampen, WU | 1 |
| Bar-Shalom, R; Blaufox, MD; Valdivia, AY | 1 |
| Fridrik, M; Hatzl-Griesenhofer, M; Huber, H; Maschek, W; Pichler, R; Wahl, G; Wimmer, G | 1 |
| Brambs, HJ; Buchmann, I; Klose, T; Leidl, R; Reske, SN | 1 |
| Grönroos, T; Jyrkkiö, S; Lehikoinen, P; Lindholm, P; Minn, H; Sutinen, E; Teräs, M; Varpula, M | 1 |
| Burke, EM; Jarboe, J; Morton, KA | 1 |
| Avril, N; Schwaiger, M; Stahl, A; Weber, WA | 1 |
| Coiffier, B | 1 |
| Altehoefer, C; Brink, I; Hoegerle, S; Moser, E; Nitzsche, EU; Reinhardt, MJ | 1 |
| Pauwels, EK; Stokkel, MP; van der Hiel, B | 1 |
| Grahek, D; Haioun, C; Kerrou, K; Meignan, M; Misset, JL; Montravers, F; Rain, JD; Talbot, JN; Wioland, M | 1 |
| Adam, LE; Alavi, A; Alnafisi, N; Herman, C; Kim, W; Yun, M | 1 |
| Ariannejad, M; Czernin, J; Meta, J; Phelps, ME; Rao, J; Sayre, J; Schöder, H; Valk, PE; Yap, C | 1 |
| Golder, W | 1 |
| Angelberger, P; Dudczak, R; Füger, B; Kletter, K; Kurtaran, A; Leimer, M; Li, SR; Novotny, C; Patri, P; Raderer, M; Traub, T; Virgolini, I; Wogritsch, S | 1 |
| Healey, J; Macapinlac, H; Núñez, R; Sánchez Salmón, A; Yeung, H | 1 |
| Becherer, A; Dudczak, R; Greinix, HT; Jaeger, U; Kalhs, P; Karanikas, G; Kletter, K; Mitterbauer, M; Pötzi, C; Raderer, M | 1 |
| Alavi, A; Alnafisi, N; Yun, M | 1 |
| Ricart, Y | 1 |
| Cabrera Villegas, A; Gámez Cenzano, C; Martín Urreta, JC | 1 |
| Bomanji, JB; Costa, DC; Ell, PJ | 1 |
| Hoskin, PJ | 1 |
| Askienazy, S; Bok, B; Grall, Y; Meignan, M; Misset, JL; Rain, JD; Talbot, JN | 1 |
| Nabi, HA; Zubeldia, JM | 1 |
| Agoston, P; Esik, O; Fekésházy, A; Galuska, L; Kálvin, B; Lengyel, E; Lengyel, Z; Szakáll, S; Székely, J; Trón, L; Várady, E | 1 |
| Bĕlohlávek, O; Klener, P; Procházka, M; Slabý, J; Táborská, K; Trnĕný, M | 1 |
| Coleman, RE; Glantz, MJ; Hanson, MW; Hoffman, JM; Rosenfeld, SS; Schold, SC | 1 |
| Ido, T; Ito, M; Kubota, K; Yamada, K; Yamada, S; Yoshioka, S | 1 |
| Fukumura, T; Ichiya, Y; Jingu, K; Kuwabara, Y; Masuda, K; Otsuka, M; Tahara, T; Yoshikai, T | 1 |
| Darling, JL; Gill, SS; Parkins, CS; Thomas, DG; Wilson, CB | 1 |
| Ahonen, A; Joensuu, H; Klemi, PJ | 1 |
| Abe, Y; Fukuda, H; Hatazawa, J; Ido, T; Ito, M; Kiyosawa, M; Matsuzawa, T; Mizuno, K; Ohmura, M | 1 |
168 review(s) available for fluorodeoxyglucose f18 and Lymphoma
| Article | Year |
|---|---|
Artificial Intelligence in Lymphoma PET Imaging:: A Scoping Review (Current Trends and Future Directions).
Topics: Artificial Intelligence; Fluorodeoxyglucose F18; Humans; Lymphoma | 2022 |
Modern PET-Guided Radiotherapy Planning and Treatment for Malignant Lymphoma.
Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis | 2023 |
[18F]FDG PET/CT and PET/MR in Patients with Adrenal Lymphoma: A Systematic Review of Literature and a Collection of Cases.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2022 |
Molecular Imaging of Lymphoma: Future Directions and Perspectives.
Topics: Artificial Intelligence; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Molecular Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2023 |
Role of Artificial Intelligence in PET/CT Imaging for Management of Lymphoma.
Topics: Artificial Intelligence; Fluorodeoxyglucose F18; Humans; Lymphoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2023 |
Contribution of nuclear medicine to the diagnosis and management of primary brain tumours.
Topics: Amino Acids; Brain Neoplasms; Fluorodeoxyglucose F18; Glioma; Humans; Lymphoma; Meningeal Neoplasms; Meningioma; Neoplasm Recurrence, Local; Nuclear Medicine; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
Advances in positron emission tomography and radiomics.
Topics: Fluorodeoxyglucose F18; Genomics; Humans; Lymphoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies | 2023 |
Clinical Application of
Topics: Fluorodeoxyglucose F18; Hematologic Neoplasms; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2023 |
Diagnostic accuracy of whole-body magnetic resonance imaging versus positron emission tomography-computed tomography for the staging of pediatric lymphoma: a systematic review and meta-analysis.
Topics: Child; Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2023 |
The use of positron emission tomography imaging to guide radiation therapy.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphoma; Male; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals | 2023 |
Revised staging system for malignant lymphoma based on the Lugano classification.
Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphoma; Neoplasm Staging; Organ Specificity; Positron Emission Tomography Computed Tomography | 2019 |
RESISTing the Need to Quantify: Putting Qualitative FDG-PET/CT Tumor Response Assessment Criteria into Daily Practice.
Topics: Animals; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Lymphoma; Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals | 2019 |
Systematic review on the value of end-of-treatment FDG-PET in improving overall survival of lymphoma patients.
Topics: Cohort Studies; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Positron-Emission Tomography; Survival Rate | 2020 |
[Diagnostic imaging of malignant lymphomas].
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2020 |
[Hybrid imaging in lymphoma].
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Practice Guidelines as Topic; Radiopharmaceuticals | 2020 |
Radiogenomics and Its Role in Lymphoma.
Topics: Biomarkers, Tumor; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Lymphoma; Molecular Imaging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Reproducibility of Results | 2020 |
Molecular imaging in lymphoma beyond
Topics: Biomarkers, Tumor; Clinical Trials as Topic; Fluorodeoxyglucose F18; Humans; Immunotherapy; Lymphoma; Lymphoproliferative Disorders; Molecular Imaging; Neoplasm Staging; Positron-Emission Tomography; Precision Medicine; Radioimmunotherapy; Radioisotopes; Tissue Distribution | 2020 |
Functional imaging using radiomic features in assessment of lymphoma.
Topics: Diffusion Magnetic Resonance Imaging; Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphoma; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Progression-Free Survival; Radiopharmaceuticals; Risk Assessment; Tumor Burden | 2021 |
The contribution of metabolic parameters of FDG PET/CT prior and during therapy of adult patients with lymphomas.
Topics: Adult; Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Lymphoma; Positron Emission Tomography Computed Tomography | 2020 |
Direct comparison of diagnostic accuracies of F-18 FDG PET and MRI for detection of bone marrow involvement in lymphoma patients; A meta-analysis.
Topics: Bone Marrow; Bone Marrow Examination; Diffusion Magnetic Resonance Imaging; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2020 |
Practice and prospects for PET/CT guided interventions.
Topics: Bone Neoplasms; Dose-Response Relationship, Radiation; Fluorodeoxyglucose F18; Humans; Liver; Lung; Lymphoma; Nuclear Medicine; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2021 |
[Lymphoma in children and adolescents].
Topics: Adolescent; Child; Fluorodeoxyglucose F18; Humans; Lymphoma; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Whole Body Imaging | 2021 |
Positron emission tomography/computed tomography in the management of Hodgkin and B-cell non-Hodgkin lymphoma: An update.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Tumor Burden | 2021 |
Positron emission tomography/computed tomography hypermetabolism of Kikuchi-Fujimoto disease mimicking malignant lymphoma: a case report and literature review.
Topics: Fluorodeoxyglucose F18; Histiocytic Necrotizing Lymphadenitis; Humans; Lymph Nodes; Lymphoma; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2021 |
FDG-PET/CT versus bone marrow biopsy in bone marrow involvement in newly diagnosed paediatric lymphoma: a systematic review and meta-analysis.
Topics: Biopsy; Bone Marrow; Child; Fluorodeoxyglucose F18; Humans; Lymphoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2021 |
Total tumor burden in lymphoma - an evolving strong prognostic parameter.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Tumor Burden | 2021 |
The optimal use of PET/CT in the management of lymphoma patients.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted | 2021 |
The role of cardiac CT and MRI in the diagnosis and management of primary cardiac lymphoma: A comprehensive review.
Topics: Contrast Media; Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2022 |
Diagnostic value of using 18F-FDG PET and PET/CT in immunocompetent patients with primary central nervous system lymphoma: A systematic review and meta-analysis.
Topics: Central Nervous System Neoplasms; Fluorodeoxyglucose F18; Humans; Immunocompetence; Lymphoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2017 |
Usual and unusual pitfalls of 18F-FDG-PET/CT in lymphoma after treatment: a pictorial review.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Positron Emission Tomography Computed Tomography | 2017 |
[PET-CT imaging features of primary ureteric lymphoma:
A case report and literature review].
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Ureteral Neoplasms | 2017 |
Interim FDG-PET Imaging in Lymphoma.
Topics: Clinical Trials as Topic; Fluorodeoxyglucose F18; Humans; Lymphoma; Positron-Emission Tomography | 2018 |
FDG-PET/CT in the management of lymphomas: current status and future directions.
Topics: Biopsy; Bone Marrow; Cell Transformation, Neoplastic; Disease Progression; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Treatment Outcome; Tumor Burden | 2018 |
Applications of PET/CT and PET/MR Imaging in Primary Bone Malignancies.
Topics: Adult; Aged; Bone Neoplasms; Chondrosarcoma; Female; Fluorodeoxyglucose F18; Giant Cell Tumor of Bone; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Multiple Myeloma; Osteosarcoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma, Ewing; Young Adult | 2018 |
The Optimal Use of Imaging in Radiation Therapy for Lymphoma: Guidelines from the International Lymphoma Radiation Oncology Group (ILROG).
Topics: Antineoplastic Agents; Clinical Decision-Making; Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Respiration | 2019 |
Correlations Between Imaging Biomarkers and Proliferation Index Ki-67 in Lymphomas: A Systematic Review and Meta-Analysis.
Topics: Biomarkers; Cell Line, Tumor; Cell Proliferation; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Lymphoma; Multimodal Imaging; Odds Ratio; Positron-Emission Tomography | 2019 |
PET-Derived Quantitative Metrics for Response and Prognosis in Lymphoma.
Topics: Evaluation Studies as Topic; Fluorodeoxyglucose F18; Humans; Lymphoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Treatment Outcome | 2019 |
Evolving Role of PET-Based Novel Quantitative Techniques in the Management of Hematological Malignancies.
Topics: Evaluation Studies as Topic; Fluorodeoxyglucose F18; Hematologic Neoplasms; Humans; Lymphoma; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results | 2019 |
Proportion of false-positive follow-up FDG-PET scans in lymphoma: Systematic review and meta-analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy; Child; Child, Preschool; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma; Male; Middle Aged; Monitoring, Physiologic; Positron-Emission Tomography; Remission Induction; Young Adult | 2019 |
30 years of lymph node pathology: biomarkers and other advances.
Topics: Biomarkers, Tumor; Biopsy, Fine-Needle; Clinical Trials as Topic; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Karyotyping; Lymph Nodes; Lymphoma; Positron-Emission Tomography; Quality Control; Translocation, Genetic | 2013 |
FDG PET/CT in children and adolescents with lymphoma.
Topics: Adolescent; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Infant; Infant, Newborn; Lymphoma; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
Peritoneal lymphomatosis: CT and PET/CT findings and how to differentiate between carcinomatosis and sarcomatosis.
Topics: Carcinoma; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphoma; Multimodal Imaging; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Tomography, X-Ray Computed | 2013 |
Managing lymphoma with non-FDG radiotracers: current clinical and preclinical applications.
Topics: Antibodies, Anti-Idiotypic; Antigens, CD20; Diagnostic Imaging; Fluorodeoxyglucose F18; Humans; Lymphoma; Nuclear Medicine; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2013 |
18F-FDG PET in the diagnosis and treatment of primary central nervous system lymphoma.
Topics: Brain Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Positron-Emission Tomography | 2013 |
PET/computed tomography and lymphoma.
Topics: Artifacts; Fluorodeoxyglucose F18; Humans; Lymphoma; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals | 2013 |
PET/CT in malignant lymphoma: basic information, clinical application, and proposal.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
When should FDG-PET be used in the modern management of lymphoma?
Topics: Disease Management; Fluorodeoxyglucose F18; Humans; Lymphoma; Positron-Emission Tomography; Prognosis | 2014 |
Clinical value of ¹⁸F-fluoro-dexoxyglucose positron emission tomography/computed tomography in patients with adult-onset Still's disease: a seven-case series and review of the literature.
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Still's Disease, Adult-Onset | 2014 |
Current role of FDG PET/CT in lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
PET/CT in benign and malignant musculoskeletal tumors and tumor-like conditions.
Topics: Adult; Biopsy; Bone Neoplasms; Chondrosarcoma; Fasciitis; Female; Fibrosarcoma; Fibrous Dysplasia of Bone; Fluorodeoxyglucose F18; Histiocytoma, Benign Fibrous; Humans; Lymphoma; Multiple Myeloma; Musculoskeletal Diseases; Neoplasm Staging; Osteosarcoma; Paraproteinemias; Plasmacytoma; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
Primary mediastinal B-cell lymphoma and mediastinal gray zone lymphoma: do they require a unique therapeutic approach?
Topics: Antibodies, Monoclonal, Murine-Derived; B-Lymphocytes; Decision Making; Drug Therapy; Female; Fluorodeoxyglucose F18; Gene Expression Profiling; Hodgkin Disease; Humans; Immunophenotyping; Immunotherapy; Lymphoma; Lymphoma, B-Cell; Male; Mediastinal Neoplasms; Mediastinum; Positron-Emission Tomography; Recurrence; Rituximab; Treatment Outcome | 2015 |
Value of 18F-FDG PET and PET/CT for evaluation of pediatric malignancies.
Topics: Adolescent; Brain Neoplasms; Child; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Neoplasm Metastasis; Neoplasm Staging; Neoplasms; Neuroblastoma; Pediatrics; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Wilms Tumor | 2015 |
FDG PET/CT imaging as a biomarker in lymphoma.
Topics: Animals; Fluorodeoxyglucose F18; Humans; Lymphoma; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
[New trends and novel possibilities in the diagnosis of lymphomas].
Topics: Biomarkers, Tumor; Fluorodeoxyglucose F18; Humans; Lymphoma; Molecular Targeted Therapy; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed | 2015 |
Role of 2-Deoxy-2-[18F]-fluoro-d-glucose-PET/Computed Tomography in Lymphoma.
Topics: Adult; Antineoplastic Agents; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Young Adult | 2015 |
PET/CT: appropriate application in lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
VI. FDG-PET as a biomarker in lymphoma: from qualitative to quantitative analysis.
Topics: Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Positron-Emission Tomography; Radiography; Radiopharmaceuticals | 2015 |
(18)F-Flourodeoxy-Glucose PET/Computed Tomography in Brain Tumors: Value to Patient Management and Survival Outcomes.
Topics: Brain Neoplasms; Early Detection of Cancer; Fluorodeoxyglucose F18; Glioma; Humans; Lymphoma; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Precancerous Conditions; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Imaging in Lymphoma: The Key Role of Fluorodeoxyglucose-Positron Emission Tomography.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Positron-Emission Tomography; Radiography | 2015 |
[Sarcoidosis-lymphoma syndrome].
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphoma; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Syndrome; Tomography, X-Ray Computed | 2016 |
Pediatric Extranodal Lymphoma.
Topics: Adolescent; Child; Child Health; Child, Preschool; Diagnosis, Differential; Evidence-Based Medicine; Female; Fluorodeoxyglucose F18; Humans; Infant; Infant, Newborn; Lymphoma; Male; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals | 2016 |
Personalized Management Approaches in Lymphoma: Utility of Fluorodeoxyglucose-PET Imaging.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Positron-Emission Tomography; Precision Medicine; Radiopharmaceuticals | 2016 |
Proportion of false-positive lesions at interim and end-of-treatment FDG-PET in lymphoma as determined by histology: Systematic review and meta-analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results | 2016 |
18F-FDG-PET/CT of peritoneal tumors: a pictorial essay.
Topics: Carcinoma; Desmoplastic Small Round Cell Tumor; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Mesothelioma; Ovarian Neoplasms; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Pseudomyxoma Peritonei; Radiopharmaceuticals; Sarcoma; Stomach Neoplasms | 2017 |
Advancing Precision Nuclear Medicine and Molecular Imaging for Lymphoma.
Topics: Biomarkers, Tumor; Biopsy; Fluorodeoxyglucose F18; Humans; Lymphoma; Molecular Imaging; Molecular Targeted Therapy; Positron-Emission Tomography; Precision Medicine; Predictive Value of Tests; Radiopharmaceuticals | 2017 |
Topics: Adult; Child; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals | 2017 |
Radiology of the adrenal incidentalomas. Review of the literature.
Topics: 3-Iodobenzylguanidine; Addison Disease; Adrenal Cortex Neoplasms; Adrenal Gland Diseases; Adrenal Gland Neoplasms; Adrenocortical Adenoma; Adrenocortical Carcinoma; Cushing Syndrome; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Hemorrhage; Humans; Hyperaldosteronism; Indium; Indium Radioisotopes; Lymphoma; Magnetic Resonance Imaging; Myelolipoma; Octreotide; Pheochromocytoma; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Tomography, X-Ray Computed; Ultrasonography | 2017 |
The impact of fluorodeoxyglucose-positron emission tomography in primary staging and patient management in lymphoma patients.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
PET imaging for response assessment in lymphoma: potential and limitations.
Topics: False Negative Reactions; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lymphoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
Perspectives of molecular imaging and radioimmunotherapy in lymphoma.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lymphoma; Positron-Emission Tomography; Radioimmunotherapy; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
Cross-sectional evaluation of thoracic lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma; Mediastinal Neoplasms; Neoplasm Staging; Radiopharmaceuticals; Thoracic Neoplasms; Thymus Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2008 |
Utility of positron emission tomography in the mediastinum: moving beyond lung and esophageal cancer staging.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Mediastinum; Neoplasm Staging; Parathyroid Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Thoracic Neoplasms | 2009 |
Nodal status of malignant lymphoma in pelvic and retroperitoneal lymphatic pathways: PET/CT.
Topics: Contrast Media; Fluorodeoxyglucose F18; Humans; Lymphoma; Pelvis; Positron-Emission Tomography; Radiopharmaceuticals; Retroperitoneal Space; Tomography, X-Ray Computed | 2010 |
PET/CT for therapy response assessment in lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Imaging features of primary extranodal lymphomas.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Bone Neoplasms; Breast Neoplasms; Central Nervous System Neoplasms; Contrast Media; Diagnosis, Differential; Diagnostic Imaging; Digestive System Neoplasms; Eye Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Splenic Neoplasms; Tomography, X-Ray Computed; Urogenital Neoplasms | 2009 |
Unifying the predictive value of pretransplant FDG PET in patients with lymphoma: a review and meta-analysis of published trials.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Positron-Emission Tomography; Preoperative Care; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Stem Cell Transplantation | 2010 |
[Imaging in oncology and international rules for evaluation: the nuclear medicine].
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Neoplasm, Residual; Neoplasms; Nuclear Medicine; Positron-Emission Tomography; Radiopharmaceuticals | 2009 |
[FDG-PET for malignant lymphomas: important points for the hematologist].
Topics: Fluorodeoxyglucose F18; Humans; Hyperglycemia; Lymphoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
FDG PET-CT in the management of primary breast lymphoma.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Fluorine-18-fluorodeoxyglucose positron emission tomography in response assessment before high-dose chemotherapy for lymphoma: a systematic review and meta-analysis.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Child; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Salvage Therapy; Stem Cell Transplantation; Transplantation, Autologous; Treatment Outcome; Young Adult | 2010 |
Role of FDG PET/CT in imaging of renal lesions.
Topics: Adenoma, Oxyphilic; Angiomyolipoma; Carcinoma, Renal Cell; Cysts; Fluorodeoxyglucose F18; Humans; Incidental Findings; Kidney; Kidney Diseases; Kidney Neoplasms; Leukemia; Lymphoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2010 |
PET imaging in lymphoma.
Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Radiopharmaceuticals | 2009 |
18F-FDG PET, combined FDG-PET/CT and MRI for evaluation of bone marrow infiltration in staging of lymphoma: a systematic review and meta-analysis.
Topics: Bone Marrow Neoplasms; Comorbidity; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Neoplasm Staging; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2012 |
FDG-PET/CT in lymphoma.
Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed | 2011 |
PET/CT scanning with a high HIV/AIDS prevalence.
Topics: Acquired Immunodeficiency Syndrome; Central Nervous System Neoplasms; False Positive Reactions; Fluorodeoxyglucose F18; HIV Seropositivity; Humans; Lipodystrophy; Lymph Nodes; Lymphoma; Positron-Emission Tomography; Prevalence; Radionuclide Imaging; Radiopharmaceuticals; Thymus Gland; Tomography, X-Ray Computed | 2011 |
Personalized treatment of lymphoma: promise and reality.
Topics: Cancer Vaccines; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Positron-Emission Tomography; Precision Medicine | 2011 |
Role of functional imaging in the management of lymphoma.
Topics: Bone Marrow Examination; Diagnostic Errors; Fluorodeoxyglucose F18; Gallium Radioisotopes; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Neoplasm Staging; Positron-Emission Tomography; Thallium Radioisotopes; Tomography, X-Ray Computed | 2011 |
Magnetic resonance imaging of malignant lymphoma.
Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
Imaging of primary central nervous system lymphoma.
Topics: Central Nervous System Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Spectroscopy; Male; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed | 2011 |
[Significance of (18)F-FDG-PET/CT for staging and evaluation of therapeutic effect in patient with malignant lymphoma].
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Clinical significance of incidental focal colorectal (18)F-fluorodeoxyglucose uptake: our experience and a review of the literature.
Topics: Adenocarcinoma; Adenoma; Adult; Aged; Aged, 80 and over; Analysis of Variance; Chi-Square Distribution; Colonic Neoplasms; Colonic Polyps; Colonoscopy; Diverticulitis, Colonic; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Leiomyosarcoma; Lymphoma; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
Nuclear medicine and molecular imaging of the pediatric chest: current practical imaging assessment.
Topics: Adolescent; Child; Child, Preschool; Fluorodeoxyglucose F18; Gastrointestinal Diseases; Heart; Heart Diseases; Humans; Infant; Iodine Radioisotopes; Lung; Lung Diseases; Lung Neoplasms; Lymphoma; Molecular Imaging; Musculoskeletal Diseases; Myocardial Perfusion Imaging; Nuclear Medicine; Positron-Emission Tomography; Radiopharmaceuticals; Technetium Compounds; Thymus Neoplasms; Tomography, X-Ray Computed; Xenon Radioisotopes | 2011 |
Hematopoietic tumors and metastases involving bone.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Hematologic Neoplasms; Histiocytosis, Langerhans-Cell; Humans; Leukemia; Lymphoma; Magnetic Resonance Imaging; Multiple Myeloma; Neoplasms, Second Primary; Positron-Emission Tomography; Radiopharmaceuticals; Technetium Tc 99m Medronate; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
Impact of FDG-PET/CT in the management of lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Sarcoidosis and lymphoma: case series and literature review.
Topics: Adolescent; Adult; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed | 2011 |
Extranodal manifestations of lymphoma on [¹⁸F]FDG-PET/CT: a pictorial essay.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Tomography, X-Ray Computed | 2011 |
Application of metabolic PET imaging in radiation oncology.
Topics: Acetates; Carbon Radioisotopes; Carcinoma; Choline; Confounding Factors, Epidemiologic; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Inflammation; Lymphoma; Male; Methionine; Molecular Imaging; Neoplasms; Organ Specificity; Positron-Emission Tomography; Radiation Oncology; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted | 2012 |
[Progress of (18)F-FDG PET/CT application in the management of lymphoma].
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
PET/CT and renal pathology: a blind spot for radiologists? Part 2--lymphoma, leukemia, and metastatic disease.
Topics: Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Leukemia; Lymphoma; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
FDG-PET/CT based response-adapted treatment.
Topics: Adenocarcinoma; Esophageal Neoplasms; Esophagogastric Junction; Fluorodeoxyglucose F18; Humans; Lymphoma; Multimodal Imaging; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Spectrum of physiological and pathological cardiac and pericardial uptake of FDG in oncology PET-CT.
Topics: Adipose Tissue, Brown; Artifacts; Cardiomyopathies; Fluorodeoxyglucose F18; Heart Atria; Heart Diseases; Heart Ventricles; Humans; Leukemia; Lymphoma; Multimodal Imaging; Myocardium; Organ Specificity; Papillary Muscles; Pericarditis; Pericardium; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed | 2013 |
Oncological applications of positron emission tomography for evaluation of the thorax.
Topics: Breast; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Lymphoma; Mesothelioma; Positron-Emission Tomography; Radiopharmaceuticals; Solitary Pulmonary Nodule; Thorax; Thymus Gland; Thymus Neoplasms | 2013 |
Positron emission tomography imaging in melanoma and lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Melanoma; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
[A proposal for the rational use of the PET in oncology].
Topics: Brain Neoplasms; Colorectal Neoplasms; Consensus; Cost-Benefit Analysis; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Melanoma; Neoplasms; Practice Guidelines as Topic; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Spain; Tomography, Emission-Computed | 2002 |
[Cost-effective PET investigations in oncology].
Topics: Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Cost-Benefit Analysis; Diagnosis, Differential; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hungary; Lung Neoplasms; Lymphoma; Medicare; Melanoma; Neoplasm Staging; Neoplasms; Predictive Value of Tests; Radiopharmaceuticals; Solitary Pulmonary Nodule; Tomography, Emission-Computed; Tomography, X-Ray Computed; United States | 2002 |
Fluorine-18-fluorodeoxyglucose positron emission tomography metabolic imaging in patients with lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
18F-FDG PET evaluation of the response to therapy for lymphoma and for breast, lung, and colorectal carcinoma.
Topics: Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma; Male; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Treatment Outcome | 2003 |
Gallium-67 scintigraphy: a cornerstone in functional imaging of lymphoma.
Topics: Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lymphoma; Male; Predictive Value of Tests; Radioimmunodetection; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2003 |
Prognostic significance of 18F-fluorodeoxyglucose positron emission tomography in lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Prognosis; Tomography, Emission-Computed; Treatment Outcome | 2003 |
Positron emission tomography in the management of lymphomas: a summary.
Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
Positron emission tomography with [(18)F]FDG for therapy response monitoring in lymphoma patients.
Topics: Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Predictive Value of Tests; Prognosis; Radioimmunotherapy; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Prognostic value of FDG-PET in malignant lymphoma.
Topics: Citrates; Fluorodeoxyglucose F18; Gallium; Hodgkin Disease; Indium Radioisotopes; Lymphoma; Lymphoma, Non-Hodgkin; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Thallium; Tomography, Emission-Computed; Treatment Outcome | 2003 |
Assessment of therapy response by FDG PET in pediatric patients.
Topics: Adolescent; Bone Neoplasms; Brain Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Infant; Infant, Newborn; Lymphoma; Male; Neoplasms; Osteosarcoma; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Outcome | 2003 |
PET and restaging of malignant lymphoma including residual masses and relapse.
Topics: Cicatrix; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Neoplasm Staging; Predictive Value of Tests; Radiopharmaceuticals; Recurrence; Tomography, Emission-Computed | 2003 |
Impact of technology on the utilisation of positron emission tomography in lymphoma: current and future perspectives.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Radionuclide Imaging; Radiopharmaceuticals; Scintillation Counting; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Limitations of PET for imaging lymphoma.
Topics: False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Lymphoma, AIDS-Related; Male; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
[Clinical application of FDG-PET for cancer diagnosis].
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Lymphoma; Male; Middle Aged; Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
PET scans in the staging of lymphoma: current status.
Topics: Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma; Neoplasm Staging; Predictive Value of Tests; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
PET/CT in oncology: integration into clinical management of lymphoma, melanoma, and gastrointestinal malignancies.
Topics: Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lymphoma; Melanoma; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Care Management; Radiopharmaceuticals; Subtraction Technique; Systems Integration; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
[Positron-emission tomography in oncology].
Topics: Colorectal Neoplasms; Evidence-Based Medicine; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Melanoma; Neoplasms; Neoplasms, Unknown Primary; Neuroendocrine Tumors; Predictive Value of Tests; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
FDG PET and high-dose therapy for aggressive lymphomas: toward a risk-adapted strategy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Early Diagnosis; Fluorodeoxyglucose F18; Humans; Lymphoma; Radiopharmaceuticals; Risk Assessment; Risk Factors; Tomography, Emission-Computed; Treatment Outcome | 2004 |
Positron emission tomography in the evaluation of lymphoma.
Topics: Citrates; Fluorodeoxyglucose F18; Gallium; Humans; Lymphatic Metastasis; Lymphoma; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
The role of PET imaging in lymphoma.
Topics: Adult; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Neoplasm Staging; Tomography, Emission-Computed; Treatment Outcome | 2004 |
Molecular nuclear imaging: the radiopharmaceuticals (review).
Topics: Animals; Annexins; Antibodies, Monoclonal; Antigens; Apoptosis; Cysteine; Diagnostic Imaging; DNA; Fluorodeoxyglucose F18; Glycolysis; Humans; Indium Radioisotopes; Ligands; Lymphoma; Myocardial Infarction; Neoplasms; Octreotide; Organotechnetium Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Technetium; Tomography, Emission-Computed, Single-Photon; Yttrium Radioisotopes | 2005 |
18F-FDG PET for evaluation of bone marrow infiltration in staging of lymphoma: a meta-analysis.
Topics: Bone Marrow; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
A metaanalysis of 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography in the staging and restaging of patients with lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Neoplasm Staging; Positron-Emission Tomography | 2005 |
PET/CT in oncology: a major technology for cancer care.
Topics: Brain Neoplasms; Colorectal Neoplasms; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Neoplasms; Positron-Emission Tomography; Thyroid Neoplasms; Tomography, X-Ray Computed | 2005 |
Positron emission tomography imaging for lymphoma.
Topics: False Positive Reactions; Fluorodeoxyglucose F18; Gallium; Gallium Radioisotopes; Humans; Image Processing, Computer-Assisted; Lymphoma; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
Evaluation of therapy for lymphoma.
Topics: Antineoplastic Agents; Clinical Trials as Topic; Fluorodeoxyglucose F18; Humans; Lymphoma; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prognosis; Radioimmunotherapy; Radiopharmaceuticals; Treatment Outcome | 2005 |
The role of FDG-PET imaging in the management of lymphoma.
Topics: Bone Marrow; Clinical Trials as Topic; Disease Management; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Imaging, Three-Dimensional; Lymphoma; Lymphoma, Non-Hodgkin; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Recurrence; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome | 2004 |
[Clinical application of positron emission tomography and 18FDG to brain tumor].
Topics: Aged; Astrocytoma; Brain Diseases; Brain Neoplasms; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Humans; Lymphoma; Methionine; Necrosis; Neoplasm Recurrence, Local; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiation Injuries; Radiopharmaceuticals; Radiotherapy | 2005 |
[Current status of 18F-FDG PET in predicting outcome of cancer therapy].
Topics: Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Positron-Emission Tomography; Treatment Outcome | 2004 |
FDG PET in solitary metastastic/secondary tumor of the kidney: a report of three cases and a review of the relevant literature.
Topics: Adolescent; Adult; Aged; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lymphatic Metastasis; Lymphoma; Male; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Radiography; Radiopharmaceuticals | 2006 |
18F-fluoro-deoxyglucose positron emission tomography for post-treatment evaluation of malignant lymphoma: a systematic review.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Neoplasm, Residual; Positron-Emission Tomography; Sensitivity and Specificity | 2006 |
Lymphoma imaging: nuclear medicine.
Topics: Antineoplastic Agents; Citrates; Fluorodeoxyglucose F18; Gallium; Humans; Lymphoma; Magnetic Resonance Imaging; Neoplasm Staging; Nuclear Medicine; Positron-Emission Tomography; Radionuclide Imaging; Tomography, X-Ray Computed; Treatment Outcome | 2006 |
Use of FDG-PET to monitor response to chemotherapy and radiotherapy in patients with lymphomas.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Radiopharmaceuticals; Remission Induction; Treatment Outcome | 2006 |
PET and PET/CT using 18F-FDG in the diagnosis and management of cancer patients.
Topics: Breast Neoplasms; Carcinoma; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Tomography, Emission-Computed; Whole Body Imaging | 2006 |
18F-FDG PET/CT fusion imaging in paediatric solid extracranial tumours.
Topics: Child; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lymphoma; Neoplasms; Neuroblastoma; Osteosarcoma; Positron-Emission Tomography; Tissue Distribution; Tomography, X-Ray Computed | 2006 |
Integrating PET and PET/CT into the risk-adapted therapy of lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Subtraction Technique; Systems Integration; Technology Assessment, Biomedical; Tomography, X-Ray Computed; Treatment Outcome; Whole Body Imaging | 2007 |
PET and PET/CT for response evaluation in lymphoma: current practice and developments.
Topics: Antineoplastic Combined Chemotherapy Protocols; Evaluation Studies as Topic; Fluorodeoxyglucose F18; Humans; Lymphoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2007 |
The role of FDG PET in the management of lymphoma: what is the evidence base?
Topics: Clinical Trials as Topic; Evidence-Based Medicine; Fluorodeoxyglucose F18; Humans; Lymphoma; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2007 |
The role of FDG PET in the management of lymphoma: practical guidelines.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; United Kingdom | 2007 |
Usefulness of FDG PET for diagnosis and radiotherapy of the patient with malignant lymphoma involving bone marrow.
Topics: Aged; Bone Marrow Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lymphoma; Neoplasm Recurrence, Local; Radiopharmaceuticals; Tomography, Emission-Computed | 2007 |
2-[18F]fluoro-2-deoxyglucose positron-emission tomography in staging, response evaluation, and treatment planning of lymphomas.
Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Neoadjuvant Therapy; Neoplasm Staging; Neoplasm, Residual; Patient Care Planning; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Conformal; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Normal and abnormal patterns of 18F-fluorodeoxyglucose PET/CT in lymphoma.
Topics: False Negative Reactions; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lymphoma; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole Body Imaging | 2007 |
PET and PET/CT in management of the lymphomas.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
The role of FDG-PET scans in patients with lymphoma.
Topics: Delivery of Health Care; Fluorodeoxyglucose F18; Humans; Lymphoma; Monitoring, Physiologic; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Stem Cell Transplantation | 2007 |
Overview of early response assessment in lymphoma with FDG-PET.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; Disease Management; Disease Progression; Disease-Free Survival; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Middle Aged; Outcome Assessment, Health Care; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals | 2007 |
Imaging in staging of malignant lymphoma: a systematic review.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiography; Radiopharmaceuticals | 2008 |
PET/CT in oncology: for which tumours is it the reference standard?
Topics: Breast Neoplasms; Colorectal Neoplasms; Contrast Media; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms; Radiopharmaceuticals; Reference Standards; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2007 |
FDG-PET and PET/CT in malignant lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymphoma; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
The role of PET in target localization for radiotherapy treatment planning.
Topics: Carcinoma, Non-Small-Cell Lung; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Lymphatic Irradiation; Lymphoma; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Radiation Injuries; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
Role of FDG PET in the management of childhood lymphomas--case proven or is the jury still out?
Topics: Child; False Positive Reactions; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lymphoma; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
Predictive and prognostic value of FDG-PET.
Topics: Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals | 2008 |
Quantitative techniques in 18FDG PET scanning in oncology.
Topics: Breast Neoplasms; Data Interpretation, Statistical; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lymphoma; Male; Medical Oncology; Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Regression Analysis; Solitary Pulmonary Nodule; Stomach Neoplasms | 2008 |
Positron emission tomography scanning is coming to a hospital near you soon!
Topics: Colorectal Neoplasms; Diagnosis, Differential; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms; Outcome and Process Assessment, Health Care; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed; United Kingdom | 2008 |
Oncological applications of FDG PET imaging: brain tumors, colorectal cancer, lymphoma and melanoma.
Topics: Artifacts; Brain Neoplasms; Colorectal Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma; Melanoma; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
[Diagnostic value of positron emission tomography (PET) in clinical oncology].
Topics: Brain Neoplasms; Breast Neoplasms; Diagnosis, Differential; Digestive System Neoplasms; Evaluation Studies as Topic; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Male; Melanoma; Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed; Urogenital Neoplasms | 2000 |
PET imaging in oncology.
Topics: Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma; Male; Melanoma; Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; United States | 2000 |
Fluorine-18 fluorodeoxyglucose positron emission tomography in the staging and follow-up of lymphoma: is it time to shift gears?
Topics: Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lymphoma; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
Positron emission tomography and gallium metabolic imaging in lymphoma.
Topics: Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lymphoma; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
Positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose in oncology. Part IIIa: Therapy response monitoring in breast cancer, lymphoma and gliomas.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Central Nervous System Neoplasms; Evaluation Studies as Topic; Female; Fluorodeoxyglucose F18; Glioma; Humans; Lymphoma; Male; Neoplasm Metastasis; Neoplasms; Outcome Assessment, Health Care; Rats; Tomography, Emission-Computed | 2001 |
[18F]-FDG positron imaging in clinical management of lymphoma patients.
Topics: Disease Management; Fluorodeoxyglucose F18; Humans; Lymphoma; Neoplasm Staging; Prognosis; Tomography, Emission-Computed | 2001 |
Positron emission tomography in lymphoma: comparison with computed tomography and Gallium-67 single photon emission computed tomography.
Topics: Aged; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lymphoma; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2000 |
[Positron emission tomography (PET) in clinical oncology. Part II].
Topics: Adult; Aged; Colorectal Neoplasms; False Negative Reactions; False Positive Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphoma; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Clinical role of positron emission tomography in oncology.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Melanoma; Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
Clinical applications of (18)F-FDG in oncology.
Topics: Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Melanoma; Radiopharmaceuticals; Skin Neoplasms; Tomography, Emission-Computed | 2002 |
[Cost-effective PET scans in oncology].
Topics: Breast Neoplasms; Colorectal Neoplasms; Cost-Benefit Analysis; Diagnosis, Differential; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hungary; Lung Neoplasms; Lymphoma; Medicare; Melanoma; Neoplasm Staging; Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed; United States | 2002 |
28 trial(s) available for fluorodeoxyglucose f18 and Lymphoma
| Article | Year |
|---|---|
18F-FDG PET Imaging Features of Patients With Autoimmune Lymphoproliferative Syndrome.
Topics: Adolescent; Adult; Autoimmune Lymphoproliferative Syndrome; Child; Child, Preschool; fas Receptor; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Mutation; Positron-Emission Tomography; Splenomegaly; Tissue Distribution; Young Adult | 2019 |
Radiomics based on
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Lymphoma; Machine Learning; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; ROC Curve | 2020 |
Determinants of activity of brown adipose tissue in lymphoma patients.
Topics: Adipose Tissue, Brown; Adult; Age Factors; Aged; Body Mass Index; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Metabolic Syndrome; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sex Factors | 2020 |
Multicenter Comparison of Contrast-Enhanced FDG PET/CT and 64-Slice Multi-Detector-Row CT for Initial Staging and Response Evaluation at the End of Treatment in Patients With Lymphoma.
Topics: Adult; Aged; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prospective Studies; Treatment Outcome | 2017 |
Is there a reliable size cut-off for splenic involvement in lymphoma? A [18F]FDG-PET controlled study.
Topics: Adult; Aged; Databases, Factual; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Spleen; Tomography, X-Ray Computed | 2019 |
Role of 18F-FLT PET/CT in suspected recurrent or residual lymphoma: final results of a pilot prospective trial.
Topics: Adult; Aged; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2019 |
Whole-body MRI for initial staging of paediatric lymphoma: prospective comparison to an FDG-PET/CT-based reference standard.
Topics: Adolescent; Child; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Neoplasm Staging; Observer Variation; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Reference Standards; Sensitivity and Specificity; Whole Body Imaging | 2014 |
Diffusion-weighted MRI compared to FDG PET/CT for assessment of early treatment response in lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Diffusion Magnetic Resonance Imaging; Doxorubicin; Early Diagnosis; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphoma; Male; Middle Aged; Multimodal Imaging; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine; Young Adult | 2015 |
Evaluation of diffusion-weighted MRI for pretherapeutic assessment and staging of lymphoma: results of a prospective study in 140 patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lymphoma; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2014 |
Role of [18F]fluorodeoxyglucose positron emission tomography scan in the follow-up of lymphoma.
Topics: Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Recurrence | 2009 |
FDG PET-CT in the management of primary breast lymphoma.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Detection of incidental colorectal tumours with 18F-labelled 2-fluoro-2-deoxyglucose positron emission tomography/computed tomography scans: results of a prospective study.
Topics: Adenocarcinoma; Adenoma; Adult; Aged; Aged, 80 and over; Biopsy; Colonic Polyps; Colonoscopy; Colorectal Neoplasms; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lymphoma; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Positron-Emission Tomography; Proportional Hazards Models; Prospective Studies; Tomography, X-Ray Computed; Young Adult | 2011 |
The chemotherapy long-term effect on cognitive functions and brain metabolism in lymphoma patients.
Topics: Antineoplastic Agents; Brain; Cognition; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2012 |
Clinical impact of whole body FDG-PET on the staging and therapeutic decision making for malignant lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Citrates; Decision Making; Female; Fluorodeoxyglucose F18; Gallium; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Care Management; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome; Whole-Body Counting | 2002 |
Whole-body tumor imaging using PET and 2-18F-fluoro-L-tyrosine: preliminary evaluation and comparison with 18F-FDG.
Topics: Aged; Aged, 80 and over; Feasibility Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Male; Middle Aged; Neoplasms; Organ Specificity; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed; Whole-Body Counting | 2003 |
Non-malignant FDG uptake in infradiaphragmatic adipose tissue: a new site of physiological tracer biodistribution characterised by PET/CT.
Topics: Abdominal Neoplasms; Adipose Tissue; Adolescent; Adult; Diaphragm; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tissue Distribution; Tomography, X-Ray Computed | 2004 |
Characterization of the normal adrenal gland with 18F-FDG PET/CT.
Topics: Adrenal Glands; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lymphoma; Observer Variation; Radiopharmaceuticals; Reference Standards; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
Addition of 18F-FDG-PET scans to radiotherapy planning of thoracic lymphoma.
Topics: Adolescent; Adult; Aged; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Observer Variation; Patient Care Planning; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Thoracic Neoplasms; Tomography, X-Ray Computed | 2004 |
Endoscopic ultrasound-guided fine needle aspiration of mediastinal lymph node in patients with suspected lung cancer after positron emission tomography and computed tomography scans.
Topics: Aged; Biopsy, Fine-Needle; Breast Neoplasms; Carcinoma; Carcinoma, Non-Small-Cell Lung; Colonic Neoplasms; Endometrial Neoplasms; Esophagoscopy; Female; Fluorodeoxyglucose F18; Granuloma; Histiocytosis; Histoplasmosis; Humans; Kidney Neoplasms; Lung Diseases; Lung Neoplasms; Lymphatic Diseases; Lymphatic Metastasis; Lymphoma; Male; Mediastinum; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sarcoidosis; Silicosis; Tomography, X-Ray Computed; Ultrasonography, Interventional; Urinary Bladder Neoplasms | 2005 |
[18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome.
Topics: Adolescent; Adult; Aged; Anthracyclines; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Prospective Studies; Remission Induction; Rituximab; Survival Analysis | 2005 |
Effect of colony-stimulating factor and conventional- or high-dose chemotherapy on FDG uptake in bone marrow.
Topics: Adult; Antineoplastic Agents; Bone Marrow; Colony-Stimulating Factors; Dose-Response Relationship, Drug; False Positive Reactions; Female; Fluorodeoxyglucose F18; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Lymphoma; Male; Metabolic Clearance Rate; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
Fluorodeoxyglucose positron emission tomography (FDG-PET) for monitoring lymphadenopathy in the autoimmune lymphoproliferative syndrome (ALPS).
Topics: Autoimmune Diseases; Biopsy; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Diseases; Lymphoma; Lymphoproliferative Disorders; Male; Mutation; Positron-Emission Tomography; Prospective Studies | 2006 |
Evaluation of tumor FDG transport and metabolism in primary central nervous system lymphoma using [18F]fluorodeoxyglucose (FDG) positron emission tomography (PET) kinetic analysis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biological Transport, Active; Brain Neoplasms; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Kinetics; Lymphoma; Male; Metabolic Clearance Rate; Middle Aged; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Vincristine | 2005 |
The role of serial pre-transplantation positron emission tomography in predicting progressive disease in relapsed lymphoma.
Topics: Disease Progression; Fluorodeoxyglucose F18; Humans; Lymphoma; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Recurrence | 2006 |
The value of F-18 FDG triple-head coincidence PET in the posttreatment evaluation of patients with lymphoma.
Topics: Antineoplastic Agents; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lymphoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Treatment Outcome | 2006 |
Performance study of a miniature gamma ray scintillation vivo probe for tumor localization.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Citrates; Deoxyglucose; Endoscopes; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gallium; Gallium Radioisotopes; Gamma Cameras; Humans; Lung Neoplasms; Lymphatic Metastasis; Lymphoma; Male; Middle Aged; Neoplasms; Phantoms, Imaging; Tomography, Emission-Computed | 1997 |
Whole-body positron emission tomography using fluorodeoxyglucose for staging of lymphoma: effectiveness and comparison with computed tomography.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole-Body Counting | 1998 |
Effect of whole-body (18)F-FDG PET imaging on clinical staging and management of patients with malignant lymphoma.
Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Image Interpretation, Computer-Assisted; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Surveys and Questionnaires; Tomography, Emission-Computed; Whole-Body Counting | 2001 |
546 other study(ies) available for fluorodeoxyglucose f18 and Lymphoma
| Article | Year |
|---|---|
Case report of an elderly woman with atypical imaging for primary central nervous system lymphoma who needed a brain biopsy for diagnosis.
Topics: Aged; Biopsy; Brain; Central Nervous System; Central Nervous System Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2021 |
Malaysian consensus statement on FDG PET-CT reporting format for lymphoma.
Topics: Consensus; Fluorodeoxyglucose F18; Humans; Lymphoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2021 |
Baseline FDG PET/CT in free breathing versus deep inspiration breath-hold for pediatric patients with mediastinal lymphoma.
Topics: Adolescent; Breath Holding; Child; Child, Preschool; Fluorodeoxyglucose F18; Heart; Humans; Lymphoma; Organs at Risk; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Retrospective Studies | 2022 |
[Metabolic imaging in lymphoid hemopathies].
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Multiple Myeloma; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2021 |
Body CT and PET/CT detection of extracranial lymphoma in patients with newly diagnosed central nervous system lymphoma.
Topics: Central Nervous System; Cohort Studies; Fluorodeoxyglucose F18; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Positron Emission Tomography Computed Tomography; Tomography, X-Ray Computed | 2022 |
18F-FDG PET/CT imaging in the diagnosis of drug-induced lung disease and pulmonary infection in lymphoma.
Topics: Adult; Aged; Drug Interactions; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lymphoma; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2021 |
Lesion-Based Radiomics Signature in Pretherapy 18F-FDG PET Predicts Treatment Response to Ibrutinib in Lymphoma.
Topics: Adenine; Fluorodeoxyglucose F18; Humans; Lymphoma; Piperidines; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2022 |
FDG PET/CT of Primary Breast Lymphoma in a Man.
Topics: Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2022 |
Lymphogranuloma Venereum Mimicking Lymphoma on FDG PET/CT.
Topics: Adult; Chlamydia trachomatis; Fluorodeoxyglucose F18; Humans; Lymphogranuloma Venereum; Lymphoma; Male; Positron Emission Tomography Computed Tomography | 2022 |
Lymphoma pseudoprogression observed on [18F]FDG PET-CT scan 15 days after CAR-T infusion.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Chimeric Antigen | 2022 |
Dual-Layer Spectral Detector CT in Comparison with FDG-PET/CT for the Assessment of Lymphoma Activity.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Iodine; Lymphoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2022 |
Rosai-Dorman disease mimicking lymphoma on 18F-FDG PET/CT.
Topics: Female; Fluorodeoxyglucose F18; Histiocytes; Humans; Lymphoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2022 |
Automatic classification of lymphoma lesions in FDG-PET-Differentiation between tumor and non-tumor uptake.
Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Positron-Emission Tomography; Radiopharmaceuticals; Tumor Burden | 2022 |
First-in-Man Noninvasive Initial Diagnostic Approach of Primary CNS Lymphoma Versus Glioblastoma Using PET With 18 F-Fludarabine and l -[methyl- 11 C]Methionine.
Topics: Adrenal Cortex Hormones; Brain Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Glioblastoma; Humans; Lymphoma; Methionine; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Vidarabine | 2022 |
Delineating and sparing functional nephrons for radiotherapy in the case of lymphoma with polycystic kidney disease.
Topics: Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma; Male; Nephrons; Polycystic Kidney Diseases; Radiopharmaceuticals | 2022 |
Detecting marrow involvement in lymphoma: Can-
Topics: Biopsy; Bone Marrow; Fluorodeoxyglucose F18; Humans; Lymphoma; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2021 |
Neurolymphomatosis: an uncommon manifestation of lymphoma - detection and therapeutic monitoring through 18F-fluorodeoxyglucose positron-emission tomography and computed tomography imaging.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Neurolymphomatosis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
Positron emission tomography/computed tomography differentiates resectable thymoma from anterior mediastinal lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Mediastinal Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Thymoma; Thymus Neoplasms | 2023 |
Prognostic value of pre-transplantation total metabolic tumor volume on
Topics: Fluorodeoxyglucose F18; Glucose; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Tumor Burden | 2022 |
Chemotherapy-induced Cardiac18F-FDG Uptake in Patients with Lymphoma: An Early Metabolic Index of Cardiotoxicity?
Topics: Adult; Aged; Antineoplastic Agents; Cardiotoxicity; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2022 |
PET/CT morphology and cardiac conduction disorders help discriminate primary cardiac lymphoma from primary cardiac sarcoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Mediastinal Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Sarcoma | 2022 |
Topics: Fluorodeoxyglucose F18; Humans; Kidney; Lymphoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2022 |
Hepatic superscan on fluorine-18 fluorodeoxyglucose PET/computed tomography imaging: a specific manifestation for diagnosing lymphoma or leukemia involvement.
Topics: Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hematologic Neoplasms; Humans; Leukemia; Liver; Lymphoma; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2022 |
Baseline 18 F-FDG PET/CT May Portend the Prognosis of Patients With Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma After First-Line Treatment.
Topics: Fluorodeoxyglucose F18; Glycolysis; Humans; Lymphoma; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Tumor Burden; Waldenstrom Macroglobulinemia | 2022 |
64 Cu-DOTA-Rituximab PET/CT of B-Cell Non-Hodgkin Lymphoma for Imaging the CD20 Expression.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Fluorodeoxyglucose F18; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Rituximab | 2023 |
A novel predictive model for distinguishing mediastinal lymphomas from thymic epithelial tumours.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Mediastinal Neoplasms; Neoplasms, Glandular and Epithelial; Retrospective Studies; Thymus Neoplasms; Tomography, X-Ray Computed | 2022 |
Significant CT dose reduction of 2-[
Topics: Child; Drug Tapering; Fluorodeoxyglucose F18; Humans; Lymphoma; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2023 |
Superscan on 18F-FDG PET-CT imaging for lymphoma: How frequent is it?
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2022 |
Disseminated cryptococcosis mimicking malignant lymphoma on 18F-FDG PET/CT: A case report.
Topics: Adult; Cryptococcosis; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphoma; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Young Adult | 2022 |
Radiological Features of Bone Lymphoma on CT and MRI. A Retrospective Monocentric Series of 56 Patients.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Radiography; Retrospective Studies; Tomography, X-Ray Computed | 2023 |
Optimization of SUV with Changing the Dose Amount in F18-FDG PET/CT of Pediatric Lymphoma Patients.
Topics: Child; Fluorodeoxyglucose F18; Humans; Lymphoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
Neurexin-3α-associated autoimmune encephalitis with intracranial diffuse large B lymphoma diagnosed on FDG and TSPO PET/MRI.
Topics: Autoimmune Diseases of the Nervous System; Fluorodeoxyglucose F18; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, GABA | 2023 |
What is the Best Preoperative Quantitative Indicator to Differentiate Primary Central Nervous System Lymphoma from Glioblastoma?
Topics: Brain Neoplasms; Central Nervous System; Central Nervous System Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Glioblastoma; Humans; Lymphoma; Tomography, X-Ray Computed | 2023 |
Diagnostic performance of prospective same-day 18F-FDG PET/MRI and 18F-FDG PET/CT in the staging and response assessment of lymphoma.
Topics: Adult; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals | 2023 |
18 F-FDG PET/CT of a Rare Sternal Osteoblastoma in a Man With History of Lymphoma.
Topics: Adult; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Osteoblastoma; Positron Emission Tomography Computed Tomography; Sternum | 2023 |
Role of 18F-fluorodeoxyglucose PET/computed tomography in the diagnosis and treatment response assessment of primary bone lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Tomography, X-Ray Computed | 2023 |
Interobserver variability in interim PET assessment in Hodgkin lymphoma-reasons and solutions.
Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Observer Variation; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2023 |
[Thoracic SMARCA4-deficient undifferentiated tumor resembling malignant lymphoma].
Topics: Biomarkers, Tumor; DNA Helicases; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Nuclear Proteins; Positron Emission Tomography Computed Tomography; Transcription Factors | 2023 |
Whole body MRI with Diffusion Weighted Imaging versus 18F-fluorodeoxyglucose-PET/CT in the staging of lymphomas.
Topics: Adult; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Whole Body Imaging | 2023 |
Granulomatous dermatitis: a rare pitfall in lymphoma staging with [
Topics: Dermatitis; Fluorodeoxyglucose F18; Humans; Lymphoma; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
Diagnostic and management roles of FDG PET/CT imaging in post-transplant lympho-proliferation in pediatric heart transplantation.
Topics: Adolescent; Biopsy; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Heart Transplantation; Humans; Lymphoma; Male; Positron Emission Tomography Computed Tomography | 2023 |
Differentiation between rebound thymic hyperplasia and thymic relapse after chemotherapy in pediatric Hodgkin lymphoma.
Topics: Child; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Thymus Hyperplasia; Thymus Neoplasms; Tomography, X-Ray Computed | 2023 |
Case Report: FDG-PET/CT findings in co-infection of visceral leishmaniasis and chronic hepatitis B.
Topics: Adult; Coinfection; Fluorodeoxyglucose F18; Hepatitis B, Chronic; Humans; Leishmaniasis, Visceral; Lymphohistiocytosis, Hemophagocytic; Lymphoma; Male; Positron Emission Tomography Computed Tomography | 2023 |
Primary Urethra Non-Hodgkin Lymphoma in a 46-Year-Old Man on FDG PET/CT.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Urethra | 2023 |
FDG-Avid But Pentixafor-Negative in EBV-Associated T-Cell Lymphoproliferative Disorders.
Topics: Adolescent; Female; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Humans; Lymphoma; Lymphoproliferative Disorders; Positron Emission Tomography Computed Tomography; T-Lymphocytes | 2023 |
Inflammatory reactions mimic residual or recurrent lymphoma on [18F]FDG-PET/CT after CD19-directed CAR T-cell therapy.
Topics: Antigens, CD19; Fluorodeoxyglucose F18; Humans; Immunotherapy, Adoptive; Lymphoma; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography | 2023 |
Whipple Disease Misdiagnosed as Lymphoma by 18 F-FDG PET/CT: A Case Study.
Topics: Diagnostic Errors; Fluorodeoxyglucose F18; Humans; Lymphoma; Positron Emission Tomography Computed Tomography; Whipple Disease | 2023 |
The diagnostic value of dual-layer CT in the assessment of lymph nodes in lymphoma patients with PET/CT as a reference standard.
Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphoma; Positron Emission Tomography Computed Tomography; Reference Standards; Retrospective Studies | 2023 |
Sarcoid-like Histiocytic Proliferations in Patients With Lymphoma Can Be FDG-avid Concerning for Refractory or Recurrent Disease.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Histiocytes; Humans; Immunohistochemistry; Lymphoma; Middle Aged; Neoplasm Grading; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prednisolone; Sarcoidosis; Vincristine | 2019 |
18F-2-fluoro-2-deoxyglucose uptake in white adipose tissue on pediatric oncologic positron emission tomography (PET)/computed tomography (CT).
Topics: Adipose Tissue, White; Adolescent; Adrenal Cortex Hormones; Child; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2020 |
Artificial Intelligence in PET/CT Is about to Make Whole-Body Tumor Burden Measurements a Clinical Reality.
Topics: Artificial Intelligence; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma; Neural Networks, Computer; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Tumor Burden | 2020 |
Correlations between maximum standardized uptake value measured via
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Biomarkers; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Ki-67 Antigen; Lymphoma; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies; ROC Curve; Young Adult | 2019 |
Performance of Positron Emission Tomography-Computed Tomography and Bone Marrow Biopsy in Detecting Bone Marrow Infiltration in Lymphoma Cases
Topics: Adult; Aged; Biopsy; Bone Marrow; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2020 |
Interim PET Assessment of Advanced Hodgkin Lymphoma: Is It Sufficient?
Topics: Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma; Positron-Emission Tomography | 2020 |
Early Detection of Secondary Central Nervous System Lymphoma on PET/CT.
Topics: Central Nervous System Neoplasms; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Middle Aged; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography | 2020 |
18F-FDG Uptake in a T2 Hypointense Paraspinal Mass.
Topics: Aged; Amyloidosis; Biological Transport; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lymphoma; Magnetic Resonance Imaging; Male; Positron Emission Tomography Computed Tomography; Spine | 2020 |
Inflammatory Pseudotumor of Intestine Mimicking Lymphoma on 18F-FDG PET/CT.
Topics: Colonic Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Granuloma, Plasma Cell; Humans; Lymphoma; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography | 2020 |
Thymic carcinoid mimicking mediastinal lymphoma on
Topics: Adult; Carcinoid Tumor; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Mediastinal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Thymus Neoplasms | 2021 |
18F-FDG PET/CT Findings of Granulomatosis With Polyangiitis Mimicking Malignant Lymphoma.
Topics: Fluorodeoxyglucose F18; Granulomatosis with Polyangiitis; Humans; Lymphoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
FDG PET Is a Better Canary in the Coal Mine than CT for Refractory Lymphoma.
Topics: Coal; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Nivolumab; Positron-Emission Tomography; Tomography, X-Ray Computed | 2020 |
Detection of
Topics: Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Radiation Dosage; Radiometry | 2020 |
Hepatic candidiasis mimicking lymphoma on
Topics: Candidiasis; Fluorodeoxyglucose F18; Humans; Lymphoma; Lymphoma, T-Cell; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2020 |
The concomitance of lymphoma and breast carcinoma in the bone.
Topics: Biomarkers, Tumor; Biopsy; Bone Marrow; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Middle Aged; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography | 2020 |
Low ADC in CNS Lymphoma.
Topics: Aged, 80 and over; Central Nervous System Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Ischemia; Lymphoma; Magnetic Resonance Imaging | 2020 |
[18F]-FDG PET/CT for suspected lymphoma relapse in a patient with concomitant pneumococcal pneumonia during COVID-19 outbreak: unexpected SARS-Cov-2 co-infection despite double RT-PCR negativity.
Topics: Betacoronavirus; Coinfection; Coronavirus Infections; COVID-19; Fluorodeoxyglucose F18; Humans; Lymphoma; Nuclear Medicine; Pandemics; Pneumonia, Pneumococcal; Pneumonia, Viral; Positron Emission Tomography Computed Tomography; Recurrence; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2 | 2020 |
Combination of baseline total metabolic tumor volume measured on FDG-PET/CT and β2-microglobulin have a robust predictive value in patients with primary breast lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; beta 2-Microglobulin; Breast Neoplasms; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Survival Rate; Tumor Burden; Young Adult | 2020 |
Diagnostic accuracy of positron emission tomography/computed tomography-driven biopsy for the diagnosis of lymphoma.
Topics: Biopsy; Fluorodeoxyglucose F18; Humans; Lymphoma; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2020 |
Lenograstim-Induced Nodal Extramedullary Hematopoiesis: A Challenging Diagnosis in Lymphoma Evaluation With 18F-FDG PET/CT.
Topics: Fluorodeoxyglucose F18; Hematopoiesis, Extramedullary; Humans; Lenograstim; Lymphoma; Male; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Young Adult | 2020 |
Clinical spectrum of primary adrenal lymphoma: results of a multicenter cohort study.
Topics: Adrenal Gland Neoplasms; Adrenal Insufficiency; Adult; Aged; Aged, 80 and over; Canada; Cohort Studies; Diagnosis, Differential; Europe; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Multimodal Imaging; Phenotype; Positron-Emission Tomography; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed; United States | 2020 |
A Case of Primary Sacral Lymphoma Evaluated by 18F-FDG PET/CT.
Topics: Biopsy; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Sacrum | 2020 |
18F-fluorodeoxyglucose positron emission tomography/computed tomography of bilateral primary ureter lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Ureter | 2021 |
Reply: Interim PET Assessment of Advanced Hodgkin Lymphoma: Is It Sufficient?
Topics: Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma; Positron-Emission Tomography | 2020 |
Altered FDG Biodistribution in Subcutaneous White Fat on PET/CT Following l-Asparaginase Chemotherapy.
Topics: Adipose Tissue, White; Adolescent; Asparaginase; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Mediastinal Neoplasms; Positron Emission Tomography Computed Tomography; Subcutaneous Tissue; Tissue Distribution; Treatment Outcome | 2021 |
Neurolymphomatosis: a single-center experience of neuromuscular manifestations, treatments, and outcomes.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Neurolymphomatosis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies | 2021 |
Rebound adenotonsillar and thymic uptake of 18F-FDG in paediatric patients with lymphoma.
Topics: Aged; Child; Fluorodeoxyglucose F18; Humans; Lymphoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2020 |
Focal Liver 18F-FDG Uptake in a Patient Who Underwent Thrombolysis for Brachiocephalic and Subclavian Thrombosis: A Potential Pitfall.
Topics: Biological Transport; Brachiocephalic Veins; Female; Fluorodeoxyglucose F18; Humans; Liver; Lymphoma; Mediastinal Neoplasms; Positron Emission Tomography Computed Tomography; Subclavian Artery; Thrombolytic Therapy; Thrombosis; Young Adult | 2021 |
Infection Control of COVID-19: Surgical Mask-Related Facial Cutaneous Artifact on FDG PET/CT.
Topics: Artifacts; COVID-19; Fluorodeoxyglucose F18; Humans; Infection Control; Lymphoma; Male; Masks; Middle Aged; Positron Emission Tomography Computed Tomography; SARS-CoV-2; Skin Diseases | 2021 |
Case 285: Primary Breast Lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Breast; Breast Neoplasms; Cyclophosphamide; Diagnostic Imaging; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Prednisone; Radiopharmaceuticals; Rituximab; Treatment Outcome; Ultrasonography, Mammary; Vincristine | 2021 |
Primary cardiac angiosarcoma with thrombosis and multiple bone marrow metastases mimicking lymphoma on
Topics: Bone Marrow Neoplasms; Fluorodeoxyglucose F18; Hemangiosarcoma; Humans; Lymphoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Thrombosis | 2022 |
Evaluation of
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Lymphoma; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Young Adult | 2021 |
Primary Central Nervous System Lymphoma Revealed by 68Ga-FAPI and 18F-FDG PET/CT.
Topics: Aged; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Positron Emission Tomography Computed Tomography; Quinolines | 2021 |
COVID-19 mRNA Vaccination-Induced Lymphadenopathy Mimics Lymphoma Progression on FDG PET/CT.
Topics: Aged; COVID-19; COVID-19 Vaccines; Diagnosis, Differential; Disease Progression; Fluorodeoxyglucose F18; Humans; Lymphadenopathy; Lymphoma; Male; Positron Emission Tomography Computed Tomography; RNA, Messenger; SARS-CoV-2; Subcutaneous Tissue; Vaccination | 2021 |
Clinical impact of endoscopic ultrasound in the study of adrenal gland: cytomegalovirus infection mimicking a neoplasic hypercaptation in PET.
Topics: Adrenal Glands; Aged; Cytomegalovirus Infections; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Neoplasm Recurrence, Local; Positron-Emission Tomography | 2021 |
Benign Adrenal Nodule Mimicking Lymphoma Differentially Diagnosed by 18F-FDG and 18F-FGln PET/CT.
Topics: Adrenal Gland Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glutamine; Humans; Lymphoma; Middle Aged; Positron Emission Tomography Computed Tomography | 2021 |
Topics: Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lymphoma; Positron Emission Tomography Computed Tomography; Quinolines; Thyroid Gland | 2021 |
Primary sacral lymphoma with multiple bone involvement evaluated using 18F-FDG PET/CT.
Topics: Bone and Bones; Fluorodeoxyglucose F18; Humans; Lymphoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2021 |
Intraperitoneal Glucose Transport to Micrometastasis: A Multimodal In Vivo Imaging Investigation in a Mouse Lymphoma Model.
Topics: Animals; Disease Models, Animal; Fluorodeoxyglucose F18; Glucose; Injections, Intraperitoneal; Lymphatic Metastasis; Lymphoma; Mice; Mice, Inbred BALB C; Multimodal Imaging; Neoplasm Micrometastasis; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2021 |
Differentiating between Primary Central Nervous System Lymphoma and Glioblastoma: The Diagnostic Value of Combining
Topics: Brain Neoplasms; Central Nervous System; Diagnosis, Differential; Fluorodeoxyglucose F18; Glioblastoma; Humans; Lymphoma; Positron-Emission Tomography; Retrospective Studies; Spin Labels | 2021 |
The value of bone marrow biopsy for staging of patients with primary CNS lymphoma.
Topics: Biopsy; Bone Marrow; Fluorodeoxyglucose F18; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Neoplasm Staging; Retrospective Studies | 2021 |
A reduced physiological
Topics: Brain; Fluorodeoxyglucose F18; Humans; Liver; Lymphoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2021 |
Chemokine Receptor 4-Targeted 68Ga-Pentixafor PET/CT in Response Assessment of Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma: Comparison to 18F-FDG PET/CT.
Topics: Coordination Complexes; Fluorodeoxyglucose F18; Humans; Lymphoma; Peptides, Cyclic; Positron Emission Tomography Computed Tomography; Prospective Studies; Receptors, CXCR4; Waldenstrom Macroglobulinemia | 2021 |
Correlation of 18F-FDG PET/CT SUVmax with clinical features, D-dimer and LDH in patients with primary intestinal lymphoma.
Topics: Fibrin Fibrinogen Degradation Products; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Intestinal Neoplasms; L-Lactate Dehydrogenase; Lymphoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2021 |
A Stromal Tumor Presenting as a Pseudoaneurysmal Dilation of the Small Bowel Mimicking a Lymphoma on FDG PET/CT.
Topics: Aged, 80 and over; Dilatation; Female; Fluorodeoxyglucose F18; Humans; Intestine, Small; Lymphoma; Positron Emission Tomography Computed Tomography | 2022 |
Diagnostic challenges in primary cardiac lymphoma, the opportunity of
Topics: Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2022 |
Early 18F-FDG PET Flare-up Phenomenon After CAR T-Cell Therapy in Lymphoma.
Topics: Female; Fluorodeoxyglucose F18; Humans; Immunotherapy, Adoptive; Lymphoma; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2022 |
Contrast-enhanced
Topics: Fluorodeoxyglucose F18; Hemangiosarcoma; Humans; Lymphoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2022 |
Simultaneous adrenal tuberculosis and renal oncocytoma mimicking malignant masses incidentally detected by
Topics: Adenoma, Oxyphilic; Adrenal Gland Neoplasms; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lymphoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tuberculosis | 2022 |
[Kikuchi-Fujimoto disease mimicking malignant lymphoma in adolescents].
Topics: Adolescent; Biopsy; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Histiocytic Necrotizing Lymphadenitis; Humans; Lymph Nodes; Lymphadenopathy; Lymphoma; Male; Positron-Emission Tomography | 2017 |
Reply: Fact Sheet About Interim and End-of-Treatment
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2017 |
Drug-induced lupus erythematosus mimicking lymphoma on
Topics: Aged; Autoantibodies; Diagnosis, Differential; Flecainide; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Lupus Erythematosus, Systemic; Lymphoma; Male; Omeprazole; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
Reply: The Need for Prudence When Using
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Positron-Emission Tomography | 2017 |
Association between textural and morphological tumor indices on baseline PET-CT and early metabolic response on interim PET-CT in bulky malignant lymphomas.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Retrospective Studies; Tumor Burden | 2017 |
Evaluation of clinical target volume expansion required for involved site neck radiotherapy for lymphoma to account for the absence of a pre-chemotherapy PET-CT in the radiotherapy treatment position.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphoma; Male; Middle Aged; Observer Variation; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Young Adult | 2017 |
Haematological cancer: Staging and restaging patients with lymphoma - a better approach?
Topics: Consensus; Fluorodeoxyglucose F18; Hematologic Neoplasms; Humans; Lymphoma | 2017 |
Lugano 2014 criteria for assessing FDG-PET/CT in lymphoma: an operational approach for clinical trials.
Topics: Adult; Aged; Aged, 80 and over; Clinical Trials as Topic; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lymphoma; Male; Middle Aged; Molecular Imaging; Neoplasm Staging; Observer Variation; Positron Emission Tomography Computed Tomography; Reproducibility of Results; Research Design; Workflow | 2017 |
Case report: multiple systemic disseminated tuberculosis mimicking lymphoma on 18F-FDG PET/CT.
Topics: Antitubercular Agents; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Tuberculosis; Whole Body Imaging | 2017 |
Regulation of glucose uptake in lymphoma cell lines by c-MYC- and PI3K-dependent signaling pathways and impact of glycolytic pathways on cell viability.
Topics: Cell Line, Tumor; Cell Survival; Chromones; Fluorodeoxyglucose F18; Glucose; Glycolysis; Humans; Inhibitory Concentration 50; Lymphoma; Morpholines; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-myc; Sirolimus; Time Factors | 2017 |
Interim
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cytarabine; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Positron-Emission Tomography; Registries; Retrospective Studies; Survival Rate | 2017 |
Interim FDG-PET in lymphoma, a questionable practice in hematology.
Topics: Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; Hematology; Hodgkin Disease; Humans; Lymphoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2017 |
Lymphoma Causing Gastrosplenic Fistula Revealed by FDG PET/CT.
Topics: Aged; Fistula; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Positron Emission Tomography Computed Tomography; Spleen; Stomach | 2017 |
Differential diagnosis of posterior fossa brain tumors: Multiple discriminant analysis of Tl-SPECT and FDG-PET.
Topics: Brain Neoplasms; Diagnosis, Differential; Discriminant Analysis; Fluorodeoxyglucose F18; Glioma; Humans; Lymphoma; Positron Emission Tomography Computed Tomography; Retrospective Studies; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon | 2017 |
Interim PET in lymphoma: from Deauville to Peking criteria. On the road, again….
Topics: Beijing; Fluorodeoxyglucose F18; Humans; Lymphoma; Positron-Emission Tomography | 2018 |
Clinical utility of
Topics: Biopsy; Castleman Disease; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Immunoglobulin G; Lymphoma; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sialadenitis; Sjogren's Syndrome | 2018 |
Imaging Characteristics of Chemotherapy Related Adult-Onset Still Disease.
Topics: Biopsy; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Rituximab; Still's Disease, Adult-Onset | 2017 |
Reply to: Role of PET-CT in management of post-transplant lymphoproliferative disorder: Preliminary experience on the use of PET/CT in the management of pediatric post-transplant lymphoproliferative disorder.
Topics: Child; Fluorodeoxyglucose F18; Humans; Lymphoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2018 |
Radiation dose reduction through combining positron emission tomography/computed tomography (PET/CT) and diagnostic CT in children and young adults with lymphoma.
Topics: Adolescent; Adult; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiation Dosage; Radiation Protection; Radiopharmaceuticals; Retrospective Studies | 2018 |
Correlation between glycolytic activity on [18F]-FDG-PET and cell density on diffusion-weighted MRI in lymphoma at staging.
Topics: Adult; Aged; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Glucose; Glycolysis; Hodgkin Disease; Humans; Imaging, Three-Dimensional; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Whole Body Imaging | 2018 |
18F-FDG PET/CT in primary brain lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Brain; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Tumor Burden; Whole Body Imaging | 2018 |
Usefulness of 18F-fluorodeoxyglucose-Positron Emission Tomography in Comparison with Methionine-Positron Emission Tomography in Differentiating Solid Hemangioblastoma from Adult Cerebellar Tumors.
Topics: Aged, 80 and over; Cerebellar Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glioblastoma; Hemangioblastoma; Humans; Lymphoma; Male; Methionine; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2018 |
Letter from the Editors.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Positron-Emission Tomography | 2018 |
Guest Editorial.
Topics: Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphoma; Positron Emission Tomography Computed Tomography | 2018 |
Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis Mimicking Lymphoma on FDG PET/CT.
Topics: Adolescent; Diagnosis, Differential; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Humans; Lymphohistiocytosis, Hemophagocytic; Lymphoma; Male; Positron Emission Tomography Computed Tomography | 2018 |
Staging, Restaging, and Treatment Response Assessment in Lymphomas: What We Should Know.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2018 |
Assessment of alteration in liver
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Fatty Liver; Female; Fluorodeoxyglucose F18; Humans; Liver; Lymphoma; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies; Young Adult | 2018 |
Genitourinary involvement of lymphomas on FDG-PET.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Genital Neoplasms, Male; Humans; Kidney Neoplasms; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Ureteral Neoplasms; Urethral Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms | 2018 |
Serious concerns on the inability of FDG-PET in excluding residual viable lymphoma.
Topics: Child; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Positron-Emission Tomography; Prognosis; Tumor Burden | 2018 |
Intra- and inter-observer agreement in the visual interpretation of interim 18F-FDG PET/CT in malignant lymphoma: influence of clinical information.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Clinical Competence; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Observer Variation; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
Value of contrast-enhanced ultrasound and PET/CT in assessment of extramedullary lymphoma.
Topics: Adult; Aged; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Positron Emission Tomography Computed Tomography; ROC Curve; Tumor Burden; Ultrasonography | 2018 |
Reply: Staging, Restaging, and Treatment Response Assessment in Lymphomas: What We Should Know.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma | 2018 |
Reply to: "All that glitters is not gold - new reconstruction methods using Deauville criteria for patient reporting".
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Positron-Emission Tomography | 2018 |
Diffusion-Weighted Imaging Shows a False-Negative Finding for Bone Marrow Involvement on 18F-FDG PET/MRI in a Patient With Malignant Lymphoma After Blood Transfusion.
Topics: Aged; Bone Marrow Neoplasms; Diffusion Magnetic Resonance Imaging; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals | 2018 |
Does PET Reconstruction Method Affect Deauville Scoring in Lymphoma Patients?
Topics: Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphoma; Positron Emission Tomography Computed Tomography | 2018 |
Improving lymph node characterization in staging malignant lymphoma using first-order ADC texture analysis from whole-body diffusion-weighted MRI.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Bone Marrow; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Reproducibility of Results; Retrospective Studies; ROC Curve; Whole Body Imaging | 2018 |
2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography/computed tomography in primary extranodal lymphomas: treatment response evaluation and prognosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymphoma; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Treatment Outcome; Young Adult | 2020 |
Adrenal Histoplasmosis.
Topics: Adrenal Gland Neoplasms; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Histoplasmosis; Humans; Lung Neoplasms; Lymphoma; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
[Incidence of Bone Marrow Involvement in Different Pathological Type Lymphoma Patients].
Topics: Biopsy; Bone Marrow; Fluorodeoxyglucose F18; Humans; Incidence; Lymphoma; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2018 |
Prognostic role of pretreatment 18F-FDG PET/CT in primary brain lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies | 2018 |
Reply to the Letter to the Editor from Peters et al: On the use of the liver as a reference organ for Deauville scoring in lymphoma patients and how it may be affected by liver steatosis.
Topics: Biological Transport; Fatty Liver; Fluorodeoxyglucose F18; Humans; Lymphoma | 2018 |
Assessment of alteration in liver
Topics: Fluorodeoxyglucose F18; Humans; Liver; Lymphoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2018 |
Correlations between the Maximum Standard Uptake Value of Positron Emission Tomography/Computed Tomography and Laboratory Parameters before and after Treatment in Patients with Lymphoma.
Topics: Blood Sedimentation; C-Reactive Protein; Fluorodeoxyglucose F18; Humans; L-Lactate Dehydrogenase; Lymphoma; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies | 2018 |
[
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphoma; Male; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2018 |
Combined positron emission tomography/computed tomography for diagnosis and monitoring of orbital adnexal lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy; Child; Diagnosis, Differential; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Neoplasm Staging; Orbit; Orbital Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Young Adult | 2018 |
[
Topics: Animals; Central Nervous System Neoplasms; Disease Models, Animal; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Heterografts; Histocytochemistry; Humans; Image Processing, Computer-Assisted; Lymphoma; Magnetic Resonance Imaging; Neoplasm Transplantation; Positron-Emission Tomography; Radiopharmaceuticals; Rats, Nude; Sensitivity and Specificity; Vidarabine | 2018 |
Deauville Scores 4 or 5 Assessed by Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Early Post-Allotransplant Is Highly Predictive of Relapse in Lymphoma Patients.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Recurrence; Retrospective Studies; Survival Analysis; Time Factors; Transplantation, Homologous; Young Adult | 2019 |
Feasibility of diffusion-weighted imaging with DWIBS in staging Hodgkin lymphoma in pediatric patients: comparison with PET/CT.
Topics: Adolescent; Brain; Child; Diffusion Magnetic Resonance Imaging; Feasibility Studies; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymph Nodes; Lymphoma; Male; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Whole Body Imaging | 2019 |
Sarcopenic obesity derived from PET/CT predicts mortality in lymphoma patients undergoing hematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Aged; Cohort Studies; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Middle Aged; Obesity; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Sarcopenia; Survival Analysis; Transplantation, Homologous; Treatment Outcome; Young Adult | 2019 |
Clinical Implications of Incidental Sinonasal Positive FDG Uptake on PET-CT.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lymphoma; Male; Middle Aged; Papilloma, Inverted; Paranasal Sinus Diseases; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2019 |
Usefulness of
Topics: Aged; Case-Control Studies; Female; Fluorodeoxyglucose F18; Humans; Lung; Lymph Nodes; Lymphoma; Male; Middle Aged; Parotid Gland; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Sjogren's Syndrome | 2019 |
Staging identifies non-CNS malignancies in a large cohort with newly diagnosed lymphomatous brain lesions.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Bone Marrow; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Neoplasm Staging; Neoplasms, Multiple Primary; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2019 |
Primary lymphoma of the liver: a diagnostic surprise.
Topics: Diagnosis, Differential; Diagnostic Imaging; Fluorodeoxyglucose F18; Humans; Image-Guided Biopsy; Liver; Liver Neoplasms; Lymphoma; Male; Middle Aged; Radiopharmaceuticals; Ultrasonography, Interventional | 2019 |
Spontaneous Regression of Clinically Indolent Lymphomas Revealed by 18F-FDG PET/CT.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Remission, Spontaneous | 2019 |
Lymphadenopathy Due to Kimura's Disease Mimicking Lymphoma on FDG PET/CT.
Topics: Adult; Angiolymphoid Hyperplasia with Eosinophilia; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphadenopathy; Lymphoma; Male; Positron Emission Tomography Computed Tomography | 2019 |
Increased
Topics: Adolescent; Biological Transport; Child; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Palatine Tonsil; Positron Emission Tomography Computed Tomography; Recurrence | 2019 |
Time to Prepare for Risk Adaptation in Lymphoma by Standardizing Measurement of Metabolic Tumor Burden.
Topics: Congresses as Topic; Diagnostic Imaging; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Medical Oncology; Positron-Emission Tomography; Prognosis; Reference Standards; Risk Assessment; Software; Tomography, X-Ray Computed; Tumor Burden | 2019 |
Differential diagnostic ability of 18F-FDG PET/CT radiomics features between renal cell carcinoma and renal lymphoma.
Topics: Aged; Carcinoma, Renal Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; ROC Curve; Software | 2021 |
EBV-Associated T-Cell Lymphoproliferative Disorders Demonstrated on FDG PET/CT in a Patient With Hemophagocytic Lymphohistiocytosis.
Topics: Cell Proliferation; Female; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Humans; Lymphohistiocytosis, Hemophagocytic; Lymphoma; Positron Emission Tomography Computed Tomography; T-Lymphocytes; Young Adult | 2019 |
FDG PET/CT of Gardnerella vaginalis Infection.
Topics: Adult; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Gardnerella vaginalis; Gram-Positive Bacterial Infections; Humans; Lymphoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Vaginosis, Bacterial | 2019 |
(18)F-FDG PET/CT in primary right eyelid lymphoma.
Topics: Aged; Eyelid Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
Lymphomatous involvement of epididymis: detection and response assessment with (18)F-FDG PET/CT.
Topics: Biopsy, Fine-Needle; Epididymis; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Multimodal Imaging; Radionuclide Imaging | 2013 |
Intussusception caused by an ileocecal lymphoma disclosed on 18F-FDG-PET/CT.
Topics: Cecum; Fluorodeoxyglucose F18; Humans; Ileal Diseases; Ileocecal Valve; Intussusception; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
Whole-body MRI for the detection of bone marrow involvement in lymphoma: prospective study in 116 patients and comparison with FDG-PET.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy; Bone Marrow; Bone Marrow Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Whole Body Imaging; Young Adult | 2013 |
Does enhanced CT influence the biological GTV measurement on FDG-PET images?
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Burden | 2013 |
Cryptorchidism as a potential source of misinterpretation in ¹⁸FDG-PET imaging in restaging lymphoma patients.
Topics: Adult; Cryptorchidism; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphoma; Male; Multimodal Imaging; Neoplasm Staging; Pilot Projects; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Young Adult | 2013 |
Segmental "misty mesentery" on FDG PET/CT: an uncommon manifestation of mesenteric lymphoma.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Mesentery; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
Is 18F-FDG PET/CT useful for distinguishing between primary thyroid lymphoma and chronic thyroiditis?
Topics: Aged; Aged, 80 and over; Chronic Disease; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; ROC Curve; Thyroid Gland; Thyroid Neoplasms; Thyroiditis; Tomography, X-Ray Computed | 2013 |
Teaching NeuroImages: diagnostic utility of FDG-PET in neurolymphomatosis.
Topics: Aged; Biopsy; Female; Fluorodeoxyglucose F18; Glucose-6-Phosphate; Humans; Lymphoma; Magnetic Resonance Imaging; Positron-Emission Tomography | 2013 |
FDG-PET scan in assessing lymphomas and the application of Deauville Criteria.
Topics: Adolescent; Adult; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Young Adult | 2013 |
Value of FDG-PET/CT examinations in different cancers of children, focusing on lymphomas.
Topics: Child; Female; Fluorodeoxyglucose F18; Humans; Hungary; Lymphoma; Male; Multimodal Imaging; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Retrospective Studies | 2014 |
Standardized uptake value based evaluation of lymphoma by FDG and FLT PET/CT.
Topics: Adolescent; Adult; Aged; Child; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; ROC Curve; Tomography, X-Ray Computed; Young Adult | 2014 |
Computer-aided staging of lymphoma patients with FDG PET/CT imaging based on textural information.
Topics: Adult; Aged; Diagnosis, Computer-Assisted; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphoma; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; ROC Curve; Support Vector Machine; Tomography, X-Ray Computed; Young Adult | 2014 |
Rosai-Dorfman disease mimics lymphoma on FDG PET/CT in a pediatric patient.
Topics: Child, Preschool; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Histiocytosis, Sinus; Humans; Lymphoma; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
False-Positive [18F]fluorodeoxyglucose-avid lymph nodes on positron emission tomography-computed tomography after allogeneic but not autologous stem-cell transplantation in patients with lymphoma.
Topics: Adolescent; Adult; Aged; Child; Disease-Free Survival; False Positive Reactions; Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Humans; Lymph Nodes; Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, T-Cell; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Transplantation, Autologous; Transplantation, Homologous | 2014 |
Therapeutic status-dependent thymic changes on 18F-FDG PET/CT in an adult patient with lymphoma who underwent 2 phases of chemotherapy.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Multimodal Imaging; Positron-Emission Tomography; Thymus Gland; Tomography, X-Ray Computed | 2014 |
FDG PET/CT detection of intussusception caused by lymphoma in a pediatric patient.
Topics: Child; Fluorodeoxyglucose F18; Humans; Intussusception; Lymphoma; Male; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
Hepatic tuberculosis: a rare cause of fluorodeoxyglucose hepatic superscan with background suppression on positron emission tomography.
Topics: Brain; Fluorodeoxyglucose F18; Heart; Hepatomegaly; Humans; Liver; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Tuberculosis, Hepatic; Whole Body Imaging | 2014 |
Limited positron emission tomography-computed tomography for restaging of lymphoma: a strategy for reducing radiation exposure among patients with early-stage curable lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiation Injuries; Radiation Protection; Radiopharmaceuticals; Remission Induction; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2014 |
Multiple FDG-avid injection site granulomas due to lovenox injection.
Topics: Adolescent; Enoxaparin; Female; Fluorodeoxyglucose F18; Granuloma; Humans; Injections; Lymphoma; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
18F-FDG PET scanning in pulmonary amyloidosis.
Topics: Adult; Aged; Aged, 80 and over; Amyloidosis; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Diseases; Lung Neoplasms; Lymphoma; Male; Middle Aged; Plasmacytoma; Positron-Emission Tomography; Radiopharmaceuticals; Respiratory Function Tests; Risk Factors; Tomography, X-Ray Computed | 2014 |
18F-FDG uptake in multiple splenic foci on PET/CT: an unusual case of visceral leishmaniasis.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Leishmaniasis, Visceral; Lymphoma; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Spleen; Tomography, X-Ray Computed | 2014 |
Clinical impact of contrast-enhanced computed tomography combined with low-dose (18)F-fluorodeoxyglucose positron emission tomography/computed tomography on routine lymphoma patient management.
Topics: Adult; Aged; Contrast Media; Disease Management; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lymphoma; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiation Dosage; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
[The diagnostic value of (18)F-FDG PET-CT imaging in patients with primary extranodal lymphoma].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2014 |
Comparison of 18F-FDG Pet/CT and CT: diagnosis performance in lymphoma patient after treatment.
Topics: Adolescent; Adult; Aged; Child; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2014 |
[The progress of laboratory medicine and diagnostic procedures in lymphoma and its future prospects].
Topics: Clinical Laboratory Techniques; Fluorodeoxyglucose F18; Genetic Techniques; Humans; Lymphoma; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
[Imaging examinations in lymphoma].
Topics: Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Minimal invasive biopsy of intraconal expansion by PET/CT/MRI image-guided navigation: a new method.
Topics: Adult; Aged; Carcinoma, Merkel Cell; Diplopia; Exophthalmos; Female; Fluorodeoxyglucose F18; Hamartoma; Humans; Image-Guided Biopsy; Imaging, Three-Dimensional; Lymphoma; Magnetic Resonance Imaging; Male; Melanoma; Middle Aged; Minimally Invasive Surgical Procedures; Multimodal Imaging; Orbital Diseases; Orbital Neoplasms; Patient Care Planning; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Young Adult | 2014 |
The diagnostic role of (18)F-FDG PET for primary central nervous system lymphoma.
Topics: Adrenal Cortex Hormones; Aged; Biological Transport; Brain Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies | 2014 |
[The application value of PET-CT in lymphoma].
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
Low-dose radiation from 18F-FDG PET does not increase cancer frequency or shorten latency but reduces kidney disease in cancer-prone Trp53+/- mice.
Topics: Animals; Dose-Response Relationship, Radiation; Fluorodeoxyglucose F18; Gamma Rays; Kidney Diseases; Lymphoma; Male; Mice; Neoplasms; Organ Specificity; Osteosarcoma; Positron-Emission Tomography; Survival Analysis; Tumor Suppressor Protein p53 | 2014 |
Thyroid incidentalomas discovered on positron emission tomography CT scanning - Malignancy rate and significance of standardised uptake values.
Topics: Adenocarcinoma, Follicular; Aged; Carcinoma; Carcinoma, Papillary; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lymphoma; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Thyroid Cancer, Papillary; Thyroid Gland; Thyroid Neoplasms; Tomography, X-Ray Computed | 2014 |
Chronic sialadenitis with marked lymphadenopathy mimicking lymphoma on FDG PET/CT.
Topics: Diagnostic Errors; Exocrine Glands; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphoma; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Sialadenitis; Tomography, X-Ray Computed | 2014 |
FDG PET/CT methodology for evaluation of treatment response in lymphoma: from "graded visual analysis" and "semiquantitative SUVmax" to global disease burden assessment.
Topics: Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphoma; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2014 |
Utility of fluorodeoxyglucose positron emission tomography/computed tomography in patients with fever of unknown origin diagnosed as lymphoma.
Topics: Adolescent; Adult; Aged; China; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2014 |
Use of 18F-FDG PET/CT imaging for evaluation of patients with primary splenic lymphoma.
Topics: Adolescent; Adult; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Splenic Neoplasms; Tomography, X-Ray Computed | 2014 |
FDG PET/MR for the assessment of lymph node involvement in lymphoma: initial results and role of diffusion-weighted MR.
Topics: Adolescent; Adult; Aged; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphoma; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Young Adult | 2014 |
Evaluation of staging and early response to chemotherapy with whole-body diffusion-weighted MRI in malignant lymphoma patients: A comparison with FDG-PET/CT.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Contrast Media; Cyclophosphamide; Diffusion Magnetic Resonance Imaging; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Rituximab; Tomography, X-Ray Computed; Treatment Outcome; Vincristine; Whole Body Imaging | 2015 |
Evaluation of regional cerebral glucose metabolism in patients with malignant lymphoma of the body using statistical image analysis.
Topics: Adult; Aged; Aged, 80 and over; Cerebral Cortex; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Processing, Computer-Assisted; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Whole Body Imaging | 2014 |
Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group.
Topics: Fluorodeoxyglucose F18; Humans; International Cooperation; Lymphoma; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
A pilot study of the value of 18F-fluoro-deoxy-thymidine PET/CT in predicting viable lymphoma in residual 18F-FDG avid masses after completion of therapy.
Topics: Adult; Aged; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Multimodal Imaging; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Usefulness of 18F-FDG PET/CT in the detection of neurolymphomatosis.
Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2014 |
Epiphyseal presentation of non-Hodgkin's lymphoma of bone in two pediatric patients--one with primary lymphoma of bone.
Topics: Adolescent; Biopsy; Child; Diagnosis, Differential; Epiphyses; Femur; Fluorodeoxyglucose F18; Humans; Knee; Lymphoma; Lymphoma, Non-Hodgkin; Male; Positron-Emission Tomography; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
[A clinical analysis of 40 cases of primary and secondary pulmonary lymphoma].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Lymph Nodes; Lymphoma; Lymphoma, Non-Hodgkin; Male; Mediastinum; Middle Aged; Prognosis; Retrospective Studies; Thorax; Tomography, X-Ray Computed; Young Adult | 2014 |
Multi-stage thresholded region classification for whole-body PET-CT lymphoma studies.
Topics: Computer Simulation; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lymphoma; Models, Biological; Multimodal Imaging; Pattern Recognition, Automated; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2014 |
Testicular fluorine-18 fludeoxyglucose uptake on positron emission tomography CT in patients with lymphoma: clinical significance and management impact.
Topics: Adult; Aged; Aged, 80 and over; Disease Management; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Testicular Neoplasms; Testis; Tomography, X-Ray Computed | 2014 |
Heterogeneous bone marrow uptake on interim 18F-fluorodeoxyglucose positron emission tomography for lymphoma mimicking disease progression: a case report.
Topics: Bone Marrow; Disease Progression; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Middle Aged; Positron-Emission Tomography; Treatment Outcome | 2014 |
Thymic hyperplasia following chemotherapy in adults with lymphoma: (18)F-fluorodeoxyglucose positron emission tomography/computed tomography findings and correlation with T cell repopulation.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunophenotyping; Lymphoma; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; T-Lymphocyte Subsets; Thymus Hyperplasia; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2015 |
CD30-positive primary bone marrow lymphoma mimicking Hodgkin lymphoma.
Topics: Aged, 80 and over; Bone Marrow; Bone Marrow Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Immunohistochemistry; Ki-1 Antigen; Lymphoma; Male; Positron-Emission Tomography | 2015 |
Combined use of 18 F-FDG PET and corticosteroid for diagnosis of deep-seated primary central nervous system lymphoma without histopathological confirmation.
Topics: Adrenal Cortex Hormones; Aged; Aged, 80 and over; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
A case of secondary syphilis involving tonsil, pulmonary, and multiple lymph nodes: 18F-FDG PET/CT findings.
Topics: False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lung; Lymph Nodes; Lymphoma; Male; Middle Aged; Multimodal Imaging; Palatine Tonsil; Positron-Emission Tomography; Radiopharmaceuticals; Syphilis; Tomography, X-Ray Computed | 2015 |
Classification of thresholded regions based on selective use of PET, CT and PET-CT image features.
Topics: Algorithms; Electronic Data Processing; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphoma; Multimodal Imaging; Pattern Recognition, Automated; Positron-Emission Tomography; Probability; Radiopharmaceuticals; Reproducibility of Results; Tissue Distribution; Tomography, X-Ray Computed; Whole Body Imaging | 2014 |
A 66-year-old patient with progressive left hemiparesis: question.
Topics: Acute Disease; Aged; Brain Stem Neoplasms; Central Nervous System Infections; Cerebellar Neoplasms; Demyelinating Diseases; Diagnosis, Differential; Disease Progression; Encephalomyelitis; Fluorodeoxyglucose F18; Glioblastoma; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Paresis; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
18F-FDG-PET/CT in staging, recurrence detection and response evaluation of primary splenic lymphoma with eight years follow up.
Topics: Adult; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Recurrence; Spleen; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Clinical Advances in Hematology & Oncology. Letter from the editor.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Positron-Emission Tomography; Radiopharmaceuticals | 2014 |
Quantitative positron emission tomography imaging for response assessment of [18F]fluorodeoxyglucose-avid lymphomas: should we report standard uptake value confidence limits?
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Do not abandon the bone marrow biopsy yet in diffuse large B-cell lymphoma.
Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Value of positron emission tomography in diagnosing subcutaneous panniculitis-like T-cell lymphoma.
Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Reply to B. Bennani-Baiti et al, H.J.A. Adams et al, E. Laffon et al, and E.A. Hawkes et al.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
PET/MRI for the evaluation of patients with lymphoma: initial observations.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Impact of FDG-PET findings on decisions regarding patient management strategies: a multicenter trial in patients with lung cancer and other types of cancer.
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Lymphoma; Male; Melanoma; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Young Adult | 2015 |
Cervical lymph node hyperplasia on [(18)F]-fluorodeoxyglucose positron emission tomography/computed tomography scan after treatment of children and adolescents with malignant lymphoma.
Topics: Adolescent; Child; Child, Preschool; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Hyperplasia; Lymph Nodes; Lymphoma; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
Feasibility of a multimodal (18)F-FDG-directed lymph node surgical excisional biopsy approach for appropriate diagnostic tissue sampling in patients with suspected lymphoma.
Topics: Adult; Aged; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Image-Guided Biopsy; Lymph Nodes; Lymphatic Metastasis; Lymphoma; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Surgery, Computer-Assisted; Tomography, X-Ray Computed; Young Adult | 2015 |
Lymphoma grading with FDG-PET/CT readdressed: Direct and timely histopathological correlation study.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Neoplasm Grading; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Young Adult | 2016 |
Preliminary discussion on the value of (18)F-FDG PET/CT in the diagnosis and early staging of non-mycosis fungoides/Sézary's syndrome cutaneous malignant lymphomas.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphoma; Male; Middle Aged; Multimodal Imaging; Mycosis Fungoides; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sezary Syndrome; Skin; Skin Neoplasms; Tomography, X-Ray Computed; Young Adult | 2015 |
A Case Report of High 18F-FDG PET/CT Uptake in Progressive Transformation of the Germinal Centers.
Topics: Aged; Cell Transformation, Neoplastic; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Evaluation of Mediastinal Lymph Nodes in Sarcoidosis, Sarcoid Reaction, and Malignant Lymph Nodes Using CT and FDG-PET/CT.
Topics: Adult; Aged; Diagnosis, Differential; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphoma; Male; Mediastinum; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Respiratory Function Tests; Retrospective Studies; Sarcoidosis; Tomography, X-Ray Computed | 2015 |
Anterior mediastinal solid tumours in adults: characterisation using dynamic contrast-enhanced MRI, diffusion-weighted MRI, and FDG-PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Mediastinal Neoplasms; Middle Aged; Multimodal Imaging; Neoplasms, Germ Cell and Embryonal; Neoplasms, Glandular and Epithelial; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Thymoma; Thymus Neoplasms; Tomography, X-Ray Computed; Young Adult | 2015 |
Fallacy of Quantifying Lymphoma Activity by Scaling to the Liver in [18F]Fluorodeoxyglucose Positron Emission Tomography (Deauville criteria).
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Reply to G. Keramida et al.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Utility of F-18 FDG PET/CT on the evaluation of primary bone lymphoma.
Topics: Adult; Bone Neoplasms; Extremities; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Whole Body Imaging | 2015 |
Lung positron emission tomography with FDG in patients with haematological malignancies and acute respiratory failure.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Hematologic Neoplasms; Humans; Lung; Lung Diseases, Fungal; Lung Neoplasms; Lymphoma; Male; Middle Aged; Multimodal Imaging; Pilot Projects; Pneumonia; Pneumonia, Bacterial; Pneumonia, Viral; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Respiratory Insufficiency; Sarcoma, Kaposi; Tomography, X-Ray Computed; Tuberculosis, Pulmonary | 2016 |
Diagnostic Performance of Diffusion-Weighted Imaging for Multiple Hilar and Mediastinal Lymph Nodes with FDG Accumulation.
Topics: Aged; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Diseases; Lymphatic Metastasis; Lymphoma; Male; Mediastinum; Middle Aged; Multimodal Imaging; Pneumoconiosis; Positron-Emission Tomography; Prospective Studies; Sarcoidosis; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
[Features of Acquired Immunodeficiency Syndrome-related Lymphoma on (18)F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography].
Topics: Acquired Immunodeficiency Syndrome; Fluorodeoxyglucose F18; Humans; Lymphoma; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2015 |
Impact of consensus contours from multiple PET segmentation methods on the accuracy of functional volume delineation.
Topics: Algorithms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Lymphoma; Male; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2016 |
Primary lymphoma of the spleen mimicking simple benign cysts: contrast-enhanced ultrasonography and other imaging findings.
Topics: Aged; Contrast Media; Cysts; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Spleen; Splenic Neoplasms; Tomography, X-Ray Computed; Ultrasonography | 2015 |
[Association of lymphoma and granulomatosis: A case series].
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; France; Granuloma; Humans; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2016 |
The significance of pre-therapeutic F-18-FDG PET-CT in lymphoma-associated hemophagocytic lymphohistiocytosis when pathological evidence is unavailable.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Kaplan-Meier Estimate; Lymphohistiocytosis, Hemophagocytic; Lymphoma; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2016 |
[18F]FDG PET/CT for the assessment of the volume of the spleen.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Feasibility Studies; Female; Fiducial Markers; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Organ Size; Positron Emission Tomography Computed Tomography; Spleen; Young Adult | 2016 |
PET in natural killer/T-cell lymphoma: the debate continues.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Lymphoma, T-Cell; Positron-Emission Tomography | 2015 |
Diagnostic performance of FDG-PET/MRI and WB-DW-MRI in the evaluation of lymphoma: a prospective comparison to standard FDG-PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Diagnostic Tests, Routine; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Whole Body Imaging | 2015 |
Differentiation of sarcoidosis-lymphoma syndrome lesions: a case report on the use of two different positron emission tomography tracers.
Topics: alpha-Methyltyrosine; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung; Lymphoma; Mediastinum; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed | 2016 |
Whole-body MRI with diffusion-weighted imaging: a valuable alternative to contrast-enhanced CT for initial staging of aggressive lymphoma.
Topics: Adult; Aged; Biopsy; Contrast Media; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Iohexol; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2016 |
Diagnostic usefulness of FDG-PET/CT in advanced malignant lymphoma of the uterus: report of two cases.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Neoplasms | 2015 |
Comparison between whole-body MRI with diffusion-weighted imaging and PET/CT in staging newly diagnosed FDG-avid lymphomas.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Ivermectin; Lymphoma; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed; Whole Body Imaging; Young Adult | 2016 |
Usefulness of standardized uptake value normalized by individual CT-based lean body mass in application of PET response criteria in solid tumors (PERCIST).
Topics: Adult; Biological Transport; Body Mass Index; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Liver; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Reference Standards; Retrospective Studies; Signal-To-Noise Ratio; Tomography, X-Ray Computed | 2016 |
Assessment of Sequential PET/MRI in Comparison With PET/CT of Pediatric Lymphoma: A Prospective Study.
Topics: Adolescent; Child; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
A Case Report: Systemic Lymph Node Tuberculosis Mimicking Lymphoma on 18F-FDG PET/CT.
Topics: Biopsy; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphoma; Male; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed; Tuberculosis, Lymph Node; Young Adult | 2016 |
Evaluation of diagnostic performance of whole-body simultaneous PET/MRI in pediatric lymphoma.
Topics: Adolescent; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiation Dosage; Radiopharmaceuticals; Whole Body Imaging | 2016 |
Diagnostic utility of intravoxel incoherent motion mr imaging in differentiating primary central nervous system lymphoma from glioblastoma multiforme.
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Motion; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Young Adult | 2016 |
Dual time-point FDG PET/CT and FDG uptake and related enzymes in lymphadenopathies: preliminary results.
Topics: Adolescent; Adult; Aged; Algorithms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glucose-6-Phosphatase; Hexokinase; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lymphoma; Male; Middle Aged; Pilot Projects; Positron Emission Tomography Computed Tomography; Reproducibility of Results; Sensitivity and Specificity; Tumor Burden; Young Adult | 2016 |
The (68)Ge phantom-based FDG-PET site qualification program for clinical trials adopted by FIL (Italian Foundation on Lymphoma).
Topics: Calibration; Clinical Trials as Topic; Equipment Design; Fluorodeoxyglucose F18; Germanium; Humans; Image Processing, Computer-Assisted; Lymphoma; Multicenter Studies as Topic; Patient Selection; Phantoms, Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radioisotopes; Reproducibility of Results; Retrospective Studies | 2016 |
Diagnostic accuracy of FDG PET/CT for clinical evaluation at the end of treatment of HL and NHL: a comparison of the Deauville Criteria (DC) and the International Harmonization Project Criteria (IHPC).
Topics: Adolescent; Adult; Aged, 80 and over; Child; Female; Fluorodeoxyglucose F18; Humans; Italy; Lymphoma; Male; Middle Aged; Outcome Assessment, Health Care; Positron Emission Tomography Computed Tomography; Practice Guidelines as Topic; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Survival Rate; United Kingdom; Young Adult | 2016 |
Re: Anterior mediastinal solid tumours in adults: characterisation using dynamic contrast-enhanced MRI, diffusion-weighted MRI, and FDG-PET/CT. A reply.
Topics: Adult; Aged; Aged, 80 and over; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Mediastinal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
Re: Anterior mediastinal solid tumours in adults: characterisation using dynamic contrast-enhanced MRI, diffusion-weighted MRI, and FDG-PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Mediastinal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
A False-Negative Case of Primary Central Nervous System Lymphoma on 11C-Methionine PET and Intense 18F-FDG Uptake.
Topics: Adult; Carbon Radioisotopes; Central Nervous System Neoplasms; False Negative Reactions; Fluorodeoxyglucose F18; Glioma; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Methionine; Positron-Emission Tomography; Radiopharmaceuticals | 2016 |
PET-CT for Evaluation of Spleen and Liver 18F-FDG Diffuse Uptake Without Lymph Node Enlargement in Lymphoma.
Topics: Adolescent; Adult; Aged; Bone Marrow; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Liver; Lymph Nodes; Lymphoma; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Spleen; Young Adult | 2016 |
Allergic Reaction to Ginkgo Nut on FDG PET/CT.
Topics: Adult; Female; Fluorodeoxyglucose F18; Ginkgo biloba; Humans; Hypersensitivity; Lymph Nodes; Lymphoma; Nuts; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2016 |
False-Positive Finding on 18F FDG PET/CT: Report of a Rare Case With Xanthogranulomatous Inflammation in the Spinal Epidural Space.
Topics: Diagnosis, Differential; Epidural Space; False Positive Reactions; Fluorodeoxyglucose F18; Granuloma; Humans; Inflammation; Lymphoma; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Xanthomatosis | 2016 |
Diagnostic utility of FDG-PET in neurolymphomatosis: report of five cases.
Topics: Aged; Aged, 80 and over; Contrast Media; Fluorodeoxyglucose F18; Gadolinium; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Invasiveness; Neural Conduction; Peripheral Nervous System; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
Overestimated value of FDG-PET based bone marrow evaluation in lymphoma.
Topics: Bone Marrow; Fluorodeoxyglucose F18; Humans; Lymphoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2017 |
Enhanced MRI and 18F-FDG PET/CT Findings of Primary Central Nervous System Lymphoma Mimicking Encephalitis.
Topics: Brain; Central Nervous System Neoplasms; Diagnosis, Differential; Encephalitis; Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography | 2016 |
Overestimated value of FDG-PET based bone marrow evaluation in lymphoma: Response to Adams and Kwee.
Topics: Biopsy; Bone Marrow; Fluorodeoxyglucose F18; Humans; Lymphoma; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2017 |
"Bottle Brush Sign"-Spinal Meningeal Disease on 18F-FDG PET-CT Scan.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Spinal Neoplasms | 2016 |
Sinonasal oncocytic Schneiderian papilloma accompanied by intravascular lymphoma: A case report on FDG-PET/CT imaging.
Topics: Aged, 80 and over; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Neoplasms, Multiple Primary; Papilloma; Paranasal Sinus Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2016 |
Whole-body MRI, FDG-PET/CT, and bone marrow biopsy, for the assessment of bone marrow involvement in patients with newly diagnosed lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy; Bone Marrow; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Whole Body Imaging; Young Adult | 2017 |
Comparison of PET/MRI With PET/CT in the Evaluation of Disease Status in Lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Marrow Neoplasms; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymph Nodes; Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Splenic Neoplasms; Young Adult | 2017 |
Extensive Metastases on 18F-FDG PET/CT in Primary Lymphoepithelioma-Like Carcinoma of the Ovary.
Topics: Bone Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymph Nodes; Lymphatic Metastasis; Lymphoma; Middle Aged; Omentum; Ovarian Neoplasms; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
Nonfluorodeoxyglucose-Avid Persistent Splenomegaly at Time of Transplantation Delays Neutrophil and Platelets Engraftment without Affecting Survival in Patients with Lymphomas Undergoing Allogeneic Hematopoietic Cell Transplantation.
Topics: Adult; Blood Platelets; Female; Fluorodeoxyglucose F18; Graft Survival; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Middle Aged; Neutrophils; Retrospective Studies; Splenomegaly; Survival; Transplantation, Homologous | 2016 |
Primary lymphoma involving cranial nerves and cauda equina detected by (18)F-FDG PET/CT and MRI.
Topics: Aged; Cranial Nerve Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Neoplasms, Multiple Primary; Peripheral Nervous System Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
High-risk interim PET negative patients in Hodgkin's lymphoma.
Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Retrospective Studies; Tomography, X-Ray Computed | 2016 |
Evaluation of [18F]-FDG-Based Hybrid Imaging Combinations for Assessment of Bone Marrow Involvement in Lymphoma at Initial Staging.
Topics: Adult; Aged; Aged, 80 and over; Bone Marrow; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Whole Body Imaging; Young Adult | 2016 |
Critical considerations on the predictive value of end-of-treatment FDG-PET in lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Outcome Assessment, Health Care; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2017 |
Reply to letter of Adams and Kwee: Critical considerations on the predictive value of end-of-treatment FDG/PET in lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Outcome Assessment, Health Care; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2017 |
Diagnostic Value of 68Ga PSMA-11 PET/CT Imaging of Brain Tumors-Preliminary Analysis.
Topics: Adult; Aged; Brain Neoplasms; Child; Edetic Acid; Female; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Glioblastoma; Glioma; Humans; Lymphoma; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Neoplasm Recurrence, Local; Oligopeptides; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Whole Body Imaging; Young Adult | 2017 |
The Need for Prudence When Using
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Positron-Emission Tomography | 2017 |
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphocele; Lymphoma; Male; Middle Aged; Necrosis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2017 |
Automatic detection and classification of regions of FDG uptake in whole-body PET-CT lymphoma studies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Machine Learning; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Young Adult | 2017 |
18F-FDG super bone marrow uptake: A highly potent indicator for the malignant infiltration.
Topics: Adolescent; Adult; Aged; Bone Marrow; Bone Neoplasms; C-Reactive Protein; Child; Female; Fever; Fluorodeoxyglucose F18; Hemoglobins; Humans; L-Lactate Dehydrogenase; Leukemia; Leukocyte Count; Lymphoma; Male; Middle Aged; Multiple Myeloma; Platelet Count; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Young Adult | 2016 |
Fact Sheet About Interim and End-of-Treatment
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Positron Emission Tomography Computed Tomography | 2017 |
The role of 18F-FDG PET/CT in staging and restaging primary bone lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2017 |
Combined PET and low-dose, noncontrast CT scanning obviates the need for additional diagnostic contrast-enhanced CT scans in patients undergoing staging or restaging for lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2008 |
A case of lymphocytic mastopathy requiring differential diagnosis from primary breast lymphoma.
Topics: Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphocytes; Lymphoma; Magnetic Resonance Imaging; Mammography; Mastitis; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Ultrasonography, Mammary | 2009 |
Protocol considerations for positron emission tomography-computed tomography of the abdomen and pelvis.
Topics: Abdominal Neoplasms; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Genital Neoplasms, Female; Humans; Lymphoma; Lymphoproliferative Disorders; Pancreatic Neoplasms; Pelvic Neoplasms; Positron-Emission Tomography; Sarcoma; Stomach Neoplasms; Tomography, X-Ray Computed | 2008 |
Marginal zone lymphoma involving subcutaneous fat: appearance by FDG-PET/CT, MRI, and contrast-enhanced CT imaging.
Topics: Adipose Tissue; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Middle Aged; Neoplasms, Adipose Tissue; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
Thyroid lymphoma: early clinical suspicion may be critical for cure.
Topics: Aged, 80 and over; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Hashimoto Disease; Humans; Lymphoma; Thyroid Neoplasms | 2008 |
Cervical toxoplasmic lymphadenitis can mimic malignant lymphoma on FDG PET.
Topics: Antibodies, Protozoan; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphadenitis; Lymphoma; Magnetic Resonance Imaging; Middle Aged; Neck; Positron-Emission Tomography; Tomography, X-Ray Computed; Toxoplasmosis; Whole Body Imaging | 2008 |
18F-FDG-PET in patients with malignant lymphoma having long-term follow-up: staging and restaging, and evaluation of treatment response and recurrence.
Topics: Adolescent; Adult; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Longitudinal Studies; Lymphoma; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Young Adult | 2008 |
Fluorodeoxyglucose positron emission tomography (FDG-PET) and PET/computed tomography imaging characteristics of thyroid lymphoma and their potential clinical utility.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2009 |
18F-FDG PET/CT for monitoring the response of lymphoma to radioimmunotherapy.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Radioimmunotherapy; Retrospective Studies; Survival Rate; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Abnormal FDG uptake on 18F-fluorodeoxyglucose positron emission tomography in patients with cancer diagnosis: case reports of tuberculous lymphadenitis.
Topics: Antitubercular Agents; Breast Neoplasms; Colonic Neoplasms; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Lymphoma; Middle Aged; Neoplasm Recurrence, Local; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tuberculosis, Lymph Node | 2009 |
Utility of brain FDG-PET in primary CNS lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Brain; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
CT and 18F-FDG PET for noninvasive detection of splenic involvement in patients with malignant lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Lymphoma; Male; Middle Aged; Neoplasm Staging; Patient Selection; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Splenic Neoplasms; Tomography, X-Ray Computed | 2009 |
The case against heavy PETing.
Topics: False Negative Reactions; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lymphoma; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals | 2009 |
Primary testicular lymphoma involving the spermatic cord and gonadal vein.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Positron-Emission Tomography; Radiopharmaceuticals; Spermatic Cord; Testicular Neoplasms; Testis; Tomography, X-Ray Computed; Veins | 2009 |
18F- FDG-PET/CT for the diagnosis of tumor thrombosis.
Topics: Adult; Aged; Carcinoma; Cohort Studies; Diagnosis, Differential; Digestive System Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lymphoma; Male; Middle Aged; Neoplastic Cells, Circulating; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Thromboembolism; Tomography, X-Ray Computed | 2009 |
A comparison between radiolabeled fluorodeoxyglucose uptake and hyperpolarized (13)C-labeled pyruvate utilization as methods for detecting tumor response to treatment.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Carbon Isotopes; Carbon Radioisotopes; Cell Line, Tumor; Etoposide; Female; Flow Cytometry; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Glucose Transporter Type 3; Lactates; Lymphoma; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred C57BL; Poly(ADP-ribose) Polymerases; Positron-Emission Tomography; Pyruvates; Treatment Outcome | 2009 |
Diagnostic accuracy of 18F-2-deoxy-fluoro-D-glucose positron emission tomography for pN1 lymph nodes in patients with lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Lymphoma; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed | 2009 |
Diagnostic value of kinetic analysis using dynamic 18F-FDG-PET in patients with malignant primary brain tumor.
Topics: Adult; Aged; Brain Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glioma; Glucose; Humans; Kinetics; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies | 2009 |
(18)F-FDG and (18)F-FLT uptake early after cyclophosphamide and mTOR inhibition in an experimental lymphoma model.
Topics: Animals; Antineoplastic Agents, Alkylating; Cell Line, Tumor; Cyclophosphamide; Dideoxynucleosides; Fluorodeoxyglucose F18; Humans; Lymphoma; Metabolic Clearance Rate; Mice; Mice, SCID; Protein Kinase Inhibitors; Protein Kinases; Radionuclide Imaging; Radiopharmaceuticals; Sirolimus; Tissue Distribution; TOR Serine-Threonine Kinases; Treatment Outcome | 2009 |
Glut1 and Glut3 expression in lymphoma and their association with tumor intensity on 18F-fluorodeoxyglucose positron emission tomography.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glucose Transporter Type 1; Glucose Transporter Type 3; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography | 2009 |
Comparison of 18F-FDG positron emission tomography and computed tomography in patients with colorectal carcinoma and lymphoma: our initial clinical experience.
Topics: Adenocarcinoma; Adult; Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Young Adult | 2009 |
[Differentiation of malignant and benign superficial lymph nodes by dual time point 18F-FDG PET].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Young Adult | 2009 |
[Application of 18F-FDG PET for the assessment of early response to the treatment and prognosis of patients].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Prognosis; Radiopharmaceuticals; Rituximab; Vinblastine; Vincristine; Young Adult | 2009 |
Disseminated Kikuchi-Fujimoto disease mimicking malignant lymphoma on positron emission tomography in a child.
Topics: Biopsy; Child; Diagnosis, Differential; Fatigue; Female; Fever; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Histiocytic Necrotizing Lymphadenitis; Humans; Hyperplasia; Lymph Nodes; Lymphoma; Necrosis; Positron-Emission Tomography; Radiopharmaceuticals; Remission Induction; Weight Loss | 2009 |
The utility of FDG-PET for managing patients with malignant lymphoma: analysis of data from a single cancer center.
Topics: Disease Management; Fluorodeoxyglucose F18; Humans; Lymphoma; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Statistics as Topic; Tomography, X-Ray Computed | 2009 |
[The role of FDG-PET in staging of lymphoma and evaluation of therapeutic efficiency].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphoma; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2009 |
Observer variation in interpreting 18F-FDG PET/CT findings for lymphoma staging.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lymphoma; Middle Aged; Neoplasm Staging; Observer Variation; Positron-Emission Tomography; Tomography, X-Ray Computed; Young Adult | 2009 |
Time-dependent changes in 18F-FDG activity in the thymus and bone marrow following combination chemotherapy in paediatric patients with lymphoma.
Topics: Adolescent; Biological Transport; Bone Marrow; Child; Child, Preschool; Cytokines; Drug Therapy, Combination; Female; Fluorodeoxyglucose F18; Hematopoiesis; Humans; Lymphoma; Male; Retrospective Studies; Thymus Gland; Time Factors | 2010 |
Early FDG-PET response-adapted risk stratification and further therapeutic decision-making in lymphoma: will this replace the established prognostic indices and be the standard-of-care in clinical management?
Topics: Decision Making; Fluorodeoxyglucose F18; Humans; Lymphoma; Positron-Emission Tomography; Prognosis; Risk Assessment; Standard of Care; Time Factors | 2009 |
Diagnosis of silent myocardial ischemia during the staging of HIV-associated lymphoma with FDG PET/CT.
Topics: Fluorodeoxyglucose F18; HIV Infections; Humans; Lymphoma; Male; Middle Aged; Myocardial Ischemia; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2009 |
Intra-operative use of PET probe for localization of FDG avid lesions.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Melanoma; Neoplasms; Positron-Emission Tomography; Stomach Neoplasms | 2009 |
Comparative PET study using F-18 FET and F-18 FDG for the evaluation of patients with suspected brain tumour.
Topics: Adult; Aged; Brain; Brain Neoplasms; Diagnosis, Differential; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Glioma; Humans; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radioisotopes; Reproducibility of Results; Sensitivity and Specificity; Tyrosine; Young Adult | 2010 |
(18)F-FDG avidity in lymphoma readdressed: a study of 766 patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Young Adult | 2010 |
[Malignant lymphoma].
Topics: Fluorodeoxyglucose F18; Gallium Radioisotopes; Hodgkin Disease; Humans; Lymphoma; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals | 2009 |
Interesting image. Situs inversus totalis in newly diagnosed lymphoma: additional value of hybrid imaging.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung Neoplasms; Lymphoma; Male; Positron-Emission Tomography; Radiopharmaceuticals; Situs Inversus; Subtraction Technique; Tomography, X-Ray Computed | 2010 |
Interesting image. Incidental diagnosis of prostate cancer by F-18 FDG PET/CT.
Topics: Adenocarcinoma; Aged; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lymphoma; Male; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed | 2010 |
Epstein-Barr virus mimicking lymphoma on FDG-PET/CT.
Topics: Adolescent; Diagnosis, Differential; Epstein-Barr Virus Infections; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
Primary pituitary lymphoma diagnosis by FDG-PET/CT.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Pituitary Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
Varicose vein as a cause of increased FDG uptake.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lymphoma; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed; Varicose Veins | 2010 |
Pediatric and adolescent lymphoma: comparison of whole-body STIR half-Fourier RARE MR imaging with an enhanced PET/CT reference for initial staging.
Topics: Adolescent; Child; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Iohexol; Lymphatic Metastasis; Lymphoma; Magnetic Resonance Imaging; Male; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Reference Standards; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2010 |
When 18-fluorodeoxyglucose-positron emission tomography is indeterminate, the International Prognostic Index is the answer.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Guidelines as Topic; Health Status Indicators; Humans; Internationality; Lymphoma; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Registries | 2010 |
Use of PET in the diagnosis of primary CNS lymphoma in patients with atypical MR findings.
Topics: Adult; Aged; Central Nervous System Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Positron-Emission Tomography; Retrospective Studies | 2010 |
Prognostic value of pretreatment 18F-FDG PET in patients with primary central nervous system lymphoma: SUV-based assessment.
Topics: Aged; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cranial Irradiation; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2010 |
FDG-PET scans in patients with lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Neoplasm Staging; Positron-Emission Tomography; Stem Cell Transplantation; Tomography, X-Ray Computed | 2008 |
Retrospective evaluation of PET-MRI registration algorithms.
Topics: Algorithms; Brain; Brain Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Lymphoma; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies | 2011 |
Intussusception incidentally detected by FDG-PET/CT in a pediatric lymphoma patient.
Topics: Adolescent; Fluorodeoxyglucose F18; Humans; Incidental Findings; Intussusception; Lymphoma; Male; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
FDG-PET/CT in evaluation and prognostication of primary prostate lymphoma.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Positron-Emission Tomography; Prognosis; Prostatic Neoplasms; Tomography, X-Ray Computed | 2010 |
Prognostic significance of the standardized uptake value of pre-therapeutic (18)F-FDG PET in patients with malignant lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Glucose; Humans; Immunotherapy; Lymphoma; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy; Retrospective Studies; Treatment Outcome; Young Adult | 2011 |
18F-FDG PET/CT evaluation of lymphoma with renal involvement: comparison with renal carcinoma.
Topics: Adolescent; Adult; Aged; Carcinoma, Renal Cell; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed; Young Adult | 2010 |
FDG PET/CT manifestations of hematopoietic malignancies of the breast.
Topics: Adult; Breast Neoplasms; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Hematologic Neoplasms; Humans; Leukemia; Lymphoma; Male; Middle Aged; Multiple Myeloma; Plasmacytoma; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
Measuring the "unmeasurable": assessment of bone marrow response to therapy using FDG-PET in patients with lymphoma.
Topics: Bone Marrow; Bone Marrow Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Treatment Outcome | 2010 |
The prevalence and clinical significance of (18) F-2-fluoro-2-deoxy-D-glucose (FDG) uptake in the thyroid gland on PET or PET-CT in patients with lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Neoplasm Staging; Outcome Assessment, Health Care; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Thyroid Gland; Thyroid Neoplasms; Tomography, X-Ray Computed | 2011 |
18[F]FDG small animal PET study of sorafenib efficacy in lymphoma preclinical models.
Topics: Animals; Antineoplastic Agents; Benzenesulfonates; Cell Line, Tumor; Drug Evaluation, Preclinical; Fluorodeoxyglucose F18; Humans; Lymphoma; Mice; Niacinamide; Phenylurea Compounds; Positron-Emission Tomography; Prognosis; Pyridines; Radiopharmaceuticals; Sorafenib; Treatment Outcome | 2010 |
Small-animal PET/CT for monitoring the development and response to chemotherapy of thymic lymphoma in Trp53-/- mice.
Topics: Aging; Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Cell Proliferation; Deoxycytidine; Disease Progression; Fluorodeoxyglucose F18; Gemcitabine; Image Processing, Computer-Assisted; Lymphoma; Mice; Mice, Knockout; Mitotic Index; Positron-Emission Tomography; Radiopharmaceuticals; Thymus Neoplasms; Tomography, Emission-Computed; Tumor Suppressor Protein p53 | 2010 |
Splenic sclerosing haemangioma causes false-positive finding at FDG-PET.
Topics: Adult; False Positive Reactions; Female; Fluorodeoxyglucose F18; Histiocytoma, Benign Fibrous; Humans; Lymphoma; Positron-Emission Tomography; Splenectomy; Splenic Diseases; Tomography, X-Ray Computed | 2010 |
Clinical analysis of thymic regrowth following chemotherapy in children and adolescents with malignant lymphoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Disease-Free Survival; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphoma; Male; Positron-Emission Tomography; Radiopharmaceuticals; Thymus Gland; Time Factors; Tomography, X-Ray Computed | 2010 |
F-18 FDG PET/CT in primary tonsillar lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed; Tonsillar Neoplasms | 2010 |
[Application of SPECT/PET in patients with lymphoma and its significance in monitoring relapse].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Tomography, Emission-Computed, Single-Photon; Young Adult | 2010 |
The management of pyothorax-associated lymphoma using 18F-FDG PET/CT.
Topics: Aged; Aged, 80 and over; Biological Transport; Empyema, Pleural; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma; Male; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
Methodological issues in the evaluation of FDG PET/CT accuracy in pediatric lymphoma.
Topics: Child; Fluorodeoxyglucose F18; Humans; Lymphoma; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2010 |
Diffuse FDG renal uptake in lymphoma.
Topics: Aged; Biological Transport; Diffusion; Fluorodeoxyglucose F18; Humans; Kidney; Lymphoma; Male; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
F-18 FDG PET/CT findings in two patients with pyothorax-associated lymphoma.
Topics: Aged, 80 and over; Empyema, Pleural; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
18F-FDG PET/CT in paediatric lymphoma: comparison with conventional imaging.
Topics: Adolescent; Child; Child, Preschool; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
[The role of PET imaging in patients with lymphoma].
Topics: Antineoplastic Agents; Disease Progression; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphoma; Neoplasm Staging; Neoplasm, Residual; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2010 |
Interesting image. Dermatopathic lymphadenitis: a pitfall for lymphoma evaluation by F-18 FDG PET/CT.
Topics: Child; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphadenitis; Lymphoma; Male; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
Interesting image. Assessment of plasmablastic lymphoma by F-18 FDG PET/CT: case report.
Topics: Aged; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Plasmacytoma; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
Incidental carcinomas detected by PET/CT scans in patients with malignant lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Incidence; Incidental Findings; Lymphoma; Male; Middle Aged; Neoplasms, Second Primary; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2010 |
Comparison of 11C-methionine PET and 18F-FDG PET in patients with primary central nervous system lymphoma.
Topics: Aged; Aged, 80 and over; Carbon Radioisotopes; Central Nervous System Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Linear Models; Lymphoma; Male; Methionine; Middle Aged; Positron-Emission Tomography; Radiography | 2011 |
Diagnostic value of CT, PET and combined PET/CT performed with low-dose unenhanced CT and full-dose enhanced CT in the initial staging of lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Contrast Media; Diatrizoate Meglumine; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiation Dosage; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2011 |
Lymph node uptake of 18F-fluorodeoxyglucose detected with positron emission tomography/computed tomography mimicking malignant lymphoma in a patient with Kikuchi disease.
Topics: Adolescent; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Histiocytic Necrotizing Lymphadenitis; Humans; Lymph Nodes; Lymphoma; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2010 |
Intraocular lymphoma and central nervous system lymphoma involving the hypothalamus: staging and evaluation of response to therapy with F-18 FDG PET/CT.
Topics: Aged; Eye Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Hypothalamic Neoplasms; Lymphoma; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
F-18 FDG PET/CT for detection of malignant involvement of peripheral nerves: case series and literature review.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Peripheral Nervous System Neoplasms; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2011 |
F-18 FDG avid primary CNS lymphoma located in the ventricles.
Topics: Biological Transport; Cerebral Ventricle Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
[Application of SPECT/PET to 70 patients with lymphoma: monitoring response to therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; Humans; Lymphoma; Prognosis; Retrospective Studies; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2010 |
FDG PET/CT imaging suggests lymphoma involving prostate may be more resistant to treatment.
Topics: Drug Resistance, Neoplasm; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Prostate; Tomography, X-Ray Computed | 2011 |
PET and PET/CT in the management of thyroid cancer.
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymphoma; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Gland; Thyroid Neoplasms | 2011 |
Newly diagnosed lymphoma: initial results with whole-body T1-weighted, STIR, and diffusion-weighted MRI compared with 18F-FDG PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
Role of PET/CT screening in detecting a second primary carcinoma in patients with malignant lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Middle Aged; Multimodal Imaging; Neoplasms, Second Primary; Positron-Emission Tomography; Tomography, X-Ray Computed; Young Adult | 2011 |
F-18 FDG PET/CT imaging of solitary genital tuberculosis mimicking recurrent lymphoma.
Topics: Aged; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed; Tuberculosis, Male Genital | 2011 |
Value of FDG-PET/CT using unfractionated heparin for managing primary cardiac lymphoma and several key findings.
Topics: Aged; Anticoagulants; Female; Fluorodeoxyglucose F18; Heart Neoplasms; Heparin; Humans; Lymphoma; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed | 2011 |
Does adding FDG-PET to MRI improve the differentiation between primary cerebral lymphoma and glioblastoma? Observer performance study.
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Diagnosis, Differential; Diffusion; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Observer Variation; Positron-Emission Tomography; ROC Curve | 2011 |
Radiologists urge FDA to accept PET-based tumor response criteria in clinical trials.
Topics: Biomarkers, Tumor; Clinical Trials as Topic; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma; Molecular Targeted Therapy; Neoplasms; Nuclear Medicine; Positron-Emission Tomography; Radiopharmaceuticals; Treatment Outcome; United States; United States Food and Drug Administration; Workforce | 2011 |
Whole-body diffusion-weighted imaging compared with FDG-PET/CT in staging of lymphoma patients.
Topics: Adolescent; Adult; Aged; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphoma; Male; Middle Aged; Neoplasm Staging; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Whole Body Imaging; Young Adult | 2011 |
Role of limited whole-body PET/CT in pediatric lymphoma.
Topics: Adolescent; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma; Male; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Tomography, X-Ray Computed; Whole Body Imaging; Young Adult | 2011 |
Role of routine imaging in lymphoma.
Topics: Clinical Trials as Topic; Cost-Benefit Analysis; Fluorodeoxyglucose F18; Humans; Lymphoma; Positron-Emission Tomography; Practice Guidelines as Topic; Tomography, X-Ray Computed | 2011 |
Manifestation of lymphoma expansion following lymphatic drainage on 18F-FDG PET/CT.
Topics: Aged; Drainage; Female; Fluorodeoxyglucose F18; Humans; Lymphatic System; Lymphoma; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
Clinical role of FDG PET/CT for methotrexate-related malignant lymphoma.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Radionuclide Imaging; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
F-18 FDG PET/CT as a crucial guide toward optimal treatment planning in a case of postirradiation sarcoma 10 years after primary bone lymphoma of the pelvis.
Topics: Adult; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Pelvic Neoplasms; Positron-Emission Tomography; Sarcoma; Tomography, X-Ray Computed | 2011 |
Quality assessment of fluorodeoxyglucose positron emission tomography imaging in clinical setting: definition of standard quality control parameters for patients treated for lymphoma.
Topics: Calibration; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Quality Control; Reproducibility of Results; Retrospective Studies; Time Factors | 2011 |
Primary cardiac lymphoma detected by 18F-FDG PET scan: a case report.
Topics: Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2011 |
FDG PET/CT in evaluation of pyrexia of unknown origin.
Topics: Adult; Aged; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Sarcoidosis; Still's Disease, Adult-Onset; Thyroiditis, Autoimmune; Tomography, X-Ray Computed | 2011 |
False-positive PET/CT for lymphoma recurrence secondary to Langerhans cell histiocytosis.
Topics: Adult; False Positive Reactions; Fluorodeoxyglucose F18; Histiocytosis, Langerhans-Cell; Humans; Lymphoma; Male; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed | 2011 |
The role of PET and PET/CT in managing the care of lymphoma patients.
Topics: Adult; Citrates; Female; Fluorodeoxyglucose F18; Gallium; Humans; Lymphoma; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Remission Induction; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Positron emission tomography findings in patients with lymphoma-associated haemophagocytic syndrome.
Topics: Aged; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Lymphohistiocytosis, Hemophagocytic; Lymphoma; Male; Middle Aged; Multimodal Imaging; Pancytopenia; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2011 |
Whole-body diffusion-weighted imaging: the added value to whole-body MRI at initial diagnosis of lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Chi-Square Distribution; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Lymphoma; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
Fluorodeoxyglucose positron emission tomography in primary thyroid lymphoma with coexisting lymphocytic thyroiditis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Comorbidity; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Thyroid Neoplasms; Thyroiditis, Autoimmune; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2011 |
Progressive transformation of germinal centers in a pediatric patient: initial evaluation and follow-up with serial F-18 FDG PET/CT imaging.
Topics: Adolescent; Cell Transformation, Neoplastic; DiGeorge Syndrome; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
Underperformance of gallium-67 scan is greater in relapse than in initial staging, compared with FDG PET.
Topics: Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lymphoma; Male; Neoplasm Staging; Positron-Emission Tomography; Recurrence; Whole Body Imaging | 2011 |
[18F-FDG PET/CT in lymphomas: assessment difficulties due to illness characteristics, and comparison with literature data].
Topics: Bone Marrow Neoplasms; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphoma; Muscle Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2011 |
Multimodal imaging with (18)F-FDG PET and Cerenkov luminescence imaging after MLN4924 treatment in a human lymphoma xenograft model.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Transformation, Neoplastic; Cyclopentanes; Female; Fluorodeoxyglucose F18; Humans; Luminescent Measurements; Lymphoma; Mice; Molecular Imaging; Positron-Emission Tomography; Pyrimidines | 2011 |
Improved radiosynthesis of the apoptosis marker 18F-ICMT11 including biological evaluation.
Topics: Animals; Apoptosis; Azides; Biomarkers; Diagnostic Imaging; Disease Models, Animal; Fluorodeoxyglucose F18; Indoles; Isatin; Lymphoma; Mice; Molecular Structure; Positron-Emission Tomography; Radiopharmaceuticals | 2011 |
Age and dose-limited PET-CT scan regime in lymphoma: between the devil and the deep blue sea?
Topics: Adolescent; Adult; Age Factors; Aged; Child; Dose-Response Relationship, Radiation; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Time Factors; Tomography, X-Ray Computed; Young Adult | 2012 |
Intratumoral heterogeneity of F-18 FDG uptake differentiates between gastrointestinal stromal tumors and abdominal malignant lymphomas on PET/CT.
Topics: Abdominal Neoplasms; Biological Transport; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Lymphoma; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
Micro-chemical synthesis of molecular probes on an electronic microfluidic device.
Topics: Animals; Chromatography, Thin Layer; Electronics; Electrowetting; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Halogenation; Humans; Lymphoma; Mice; Mice, SCID; Microchemistry; Microfluidic Analytical Techniques; Molecular Probes; Positron-Emission Tomography; Quality Control; Tissue Distribution; Tomography, X-Ray Computed; Xenograft Model Antitumor Assays | 2012 |
Differential diagnosis of primary nasopharyngeal lymphoma and nasopharyngeal carcinoma focusing on CT, MRI, and PET/CT.
Topics: Adolescent; Adult; Aged; Carcinoma; Child; Contrast Media; Cross-Sectional Studies; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
Fluorodeoxyglucose PET/CT in subcutaneous sarcoidosis mimicking cutaneous lymphoma.
Topics: Adult; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Multimodal Imaging; Positron-Emission Tomography; Sarcoidosis; Skin Neoplasms; Tomography, X-Ray Computed | 2012 |
Relation between FDG uptake and apparent diffusion coefficients in glioma and malignant lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biological Transport; Child; Diagnosis, Differential; Diffusion; Female; Fluorodeoxyglucose F18; Glioma; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Grading; Observer Variation; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2012 |
Semi-automatic analysis of standard uptake values in serial PET/CT studies in patients with lung cancer and lymphoma.
Topics: Algorithms; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lung Neoplasms; Lymphoma; Male; Metabolic Clearance Rate; Middle Aged; Pattern Recognition, Automated; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2012 |
[Importance of PET/CT in lymphoma diagnostics].
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Outcome Assessment, Health Care; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Investigation of dose minimisation protocol for 18F-FDG PET-CT in the management of lymphoma postchemotherapy followup.
Topics: Antineoplastic Agents; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma; Multimodal Imaging; Positron-Emission Tomography; Radiation Dosage; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
[Malignant lymphoma presenting as inflammation of unknown origin].
Topics: Aged; Aged, 80 and over; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
[The role of PET-CT in detecting unknown primary tumour in patients with cervical lymph node metastases].
Topics: Adult; Aged; Carcinoma; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Lymphoma; Male; Melanoma; Middle Aged; Multimodal Imaging; Neck; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
Chronic HIV-1 infection mimicking splenic malignant lymphoma on F-18 FDG-PET/CT.
Topics: Fluorodeoxyglucose F18; HIV Infections; Humans; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Radiography; Spleen; Splenic Neoplasms | 2012 |
Conversion from FDG-negative to -positive during follow-up in a rare case of pulmonary lymphoepithelioma-like carcinoma.
Topics: Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymphoma; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
18F-FDG uptake in diffuse peritoneal lymphomatosis.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Lymphoma; Peritoneal Neoplasms; Peritoneum; Radionuclide Imaging; Tomography, X-Ray Computed | 2012 |
Dual-time-point F-18 FDG PET/CT for evaluation in patients with malignant lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Time Factors; Tomography, X-Ray Computed | 2012 |
[Contingent diagnosis of sarcoidosis by 18F-fluorodeoxyglucose-positron emission tomography (FDG-PET) after completion of chemotherapy for malignant lymphoma].
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2012 |
Differentiating primary CNS lymphoma from glioblastoma multiforme: assessment using arterial spin labeling, diffusion-weighted imaging, and ¹⁸F-fluorodeoxyglucose positron emission tomography.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain Neoplasms; Child; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Spin Labels; Young Adult | 2013 |
False positive spinal cord uptake on fluorodeoxyglucose positron-emission tomography following treatment of lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy; Spinal Cord; Young Adult | 2012 |
PET/MR for therapy response evaluation in malignant lymphoma: initial experience.
Topics: Adolescent; Adult; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
The role of FDG-PET and bone marrow examination in lymphoma staging.
Topics: Biopsy; Bone Marrow; Bone Marrow Examination; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed | 2012 |
FDG-PET/CT findings of peritoneal lymphomatosis.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Lymphoma, B-Cell; Male; Middle Aged; Multimodal Imaging; Peritoneal Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
Primary cardiac lymphoma: echocardiography and F-18-fluorodeoxyglucose positron emission tomography in selection of a biopsy site.
Topics: Echocardiography; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Image-Guided Biopsy; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2013 |
[Clinical diagnostic imaging (including FDG-PET/CT)].
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Multiple Myeloma; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
Dual-time-point F-18 FDG PET/CT imaging for differentiating the lymph nodes between malignant lymphoma and benign lesions.
Topics: Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphoma; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies; ROC Curve; Time Factors; Tomography, X-Ray Computed | 2013 |
Apoptosis imaging probe predicts early chemotherapy response in preclinical models: A comparative study with 18F-FDG PET.
Topics: Animals; Apoptosis; Biological Transport; Cell Line, Tumor; Female; Fluorodeoxyglucose F18; Lymphoma; Melanoma, Experimental; Mice; Oligopeptides; Organotechnetium Compounds; Peptides; Positron-Emission Tomography; Time Factors; Treatment Outcome; Tumor Burden | 2013 |
The role of FDG-PET scanning in assessing lymphoma in 2012.
Topics: Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; France; Hodgkin Disease; Humans; Immunotherapy; Lymphoma; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
[Clinical values of 18F-FDG PET in lymphoma].
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Positron-Emission Tomography | 2012 |
Staging and monitoring in the treatment of lymphomas.
Topics: Biopsy; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Image-Guided Biopsy; Interdisciplinary Communication; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Multimodal Imaging; Neoplasm Staging; Neoplasm, Residual; Radiography; Radionuclide Imaging; Treatment Outcome | 2013 |
The combination of 13N-ammonia and 18F-FDG in predicting primary central nervous system lymphomas in immunocompetent patients.
Topics: Adult; Aged; Ammonia; Central Nervous System Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Immunocompetence; Lymphoma; Male; Middle Aged; Multimodal Imaging; Nitrogen Radioisotopes; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2013 |
[Usefulness and limitation of FDG-PET in the diagnosis of primary central nervous system lymphoma].
Topics: Aged; Aged, 80 and over; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2013 |
[False positive (18)F-FDG PET/CT uptake by fat necrosis during chemotherapy for malignant lymphoma].
Topics: Adult; False Positive Reactions; Fat Necrosis; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Radionuclide Imaging; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
[F-18 fluorodeoxyglucose positron emission tomography in malignant lymphoma].
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Neoplasm Staging; Neoplasm, Residual; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome | 2002 |
Advantages of positron emission tomography (PET) with respect to computed tomography in the follow-up of lymphoma patients with abdominal presentation.
Topics: Abdominal Neoplasms; Adolescent; Adult; Aged; Aged, 80 and over; Cohort Studies; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma; Male; Middle Aged; Neoplasm, Residual; Radiopharmaceuticals; Recurrence; Remission Induction; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 2002 |
[(18)F]FDG in childhood lymphoma: clinical utility and impact on management.
Topics: Adult; Age Factors; Child; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
Simultaneous occurrence of Hodgkin's lymphoma and eosinophilic granuloma: a potential pitfall in positron emission tomography imaging.
Topics: Adult; Eosinophilic Granuloma; Eosinophils; Fluorodeoxyglucose F18; Histiocytosis, Langerhans-Cell; Hodgkin Disease; Humans; Islets of Langerhans; Lymphoma; Male; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
[Valence of F-18-FDG-PET in the diagnosis of malignant lymphoma].
Topics: Blood Glucose; Energy Metabolism; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphoma; Neoplasm Staging; Prognosis; Tomography, Emission-Computed | 2002 |
Prognostic value of pretransplantation positron emission tomography using fluorine 18-fluorodeoxyglucose in patients with aggressive lymphoma treated with high-dose chemotherapy and stem cell transplantation.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Middle Aged; Patient Selection; Prognosis; Retrospective Studies; Salvage Therapy; Survival Analysis; Tomography, Emission-Computed; Treatment Outcome | 2003 |
Accuracy of whole-body 18F-FDP-PET for restaging malignant lymphoma.
Topics: Adolescent; Adult; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymph Nodes; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Tissue Distribution; Tomography, Emission-Computed | 2003 |
Right atrial tumor and sick sinus syndrome.
Topics: Aged; Aged, 80 and over; Cardiac Pacing, Artificial; Electrocardiography; Fatal Outcome; Female; Fluorodeoxyglucose F18; Heart Atria; Heart Neoplasms; Humans; Lymphoma; Radiopharmaceuticals; Sick Sinus Syndrome; Tomography, Emission-Computed | 2003 |
18F-FDG PET versus CT for evaluating the spleen during initial staging of lymphoma.
Topics: Adolescent; Adult; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Single-Blind Method; Spleen; Splenic Neoplasms; Tomography, Emission-Computed; Tomography, Spiral Computed | 2003 |
Value of F-18 fluorodeoxyglucose positron emission tomography for predicting the clinical outcome of patients with aggressive lymphoma prior to and after autologous stem-cell transplantation.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Predictive Value of Tests; Salvage Therapy; Stem Cell Transplantation; Tomography, Emission-Computed | 2003 |
Predictive value of early 18F-fluoro-deoxyglucose positron emission tomography in chemosensitive relapsed lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Recurrence; Stem Cell Transplantation; Survival Analysis; Tomography, Emission-Computed; Treatment Outcome | 2003 |
18F-fluorodeoxyglucose-positron emission tomography in the staging of malignant lymphoma compared with CT and 67Ga scan.
Topics: Adult; Aged; Aged, 80 and over; Bone and Bones; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lymph Nodes; Lymphoma; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Dynamic infrared imaging of newly diagnosed malignant lymphoma compared with Gallium-67 and Fluorine-18 fluorodeoxyglucose (FDG) positron emission tomography.
Topics: Adult; Diagnostic Imaging; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Infrared Rays; Lymphoma; Male; Middle Aged; Temperature; Tomography, Emission-Computed | 2003 |
[The role of positron emission tomography with C18-Fluorodeoxyglucose in clinical oncology].
Topics: Brain Neoplasms; Breast Neoplasms; Carbon Radioisotopes; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphoma; Male; Medical Oncology; Neoplasms; Outcome Assessment, Health Care; Pancreatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Testicular Neoplasms; Tomography, Emission-Computed | 2003 |
Abnormal FDG PET imaging in tuberculosis appearing like lymphoma.
Topics: Antitubercular Agents; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphoma; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed; Tuberculosis, Lymph Node | 2004 |
[The clinical application of 18F-fluorodeoxyglucose coincidence imaging in lymphoma].
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Magnetic Resonance Angiography; Male; Middle Aged; Phantoms, Imaging; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed | 2004 |
Iatrogenic artifacts on whole-body F-18 FDG PET imaging.
Topics: Adult; Artifacts; Breast Neoplasms; Catheterization; Catheters, Indwelling; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Intubation; Lung Neoplasms; Lymphoma; Male; Middle Aged; Ostomy; Prostheses and Implants; Radiopharmaceuticals; Tomography, Emission-Computed; Whole-Body Counting | 2004 |
Can[18F] fluorodeoxyglucose positron emission tomography replace bone marrow biopsy in staging of malignant lymphoma?
Topics: Biopsy; Bone Marrow; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Magnetic Resonance Imaging; Middle Aged; Neoplasm Staging; Radiopharmaceuticals | 2004 |
[PET/CT in lymphoma patients].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Artifacts; Child; Child, Preschool; Equipment Design; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Image Enhancement; Image Processing, Computer-Assisted; Lymphoma; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2004 |
18F-FDG PET for evaluation of the treatment response in patients with gastrointestinal tract lymphomas.
Topics: Adult; Aged; Antineoplastic Agents; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Lymphoma; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome | 2004 |
PET imaging with F-18 fluorodeoxyglucose for primary lymphoma of bone.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Doxorubicin; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prednisone; Prognosis; Radiopharmaceuticals; Treatment Outcome; Vincristine | 2005 |
18F-FDG PET early after radiotherapy in lymphoma patients.
Topics: Adult; False Positive Reactions; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Inflammation; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2004 |
Direct comparison of 18F-fluorodeoxyglucose coincidence gamma camera tomography with gallium scanning for the staging of lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lymphoma; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies | 2005 |
18F-FDG PET in malignant lymphoma: significance of positive findings.
Topics: Adolescent; Adult; Aged; False Positive Reactions; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Time Factors; Treatment Outcome | 2005 |
Imaging: staging and evaluation of lymphoma using nuclear medicine.
Topics: Bone Marrow Neoplasms; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lymphoma; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2005 |
FDG uptake in a catheter-related thrombus simulating relapse of lymphoma.
Topics: Adolescent; Catheterization; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Venous Thrombosis | 2005 |
Role of positron emission tomography in lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Positron-Emission Tomography | 2005 |
Clinical impact of whole-body FDG-PET for evaluation of response and therapeutic decision-making of primary lymphoma of bone.
Topics: Adult; Aged; Bone Neoplasms; Decision Making; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Outcome; Whole-Body Counting | 2005 |
[PET in lymphomas: a pattern for the treatment at measure].
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals | 2004 |
Potential pitfalls of 18F-FDG PET in a large series of patients treated for malignant lymphoma: prevalence and scan interpretation.
Topics: Artifacts; Diagnostic Errors; Fluorodeoxyglucose F18; Humans; Lymphoma; Observer Variation; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome | 2005 |
Role of PET in lymphoma.
Topics: Amino Acids; Bone Marrow; Cell Proliferation; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lymphoma; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2005 |
FDG-PET in immunocompetent patients with primary central nervous system lymphoma: correlation with MRI and clinical follow-up.
Topics: Aged; Central Nervous System Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Treatment Outcome | 2006 |
Variable problems in lymphomas: CASE 2. Sarcoidosis mimicking progressive lymphoma.
Topics: Diagnosis, Differential; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis, Pulmonary; Tomography, X-Ray Computed | 2005 |
Direct comparison of FDG PET and CT findings in patients with lymphoma: initial experience.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphoma; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2005 |
Primary skeletal muscle marginal zone lymphoma with persistent tissue tropism and PET-avidity.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Muscle Neoplasms; Muscle, Skeletal; Positron-Emission Tomography; Prednisone; Recurrence; Remission Induction; Sensitivity and Specificity; Vincristine | 2006 |
Guess the diagnosis. Lymphoma or sarcoidosis.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphoma; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Subtraction Technique; Tomography, X-Ray Computed; Whole Body Imaging | 2005 |
Can [18F]fluorodeoxyglucose positron emission tomography imaging complement biopsy results from the iliac crest for the detection of bone marrow involvement in patients with malignant lymphoma?
Topics: Biopsy, Needle; Bone Marrow; Female; Fluorodeoxyglucose F18; Humans; Ilium; Lymphoma; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity | 2006 |
Recurrence of lymphoma presenting as asymmetrically increased testicular activity on FDG-PET/CT.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Testicular Neoplasms; Tomography, X-Ray Computed | 2006 |
Quantitative CT analysis for assessing response in lymphoma (Cheson's criteria).
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Thoracic Neoplasms; Tomography, X-Ray Computed | 2005 |
MRI and PET in monitoring response in lymphoma.
Topics: Contrast Media; Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2005 |
The clinical role of CT/PET in oncology: an update.
Topics: Colonic Neoplasms; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Melanoma; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Radiation Oncology; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2005 |
FDG PET in primary effusion lymphoma (PEL) of the pericardium.
Topics: Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Lymphoma; Male; Middle Aged; Pericardial Effusion; Pericardium; Positron-Emission Tomography; Radiopharmaceuticals | 2006 |
The place of positron emission tomography imaging in the management of patients with malignant lymphoma.
Topics: Disease Management; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Positron-Emission Tomography | 2006 |
Diagnostic role of 18F-FDG PET in gastric MALT lymphoma.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Remission Induction; Retrospective Studies; Stomach Neoplasms; Time Factors | 2006 |
Changing PET/CT manifestation of neurolymphomatosis.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed; Whole Body Imaging | 2006 |
Discordant response to chemotherapy: an unusual pattern of fluoro-deoxy-D-glucose uptake in heavily pre-treated lymphoma patients.
Topics: Adult; Aged; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Remission Induction; Time Factors | 2006 |
Diagnostic value of kinetic analysis using dynamic FDG PET in immunocompetent patients with primary CNS lymphoma.
Topics: Adult; Brain Neoplasms; Computer Simulation; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Immunocompetence; Kinetics; Lymphoma; Male; Middle Aged; Models, Biological; Positron-Emission Tomography; Radiopharmaceuticals | 2007 |
Combined increased and decreased skeletal uptake of F-18 FDG.
Topics: Bone and Bones; Bone Marrow; Bone Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Thoracic Vertebrae; Tomography, X-Ray Computed | 2006 |
[Use of PET for evaluation of treatment response in oncology].
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Treatment Outcome | 2006 |
Bone involvement in patients with lymphoma: the role of FDG-PET/CT.
Topics: Adolescent; Adult; Bone Marrow Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2007 |
Unsuspected FDG-PET findings in the follow-up of patients with lymphoma.
Topics: Aged; Biopsy; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Incidental Findings; Infections; Lymphoma; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Second Primary; Positron-Emission Tomography; Recurrence; Retrospective Studies | 2007 |
Positron emission tomography/computed tomography: diagnostic accuracy in lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Bone Marrow; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2006 |
The incremental value of 18F-FDG PET/CT in paediatric malignancies.
Topics: Adolescent; Adult; Child; Child, Preschool; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2007 |
The evolving role of fluorodeoxyglucose positron emission tomography (FDG PET) in lymphoma: how do we reconcile conflicting results in the era of evidence-based medicine?
Topics: Evidence-Based Medicine; Fluorodeoxyglucose F18; Humans; Lymphoma; Positron-Emission Tomography; Radiopharmaceuticals; Research Design | 2006 |
18F-FDG PET in mucosa-associated lymphoid tissue (MALT) lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphoma; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2006 |
Molecular imaging of proliferation in malignant lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Cell Growth Processes; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tissue Distribution | 2006 |
FDG PET/CT flip flop phenomenon in treated lymphoma of bone.
Topics: Antineoplastic Agents; Bone Marrow Neoplasms; Bone Neoplasms; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed | 2006 |
Ga-67 SPECT: ave atque vale! Or have we bid a premature farewell to a trusted friend?
Topics: Bone and Bones; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Image Processing, Computer-Assisted; Lymphoma; Male; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2006 |
Prognostic value of early 18 fluorodeoxyglucose positron emission tomography and gallium-67 scintigraphy in aggressive lymphoma: a prospective comparative study.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2006 |
Hypermetabolic change as a possible predictive sign of a relapsed central nervous system lymphoma.
Topics: Central Nervous System Neoplasms; Dysarthria; Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiography; Recurrence | 2007 |
FDG PET/CT for assessing therapy response in primary thyroid lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2007 |
Anatomical accuracy of interactive and automated rigid registration between X-ray CT and FDG-PET.
Topics: Adolescent; Adult; Aged; Automation; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Melanoma; Middle Aged; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Cost-effective therapy remission assessment in lymphoma patients using 2-[fluorine-18]fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography: is an end of treatment exam necessary in all patients?
Topics: Adolescent; Adult; Aged; Child; Cost-Benefit Analysis; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2007 |
Cervical and axillary lymph node sarcoidosis misdiagnosed as lymphoma on F-18 FDG PET-CT.
Topics: Axilla; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphoma; Middle Aged; Neck; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Tomography, Emission-Computed | 2007 |
Potential clinical role of fluorodeoxyglucose-positron emission tomography in assessing primary or secondary lymphomas of the parotid gland.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Parotid Neoplasms; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 2007 |
New guidelines for response in malignant lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Positron-Emission Tomography; Practice Guidelines as Topic; Radiopharmaceuticals; Treatment Outcome | 2007 |
(18)F-FDG-PET-facilitated diagnosis of lymphoma presenting with fever of unknown origin and cold agglutination.
Topics: Aged; Agglutination; Cold Temperature; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Lymphoma; Tomography, Emission-Computed | 2007 |
Comparison of (18)F Flurodeoxyglucose PET with Ga-67 scintigraphy and conventional imaging modalities in pediatric lymphoma.
Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Radionuclide Imaging; Tomography, X-Ray Computed | 2007 |
Functional diagnosis of residual lymphomas after radiochemotherapy with positron emission tomography comparing FDG- and FLT-PET.
Topics: Adolescent; Adult; Aged; Combined Modality Therapy; Dideoxynucleosides; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Neoplasm, Residual; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals | 2007 |
NCCN task force report: positron emission tomography (PET)/computed tomography (CT) scanning in cancer.
Topics: Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphoma; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed | 2007 |
The impact of pre- and post-transplantation positron emission tomography using 18-fluorodeoxyglucose on poor-prognosis lymphoma patients undergoing autologous stem cell transplantation.
Topics: Adult; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Stem Cell Transplantation; Survival Analysis; Transplantation, Autologous | 2007 |
Nonossifying fibroma can mimic residual lymphoma in FDG PET: additional value of combined PET/CT.
Topics: Antineoplastic Agents; Child; Diagnosis, Differential; False Positive Reactions; Female; Femoral Neoplasms; Fibroma; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Image Enhancement; Lymphoma; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed | 2007 |
Kikuchi Disease Mimicking Malignant Lymphoma on FDG PET/CT.
Topics: Child; Female; Fluorodeoxyglucose F18; Histiocytic Necrotizing Lymphadenitis; Humans; Lymph Nodes; Lymphoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2007 |
FDG-PET is useful in staging and follow-up of primary uterine cervical lymphoma.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2007 |
FDG PET in lymphoma: the need for standardization of interpretation. An observer variation study.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Netherlands; Observer Variation; Physicians; Positron-Emission Tomography; Professional Competence; Radiopharmaceuticals; Reference Standards; Reproducibility of Results; Sensitivity and Specificity | 2007 |
FDG-PET interpretation in tonsillar lymphoma.
Topics: Adult; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Tonsillar Neoplasms | 2007 |
Primary duodenal lymphoma: successful rituximab treatment and evaluation by FDG-PET.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Duodenal Neoplasms; Endoscopy; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Helicobacter pylori; Humans; Lymph Nodes; Lymphatic Metastasis; Lymphoma; Magnetic Resonance Imaging; Positron-Emission Tomography; Radionuclide Imaging; Rituximab; Time Factors | 2007 |
[Comparison of 18F-FDG coincidence SPECT imaging and computed tomography in the initial staging and therapeutic evaluation of lymphomas].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Diagnosis, Differential; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Radiopharmaceuticals; Remission Induction; Retrospective Studies; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2007 |
Utility of sonographically guided biopsy in metabolically suspected recurrent lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography, Interventional | 2008 |
Incidental detection of Helicobacter pylori gastritis during FDG PET scanning for lymphoma.
Topics: Adult; Fluorodeoxyglucose F18; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Incidental Findings; Lymphoma; Male; Radionuclide Imaging; Radiopharmaceuticals | 2008 |
Conventional allogeneic hematopoietic stem cell transplantation for lymphoma may overcome the poor prognosis associated with a positive FDG-PET scan before transplantation.
Topics: Adult; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Retrospective Studies; Salvage Therapy; Transplantation, Homologous; Treatment Outcome | 2008 |
Restaging of patients with lymphoma. Comparison of low dose CT (20 mAs) with contrast enhanced diagnostic CT in combined [18F]-FDG PET/CT.
Topics: Aorta, Abdominal; Dose-Response Relationship, Radiation; Fluorodeoxyglucose F18; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
The utility of body FDG PET in staging primary central nervous system lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Central Nervous System Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography | 2008 |
FDG-PET on the trail of an unsuspected primary malignancy in the breast.
Topics: Adenocarcinoma; Biopsy; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Middle Aged; Positron-Emission Tomography; Radiography; Radiopharmaceuticals | 2008 |
Primary splenic lymphoma detected by F-18 FDG PET.
Topics: Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Laparoscopy; Lymphoma; Radionuclide Imaging; Radiopharmaceuticals; Splenectomy; Splenic Neoplasms | 2008 |
Pulmonary drug toxicity: FDG-PET findings in patients with lymphoma.
Topics: Adult; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug-Related Side Effects and Adverse Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Thorax; Tomography, X-Ray Computed | 2008 |
FDG avidity and PET/CT patterns in primary gastric lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tissue Distribution; Tomography, X-Ray Computed | 2008 |
Determination of whole-body metabolic burden as a quantitative measure of disease activity in lymphoma: a novel approach with fluorodeoxyglucose-PET.
Topics: Adult; Aged; Algorithms; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lymphoma; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Severity of Illness Index; Tissue Distribution; Whole Body Imaging | 2008 |
FDG PET/CT findings in acute adult mononucleosis mimicking malignant lymphoma.
Topics: Acute Disease; Bone Marrow Examination; Diagnosis, Differential; Epstein-Barr Virus Infections; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Infectious Mononucleosis; Lymph Nodes; Lymphoma; Male; Middle Aged; Positron-Emission Tomography | 2008 |
Extrapancreatic F-18 FDG accumulation in autoimmune pancreatitis.
Topics: Aged; Autoimmune Diseases; Cholangiopancreatography, Magnetic Resonance; Diagnosis, Differential; Fibrosis; Fluorodeoxyglucose F18; Humans; Immunoglobulin G; Immunohistochemistry; Lymphoma; Male; Neoplasm Metastasis; Pancreatitis; Positron-Emission Tomography; Radiopharmaceuticals; Salivary Gland Neoplasms; Submandibular Gland; Tomography, X-Ray Computed | 2008 |
FDG-PET for predicting the prognosis of malignant lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Head and Neck Neoplasms; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Middle Aged; Prognosis; Proportional Hazards Models; Survival Rate; Tomography, Emission-Computed | 1994 |
Neoplasms in a pediatric population: 2-[F-18]-fluoro-2-deoxy-D-glucose PET studies.
Topics: Adolescent; Child; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Infant; Lymphoma; Neoplasms; Neuroblastoma; Sarcoma, Ewing; Tomography, Emission-Computed | 1995 |
Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis.
Topics: Adult; Deoxyglucose; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Diseases; Lymphoma; Male; Middle Aged; Sarcoidosis; Sensitivity and Specificity; Tomography, Emission-Computed | 1994 |
Is there a role for FDG PET imaging in the management of patients with sarcoidosis?
Topics: Citrates; Citric Acid; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lymph Nodes; Lymphoma; Sarcoidosis; Sarcoidosis, Pulmonary; Sensitivity and Specificity; Tomography, Emission-Computed | 1994 |
Cancer or inflammation? A Holy Grail for nuclear medicine.
Topics: Citrates; Citric Acid; Deoxyglucose; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Inflammation; Lymphoma; Neoplasms; Sarcoidosis; Sensitivity and Specificity; Tomography, Emission-Computed | 1994 |
In vivo effects of insulin on tumor and skeletal muscle glucose metabolism in patients with lymphoma.
Topics: Adult; Aged; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Glucose Clamp Technique; Hodgkin Disease; Humans; Insulin; Insulin Resistance; Lymphoma; Male; Middle Aged; Muscles; Tomography, Emission-Computed | 1994 |
Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose: correlation with CT.
Topics: Adolescent; Adult; Aged; Deoxyglucose; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Male; Middle Aged; Prospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1994 |
Somatostatin receptor scintigraphy in malignant lymphoma: first results and comparison with glucose metabolism measured by positron-emission tomography.
Topics: Adult; Biomarkers, Tumor; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Granuloma; Hodgkin Disease; Humans; Hyperplasia; Indium Radioisotopes; Lymph Nodes; Lymphoma; Lymphoma, Non-Hodgkin; Male; Octreotide; Pentetic Acid; Plasmacytoma; Receptors, Somatostatin; Tomography, Emission-Computed | 1993 |
FDG-PET screening for cerebral metastases in patients with suspected malignancy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain Neoplasms; Breast Neoplasms; Child; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma; Male; Melanoma; Middle Aged; Retrospective Studies; Sarcoma; Testicular Neoplasms; Tomography, Emission-Computed | 1996 |
The role of FDG-PET in the preoperative assessment of N-staging in head and neck cancer.
Topics: Carcinoma, Squamous Cell; Cervical Vertebrae; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphoma; Male; Middle Aged; Neoplasm Metastasis; Oropharyngeal Neoplasms; Oropharynx; Retrospective Studies; Spinal Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1996 |
[Cancer screening with whole-body FDG PET].
Topics: Adult; Aged; Aged, 80 and over; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma; Male; Middle Aged; Neoplasms; Prostatic Neoplasms; Tomography, Emission-Computed | 1996 |
Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Contrast Media; Deoxyglucose; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Iodine Radioisotopes; Lymph Nodes; Lymphatic Metastasis; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Radiographic Image Enhancement; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole-Body Counting | 1997 |
Development of oncology protocol using fluorine-18-FDG: one center's experience.
Topics: Blood Glucose; Colonic Neoplasms; Deoxyglucose; Esophageal Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gamma Cameras; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Lymphoma; Neoplasm Staging; Neoplasms; Patient Education as Topic; Practice Guidelines as Topic; Problem Solving; Quality Control; Quality of Health Care; Radiation Oncology; Radiology Information Systems; Radiopharmaceuticals; Rectal Neoplasms; Stomach Neoplasms; Tomography, Emission-Computed | 1997 |
FDG-PET appearance of pelvic Castleman's disease.
Topics: Adult; Castleman Disease; Deoxyglucose; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma; Pelvic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 1997 |
[Comparison of findings with 18-FDG PET and CT in pretherapeutic staging of malignant lymphoma].
Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymph Nodes; Lymphoma; Lymphoma, Non-Hodgkin; Neoplasm Staging; Radiopharmaceuticals; Recurrence; Regression Analysis; Retrospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1997 |
Detection of lymphoma in bone marrow by whole-body positron emission tomography.
Topics: Biopsy; Bone Marrow Diseases; Fluorodeoxyglucose F18; Humans; Lymphoma; Prospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1998 |
[Computerized tomography and F-18-FDG positron emission tomography in staging of malignant lymphomas: a comparison].
Topics: Adolescent; Adult; Age Factors; Aged; Child; Child, Preschool; Evaluation Studies as Topic; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Recurrence; Retrospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1998 |
[Positron emission tomography (PET) and (F-18)-fluorodeoxyglucose in (FDG) in cancerology].
Topics: Digestive System Neoplasms; Female; Fluorodeoxyglucose F18; Glucose; Glycolysis; Humans; Lung Neoplasms; Lymphoma; Male; Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 1998 |
[Clinical value of FDG PET for therapy monitoring of malignant lymphoma--results of a retrospective study in 72 patients].
Topics: Adolescent; Adult; Aged; Biopsy; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; L-Lactate Dehydrogenase; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Monitoring, Physiologic; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
[Efficacy of F-18 fluorodeoxyglucose positron emission tomography (FDG-PET) scans in diagnosis of pulmonary nodules].
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma; Male; Middle Aged; Sensitivity and Specificity; Tomography, Emission-Computed | 1998 |
[Onco-PET: lesion detection by monitor versus standardized film documentation].
Topics: Documentation; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphoma; Neoplasms; Online Systems; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
F-18-FDG positron imaging in oncological patients: gamma camera coincidence detection versus dedicated PET.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Gamma Cameras; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Middle Aged; Neoplasms; Phantoms, Imaging; Radiopharmaceuticals; Recurrence; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
FDG PET can replace bone scintigraphy in primary staging of malignant lymphoma.
Topics: Adolescent; Adult; Aged; Biopsy; Bone and Bones; Bone Marrow; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
Positron emission tomography with 18-fluorodeoxyglucose in the staging and follow-up of lymphoma in the chest.
Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Thoracic Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
[Clinical value of FDG PET using coincident gamma cameras in staging and restaging of malignant lymphoma--compared with convenitonal diagnostic methods].
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Neoplasm, Residual; Predictive Value of Tests; Radiopharmaceuticals; Recurrence; Reproducibility of Results; Retrospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography | 2000 |
Primary staging of lymphomas: cost-effectiveness of FDG-PET versus computed tomography.
Topics: Adolescent; Adult; Aged; Cost-Benefit Analysis; Europe; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
Nodal staging of lymphoma with whole-body PET: comparison of.
Topics: Adult; Aged; Aged, 80 and over; Carbon Radioisotopes; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphoma; Male; Methionine; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
Gallium-67 imaging in lymphoma: tricks of the trade.
Topics: Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lymphoma; Predictive Value of Tests; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2000 |
Effect of N-butylscopolamine on intestinal uptake of fluorine-18-fluorodeoxyglucose in PET imaging of the abdomen.
Topics: Abdomen; Adult; Blood Glucose; Butylscopolammonium Bromide; Data Interpretation, Statistical; Female; Fluorodeoxyglucose F18; Humans; Liver; Lymphoma; Lymphoma, Non-Hodgkin; Male; Parasympatholytics; Radiopharmaceuticals; Tissue Distribution; Tomography, Emission-Computed | 2000 |
Increased metabolic activity in the thymus gland studied with 18F-FDG PET: age dependency and frequency after chemotherapy.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Agents; Child; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphoma; Middle Aged; Neoplasms; Radiopharmaceuticals; Retrospective Studies; Thymus Gland; Thymus Hyperplasia; Thymus Neoplasms; Tomography, Emission-Computed | 2001 |
F-18 FDG uptake in a patient with psoriatic arthritis: imaging correlation with patient symptoms.
Topics: Antineoplastic Agents; Arthritis, Psoriatic; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Severity of Illness Index; Tomography, Emission-Computed | 2001 |
Positron emission tomography and lymphoma therapy.
Topics: Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma; Neoplasm Staging; Neoplasm, Residual; Tomography, Emission-Computed; Treatment Outcome | 2001 |
Comparative somatostatin receptor scintigraphy using in-111-DOTA-lanreotide and in-111-DOTA-Tyr3-octreotide versus F-18-FDG-PET for evaluation of somatostatin receptor-mediated radionuclide therapy.
Topics: Adenocarcinoma; Adult; Carcinoid Tumor; Fluorodeoxyglucose F18; Heterocyclic Compounds; Humans; Intestinal Neoplasms; Ligands; Lung Neoplasms; Lymphoma; Neuroendocrine Tumors; Octreotide; Peptides, Cyclic; Radiopharmaceuticals; Receptors, Somatostatin; Tomography, Emission-Computed; Tyrosine | 2001 |
[FGD PET in a patient with pseudofractures from osteomalacia].
Topics: Adult; Antineoplastic Agents; Bone Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Fractures, Spontaneous; Humans; Hyperparathyroidism; Lymphoma; Male; Neoplasms, Unknown Primary; Osteomalacia; Radiopharmaceuticals; Tissue Distribution; Tomography, Emission-Computed | 2002 |
Positron emission tomography with [18F]2-fluoro-D-2-deoxyglucose (FDG-PET) predicts relapse of malignant lymphoma after high-dose therapy with stem cell transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Etoposide; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Podophyllotoxin; Prognosis; Radiopharmaceuticals; Survival Analysis; Survival Rate; Tomography, Emission-Computed; Transplantation Conditioning; Treatment Outcome; Whole-Body Irradiation | 2002 |
F-18 FDG uptake in congestive splenomegaly.
Topics: Aged; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Radiography; Radiopharmaceuticals; Splenomegaly; Tomography, Emission-Computed | 2002 |
[67-Gallium citrate gammagraphy in the study of lymphomas].
Topics: Citrates; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Gallium; Gallium Radioisotopes; Humans; Lymphoma; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2002 |
FDG PET in the management of lymphoma: a clinical perspective.
Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Neoplasm Staging; Predictive Value of Tests; Radiography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
[Impact of [18F]-FDG-PET on medical decision making in oncology: evaluation by the referring physicians during the opening year].
Topics: Colorectal Neoplasms; Decision Making; Fluorodeoxyglucose F18; France; Health Care Surveys; Lung Neoplasms; Lymphoma; Melanoma; Neoplasms; Otorhinolaryngologic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Surveys and Questionnaires | 2002 |
[Predictive features of positron emission tomography after two cycles of induction therapy in malignant lymphoma].
Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Predictive Value of Tests; Radiopharmaceuticals; Survival Rate; Tomography, Emission-Computed | 2002 |
Studies of primary central nervous system lymphoma with fluorine-18-fluorodeoxyglucose positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Central Nervous System Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Tomography, Emission-Computed | 1992 |
Differential diagnosis of idiopathic fibrosis from malignant lymphadenopathy with PET and F-18 fluorodeoxyglucose.
Topics: Aged; Deoxyglucose; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Peritoneum; Peritonitis; Retroperitoneal Fibrosis; Retroperitoneal Neoplasms; Sclerosis; Tomography, Emission-Computed | 1992 |
Assessment of response to cancer therapy using fluorine-18-fluorodeoxyglucose and positron emission tomography.
Topics: Adult; Aged; Carcinoma, Bronchogenic; Combined Modality Therapy; Deoxyglucose; Esophageal Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Neoplasms; Rectal Neoplasms; Thyroid Neoplasms; Tomography, Emission-Computed | 1991 |
Use of relocatable stereotactic frame to integrate positron emission tomography and computed tomography images: application in human malignant brain tumours.
Topics: Antigens, Surface; Biomarkers, Tumor; Biopsy; Blood Glucose; Brain; Brain Neoplasms; Deoxyglucose; Fluorodeoxyglucose F18; Glioma; Humans; Ki-67 Antigen; Lymphoma; Models, Anatomic; Stereotaxic Techniques; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1990 |
18F-fluorodeoxyglucose imaging in preoperative diagnosis of thyroid malignancy.
Topics: Adenoma; Adult; Aged; Carcinoma; Carcinoma, Papillary; Deoxy Sugars; Deoxyglucose; DNA, Neoplasm; Female; Flow Cytometry; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Ploidies; Radionuclide Imaging; Thyroid Neoplasms | 1988 |
[18F-FDG positron emission tomography in orbital lymphoid tumor].
Topics: Adult; Aged; Deoxyglucose; Fluorodeoxyglucose F18; Humans; Hyperplasia; Lymphatic System; Lymphoma; Male; Middle Aged; Orbital Neoplasms; Tomography, Emission-Computed | 1985 |